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Alongside increased pressure to reduce antimicrobial usage, the UK pig industry is facing 
an imminent ban on therapeutic levels of Zinc oxide. Hence, seeking suitable feeding 
concepts that promote health and prevent disease is of utmost importance for the 
industry’s sustainability and profitability. Prebiotics positively influence gut bacterial 
community composition, thus improve host health and the nutritive value of feedstuffs. 
New-generation prebiotics like xylo-oligosaccharides (XOS) are gaining attention for 
monogastric nutrition. The research in this thesis aimed to determine the effect of XOS, 
with or without alternative additives, on weaner and grower pig growth, bacteria 
modulation and fibre digestibility. In addition, faecal L-lactate concentration and inert 
markers for fibre digestibility analysis were investigated. Results showed XOS had 
limited effects on pig performance but altered ileal bacterial community composition of 
weaner pigs, including beneficial Lactobacillus stimulation. XOS increased ileal 
fermentative activity and non-starch polysaccharide (NSP) digestibility, indicating a 
stimulatory effect on increasing the bacteria’s fibre-degrading capacity. The effects of 
XOS were lost when combined with long-chain inulin, demonstrating incompatibility of 
the products. XOS and fructans increased the faecal digestibility of cellulose and NSPs. 
Furthermore, L-lactate was detected in piglet faeces at low levels, faecal bacteria 
metabolism of L-lactate was rapid, and a handheld device was found to be a suitable real-
time method for L-lactate analysis. Due to ileal fractionation, titanium dioxide (TiO2) was 
shown to be an unsuitable inert marker for NSP digestibility whilst cellulose showed 
realistic initial results, yet further validation is required. TiO2 fractionation was rectified 
at the faecal level, whilst post-ileal degradation rendered cellulose infeasible as a marker 
for total tract NSP digestibility. In conclusion, XOS affected bacterial community 




with a relatively short feeding period being the likely explanation. Further work is 
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Chapter 1  
General introduction 
1.1 United Kingdom (UK) pig industry 
The UK pig industry comprises 5.1 million pigs and produces 922,000 tonnes of pork 
each year with a value of £1.32 billion (DEFRA, 2019). Pig production in the UK consists 
of ~60 % indoor and ~40 % outdoor production, with varying systems in place including 
slatted, partially slatted or straw based accommodation. The volume of animal feed 
supplied to the UK agricultural industry equates to 30.6 million tonnes and has a value of 
£5.5 billion per year (DEFRA, 2019). Of the 13.2 million tonnes of compound feed 
supplied, approximately 2.1 million tonnes are used in the pork supply chain (DEFRA, 
2019). For producers to make a profit in pig farming, the cost to produce each pig must 
be lower than the total amount received for the carcass.  
 
1.2 Challenges in the pig industry  
With the global population forecasted to increase to 9.1 billion people by 2050 and with 
over one-third more mouths to feed, the Food and Agricultural Organisation (FAO) have 
predicted that 70 % more food will need to be produced to meet this demand (FAO, 2009). 
Regarding meat production, this equates to a requirement for an extra 200 million tonnes 
to reach a total of 470 million tonnes by 2050. This heightened demand for human food 
production naturally increases the demand for sustainable raw material supply and feed 
production. Increasing the efficiency in which food is produced is therefore paramount to 
supply this demand. Efficient meat production requires a holistic approach by improving 
a multitude of factors including animal nutrition, biosecurity, on-farm management, 
genetics, animal welfare and animal health. To this point, with feed accounting for up to 
60 % of pig production costs, improving feed efficiency is one of the biggest drivers to 
improve the scale and profitability of the pig industry, particularly with volatile prices. 
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However, maximisation of feed efficiency is only possible in healthy animals, hence 
improving and maintaining the health of production animals is fundamental to sustainable 
pig production.  
 
Antimicrobial drugs are medicines that are active against various infections, including 
those caused by bacteria, fungi, viruses and parasites, and are used in human and 
veterinary medicine to treat and prevent disease (O'Neill, 2016). Historically, 
antimicrobials were routinely included in pig feed as a method of reducing pathogenic 
bacteria and associated disease, thus consequently resulting in improved pig growth 
performance. However, on the 1st January 2006, the use of antibiotics in animal feed for 
non-medicinal growth promoting effects were banned in the European Union (EU). 
Prophylactic or metaphylactic antimicrobial treatment is still common with the intention 
that medication is only administered for a short period of time when there is a risk of an 
infectious outbreak (Barton, 2014). However, overuse or extended use of antimicrobials 
is common in animal production to prevent disease from reoccurring. Overuse of 
antimicrobials is a major driver for the emergence and spread of resistant bacteria, 
consequently threatening the treatment of human and animal infections (Barton, 2014). 
Antimicrobial resistance (AMR) occurs when microorganisms like bacteria survive 
exposure to a medicine that would usually stop their growth or kill them. This therefore 
allows resistant strains to grow and spread due to a lack of competition from other strains, 
which has ultimately led to the emergence of ‘superbugs’ like methicillin-resistant 
Staphylococcus aureus. ‘Superbugs’ are extremely difficult or even impossible to treat 
and claim the lives of 700,000 people each year globally (O'Neill, 2016). Indeed, 
resistance to antimicrobials is a natural process which has been observed since the initial 
discovery of antibiotics, yet AMR is increasing at a worryingly fast rate due to overuse 
of antimicrobials in both human and livestock medicine, with no new drugs for treatment. 
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Moreover, there are environmental concerns regarding residual antimicrobials and AMR 
genes entering the environment via the land application of animal waste, which can 
further contaminate surface and groundwater (Joy et al., 2013). Due to these concerns, 
the agricultural industry is under heightened pressure to reduce the use of antimicrobials. 
Associations in the UK like the Responsible use of medicines in agriculture alliance 
(RUMA) and the Agriculture and Horticulture Development Board (AHDB) are driving 
this change by providing reduction targets, practical strategies to reduce the need for 
antimicrobials and reporting systems to aid the accurate recording of usage. Since this 
task force was launched, great progress has been made in reducing, refining and replacing 
antimicrobials in UK farming, whereby overall sales in 2019 were 50 % lower (31 mg/kg) 
than in 2014 (RUMA, 2020). Despite this, further reductions are required, and the UK 
government has launched a 5-year national action plan to tackle AMR (HM Government, 
2019).  
 
Although great strides forward have been made in antimicrobial reduction, the pig 
industry faces further challenges in maintaining pig health. Weaning is a stressful period 
in a pig’s life. A variety of stressors are responsible including a change in diet 
composition from the sow’s milk to solid feed, internal physiological and immunological 
changes, social changes as well as environmental and bacterial challenges (Campbell, 
J.M. et al., 2013; Kim, J. et al., 2012). The combined effect of these factors makes the 
young pig vulnerable to disease, hence weaning is often associated with infection, 
disease, diarrhoea, high mortality and reduced performance (Bosi et al., 2004). Since the 
antibiotic growth promoter ban in 2006 , the UK pig industry has relied on feeding 
therapeutic levels of Zinc oxide (ZnO; 2500 ppm) for 14 days post-weaning to reduce the 
need for in feed antimicrobials, prevent diarrhoea and improve health and growth. 
However, there are increasing concerns regarding the low absorption of ZnO in the body 
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and its consequent excretion via the faeces (Milani et al., 2017). Concerns therefore relate 
to environmental pollution and its toxic effects on microorganisms and plants via soil 
accumulation, as well as its potential role in bacterial resistance (Gräber et al., 2005; 
Yazdankhah et al., 2014). Due to these concerns, the EU has stated that the use of 
therapeutic ZnO will be phased out by 2022 (EU Commission, 2017), meaning 
alternatives need to be sought. Coupled with the requirement to reduce antimicrobial 
usage, the ZnO ban has increased the demand for alternative feeding concepts to improve 
gut health, enhance disease resistance and support growth performance in pigs.  
 
1.3 Gut health  
The term ‘gut health’ is increasingly used in medical and veterinary literature, as well as 
in the food industry (Bischoff, 2011). This term covers multiple aspects of the gastro-
intestinal tract (GIT), including the effective digestion and absorption of food, a normal 
and stable intestinal microbiome, the absence of GIT illness, effective immune status and 
a state of well-being (Bischoff, 2011). It is however still very unclear exactly what good 
gut health is, how it can be defined and how it can be measured, especially as great 
variation exists in what is considered a normal and healthy GIT (Bischoff, 2011; 
Cummings et al., 2004).  
 
To sustain life, the GIT must function first and foremost as a means of digesting food and 
absorbing nutrients that are vital for maintenance and growth of the host. To enable 
efficient digestion and absorption, the GIT must first breakdown ingested food via 
physical and chemical processes, before transporting luminal nutrients, water and 
electrolytes across the gut wall and into the circulation (Moeser et al., 2017). At the same 
time, large influxes of toxins, antigens and pathogens into the lumen means the gut 
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epithelium is constantly exposed to potential pathogenic components (Moeser et al., 
2017). Hence, the gut wall must act as a barrier to these negative components to prevent 
infectious, inflammatory and functional GIT disease (Bischoff, 2011). Concurrently, 
selective uptake of microbial antigens is important in the development of the mucosal 
immune system (Moeser et al., 2017). Thus, the function of the gut wall is very complex 
and multiple barrier mechanisms exist to enable the GIT to perform such a wide range of 
functions (Moeser et al., 2017).  
 
The GIT bacterial community has been studied for many decades due to its importance 
in the health and wellbeing of animals and is defined as ‘the totality of the microbes, their 
genetic elements and the environmental interactions in a particular environment’ (Kim, 
H B and Isaacson, 2015). The bacterial content of the mammalian GIT consists of ~1014 
bacteria and has a collective genome of 3 million genes, creating a diverse bacterial 
community that has the potential to provide vast biological activities that the host lacks 
(Isaacson and Kim, 2012). The GIT bacterial community maintains a symbiotic 
relationship with the gut mucosa and provides substantial metabolic, immunological and 
protective functions in healthy individuals (Jandhyala et al., 2015). The GIT bacterial 
community ferment substrates that escape endogenous digestion and reach the hindgut, 
whereby fermentation end-products provide 5-20 % of the hosts energy requirement 
(Kim, Hyeun Bum et al., 2011).  Hence, the structure and composition of the bacterial 
community reflects natural selection at two levels; firstly, the host, whereby sub-optimal 
fermentation and functionality of the GIT bacterial community can reduce energy 
provision, host growth and fitness (Bäckhed et al., 2005). Secondly, at the microbial level, 
whereby the growth rate and substrate utilisation efficiency affects the fitness of the 




Before bacterial stability is reached at ~ 5 weeks of age, the GIT bacterial community is 
relatively dynamic and fluid in its response to various factors including time of day, 
microbe exposure, diet, environment and stress (Kim, Hyeun Bum et al., 2011; Thompson 
et al., 2008). For example, animals are born with a lack of a microbial community in the 
GIT, but during birth and thereafter, exposure to microbes increases and a process of 
bacterial succession occurs (Isaacson and Kim, 2012). Succession of bacterial populations 
occurs as the animal ages, with dietary adaptations and as the GIT tract moves to an 
anaerobic state; this succession continues until a relatively stable community is 
established (Isaacson and Kim, 2012). It has been shown that as young broilers grow and 
a stable bacterial community is established, the ability of the bacteria to ferment 
arabinoxylans (AX) increases with age, providing beneficial improvements in 
digestibility and energy provision (Bautil et al., 2019). However, large disruptions in the 
GIT bacterial community can allow pathogenic bacteria to thrive and ultimately cause 
disease, hence the GIT ecosystem is complex and dynamic in phases when the bacterial 
community is not stable.    
 
 
The ability of the bacterial community to change and respond to dietary adaptations has 
gained much attention in the literature for the potential to positively shift the bacterial 
community and metabolic capacity to the benefit of the host. This hypothesis suggests 
that changes in diet should result in bacterial community composition and metabolic 
changes that can improve substrate utilisation and energy provision, inhibit digestive 
diseases, enhance beneficial bacterial balance as well as improving host growth (Kim, H 
B and Isaacson, 2015; Isaacson and Kim, 2012). To this point, the role of many functional 
ingredients and additives have been considered including acids, probiotics, prebiotics, 
enzymes, plant extracts and essential oils. Among others, prebiotics have shown 
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promising results in this area of bacterial community composition and metabolic capacity 
manipulation to improve host growth and health.  
 
1.4 Prebiotics 
In 1995, the prebiotic concept was introduced, and prebiotics were defined as “non-
digestible food ingredients that beneficially affect the host by selectively stimulating the 
growth and/or activity of one or a limited number of bacteria in the gut, and thus 
improving host health” (Gibson and Roberfroid, 1995). For compounds to classify as a 
prebiotic they must meet various criteria. Firstly, prebiotics should be resistant to the 
acidic environment of the stomach, must not be hydrolysed by endogenous enzymes, and 
not be absorbed in the GIT (Gibson et al., 2004). Secondly, the prebiotic must be 
fermented by GIT bacteria, and finally, the growth and/or activity the GIT bacteria must 
be selectively stimulated by the prebiotic to provide benefits to the health of the host 
(Gibson et al., 2004). An improvement in pig health through the beneficial activities of 
its own microflora results in reduced use of antimicrobials, hence prebiotics are 
considered as potential antimicrobial alternatives.  
 
1.4.1 Sources, types and production 
Dietary fibre is defined as plant-based carbohydrates that cannot be broken down by 
digestive enzymes, but instead are fermented in the large intestine. Non-starch 
polysaccharides (NSP) are complex carbohydrates that form the main part of dietary fibre 
and include cellulose, pectins, glucans, gums, mucilages, inulin and chitin (Bender and 
Cunningham, 2021). The largest constituent of the plant cell wall is cellulose (40 – 45 
%), a water-insoluble, linear polymer of glucose monomers which are rotated 180 ⁰C in 
respect to the adjacent moiety and linked by β-1,4-glycosidic bonds (Bedford, M.R. and 
8 
 
Partridge, 2010). The second largest structural polysaccharide (30-35%) of the plant cell 
wall is hemicellulose, which is structurally associated with cellulose in the walls and is 
found in all terrestrial plants (Bedford, M.R. and Partridge, 2010). Hemicelluloses’ are 
named according to the main sugar residue in the polymer backbone, hence, xylans are 
polymers with D-xylose units, mannans with D-mannose units, galactans with D-
galactose units or arabinans with L-arabinose units (Bedford, M.R. and Partridge, 2010). 
Xylan is the major component of hemicellulose, and after cellulose is the second most 
abundant polysaccharide in nature, hence due to the high presence of xylans in plants it 
is a major component in animal feed. There are various types of prebiotics with the 
majority being a subset of carbohydrate groups classed as non-digestible oligosaccharides 
(Davani-Davari et al., 2019). Non-digestible oligosaccharides are low molecular weight 
carbohydrates between simple sugars and polysaccharides (Mussatto and Mancilha, 
2007). Commercial production of prebiotic oligosaccharides involves either creation from 
simple sugars by enzymatic transglycosylation, or formation by controlled enzymatic 
hydrolysis reactions of polysaccharides like xylan (Mussatto and Mancilha, 2007). The 
most commonly known prebiotics include galacto-oligosaccharides (GOS), fructo-
oligosaccharides (FOS) and inulin (INU) but there are different prebiotic types as 
summarised in Table 1.1 (Al-Sheraji et al., 2013). This thesis will focus mainly on xylo-










Table 1.1 Types, sources and example inclusions of prebiotics in pigs diets, adapted 
from Al-Sheraji et al. (2013). 
 
Type of prebiotic Sources of prebiotic 
Example inclusion 
levels in pig diets 
(g/kg)  
Fructans [Fructo-
oligosaccharides (FOS) and 
inulin (INU)] 
Asparagus, sugar beet, garlic, chicory, 
onion, Jerusalem artichoke, wheat, 
honey, banana, barley, tomato and rye 
(Sangeetha et al., 2005). 
FOS = 0 - 6 g/kg (Xu, 
Z.R. et al., 2002) 
INU = 0 – 5 g/kg (He 
et al., 2002)  
Xylo-oligosaccharides Bamboo shoots, fruits, vegetables, milk, 
honey and wheat bran (Vazquez et al., 
2000). 
0.2 g/kg (Liu, J. et al., 
2018) 
Galacto-oligosaccharides 
(GOS) or trans-GOS (TOS) 
Human’s milk and cow’s milk (Alander 
et al., 2001). 
 0-20 g/kg (Houdijk, 
JGM et al., 1998) 
Raffinose oligosaccharides Seeds of legumes, lentils, peas, beans, 
chickpeas, mallow composite, and 
mustard (Johansen et al., 1996). 
 2 – 5 g/kg (Zeng et 
al., 2021) 





XOS are sugar oligomers made up of xylose (xyl) monomers linked together by β-(1→4)-
linkages. The structure of commercial XOS varies by degree of polymerisation (DP) and 
type of linkages depending on the source of xylan that is used for production (Aachary 
and Prapulla, 2011). In general, XOS consists of mixtures of xyl residues from 2 to 10 
units, known as xylose, xylobiose, xylotriose, and so forth as seen in Figure 1.1 (Vazquez 
et al., 2000). In addition to xyl residues, xylan often has associated side groups such as α-
D-glucopyranosyl, uronic acid or its 4-O-methyl derivative, acetyl groups, or 
arabinofuranosyl residues (Aachary and Prapulla, 2011). Hence, these side groups create 
a branched XOS molecule such as arabinoxylan-oligosaccharides (AXOS). Commercial 
XOS are produced from xylan containing raw materials like corncobs by chemical 
methods (Nabarlatz et al., 2007), direct enzymatic hydrolysis from raw materials  
(Katapodis and Christakopoulos, 2005) or a combination of both chemical and enzymatic 





Figure 1.1: Schematic structure of xylose and xylo-oligosaccharides (XOS). 
 
1.4.1.1.1 XOS production from xylanase (XYL) 
Plants contain a wide variety of polysaccharides which are separated into two groups 
according to structure and function; such that starches are polymers of glucose (glu) with 
α-glycosidic linkages, whilst the remaining polysaccharides are referred to as NSPs 
containing β-linkages (Englyst, H.N. et al., 1994). Xylans, β-glucans and cellulose are the 
most prominent type of NSPs in cereal grains but the quantity of each type varies (Choct, 
1997). Large amounts of soluble and insoluble NSPs are found in wheat and rye, with 
arabinoxylan being the main soluble component (Choct, 1997). Soluble xylans are anti-
nutritive in the GIT as their higher molecular weight fractions (i.e. larger than oligomers) 
can dissolve and form viscous aggregates within the digesta. Increased viscosity traps 
nutrients leaving them inaccessible to digestive enzymes, hence reduces nutrient 
digestibility and slows the rate of passage through the GIT, which can ultimately reduce 
feed intake and host growth (Olukosi, O.A. et al., 2015). The combination of a slower 
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rate of passage and an increased level of undigested nutrients can also cause the 
proliferation of adverse pathogenic bacteria (Masey O'Neill et al., 2014). Further to this, 
the majority of energy in cereals comes from intracellularly-stored starch, but along with 
other nutrients like protein, they are trapped within cells rendering them inaccessible to 
the host due to a lack of endogenous enzyme production to degrade plant cell walls 
(Masey O'Neill et al., 2014). For the reasons described above, NSPs are often perceived 
as an anti-nutritional factor in monogastric nutrition. However, addition of exogenous β-
1,4-XYL can alleviate the anti-nutritive effects described above. XYL hydrolyses the 
xylan polysaccharide, hence decreases digesta viscosity, releases entrapped nutrients and 
improves the nutritive value of feed and host growth (Masey O'Neill et al., 2014). Yet, a 
less well-studied mechanism of XYL and its benefits on performance is the indirect 
provision of fermentable AXOS and XOS from the hydrolysis of the xylan backbone and 
its potential prebiotic effect. Hence, provision of AXOS and XOS to the hind gut can be 
indirect via the supplementation of XYL and production of AXOS and XOS in situ, or 
direct via the addition of commercially produced XOS. 
 
1.4.1.2 Fructans  
Fructan is a general term used for any carbohydrate where one or more of the fructosyl-
fructose links makes up the majority of the osidic bonds (Roberfroid and Delzenne, 1998). 
Fructans are sugar oligomers and polymers made up of β-D-fructofuranosyl monomers 
linked together by β-(2→1) linkages, usually with a terminal glu unit (Roberfroid and 
Delzenne, 1998; Davani-Davari et al., 2019). FOS consists of mixtures of fructose 
residues with varying numbers of fructose monomers, for example, kestose (GF2), nystose 
(GF3), fructosylnystose (GF4) and so forth, as seen in Figure 1.2. Further fructose addition 
to the molecule creates long-chain INU (Figure 1.2). INU-type fructans naturally occur 
in many plants but are mainly extracted from sources such as the agave plant, chicory 
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root, or Jerusalem artichoke for commercial production (Grela et al., 2014). The DP of 
fructans differs greatly between plant origins. INU extracted from chicory roots typically 
has a DP between 3 and 60 (Van De Wiele et al., 2007) whereas for native Jerusalem 
artichoke the average DP is 6 (De Leenheer, 1994). Chemical degradation or controlled 
enzymatic hydrolysis of INU produces oligofructose compounds with an average DP 
between 2 and 20 (Van De Wiele et al., 2007). Alternatively, short-chain FOS can be 
produced by transfructosylation and typically have a DP of between 2 and 4 (Van De 
Wiele et al., 2007). 
 
Figure 1.2: Schematic of fructo-oligosaccharides (FOS) and inulin (INU). 
 
 
1.4.2 Prebiotic Functionality  
1.4.2.1 Bacterial modulation  
Glycosidic bonds that contain β conformation of the C2 atom cannot be digested by 
mammalian endogenous enzymes (Csernus and Czeglédi, 2020). Hence, these 
carbohydrates survive digestion and reach the hind GIT where they act as substrates for 
fermentation by the GIT bacterial community. By provision of an energy source for the 
bacteria, prebiotics have the ability to modulate the composition and functionality of the 
GIT bacterial community (Davani-Davari et al., 2019). Modulation of the bacterial 
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community to selectively promote the growth and activity of beneficial bacteria and 
inhibit pathogenic bacteria is of importance to maintain and improve the health of pigs.  
 
Lactic acid bacteria (LAB) are a group of gram-positive, acid-tolerant bacteria that are 
associated by their common metabolic characteristics, such as the production of lactic 
acid as the major metabolic end-product of carbohydrate fermentation (Yang, F. et al., 
2015). LAB such as Lactobacillus spp and Bifidobacterium spp, have shown beneficial 
effects on the regulation of the intestinal microflora, inhibition of GIT pathogens, 
improving intestinal mucosal immunity and maintaining intestinal barrier function, all of 
which contributes to the health and growth of the host (Yang, F. et al., 2015). Contrary to 
beneficial bacteria, pathogenic bacteria like Escherichia coli (E. coli) and Salmonella 
enterica exploit sources of carbon and nitrogen in the GIT environment as nutrients and 
regulatory signals to promote their own virulence and growth (Bäumler and Sperandio, 
2016). Release of cytokines during an inflammatory response triggers the release of 
reactive oxygen and nitrogen species from the intestinal epithelium, which react to form 
nitrates (Bäumler and Sperandio, 2016). Elevated levels of nitrates drive the growth of 
bacteria like Enterobacteriaceae as they are able to produce nitrate reductase which 
couples the reduction of nitrate to energy-conserving electron transport systems for 
respiration (Bäumler and Sperandio, 2016). Hence, a niche is created in the lumen of the 
intestines that supports the uncontrolled expansion of the pathogenic bacteria like 
Enterobacteriaceae which ultimately leads to disease. On the contrary, obligate anaerobic 
bacteria lack the conserved ability to produce nitrate reductase hence do not thrive. 
Common pathogenic bacteria in pigs include E. coli, Clostridium perfringens, 
Clostridium difficile and Salmonella enterica (Li, 2017). Typical symptoms of these 
bacterial infections include intestinal lesions, diarrhoea, host growth reduction, 
necrohaemorrhagic enteritis and high mortality (Li, 2017). To this point, prebiotics that 
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selectively promote the growth and activity of beneficial bacteria whilst reducing 
pathogenic bacteria are of great importance.  
 
1.4.2.1.1 In vitro fermentation 
The fermentation of prebiotics in the GIT depends on a multitude of factors including the 
sugar composition, DP, type of linkages, structure complexity, as well as the presence of 
substrate specific degrading bacteria and access to the substrate itself within the GIT 
(Houdijk, Jos, 1998). Hence, together these factors determine the site and rate of 
fermentation as well as the bacterial stimulation effect. The effect of these factors on 
substrate fermentability have mainly been studied in vitro.  
 
In vitro fermentability studies investigating XOS have previously shown that it is a good 
substrate for the growth of many different Bifidobacterium species and specific species 
like Lactobacillus brevis (Wang et al., 2010; Crittenden et al., 2002). However, it is clear 
that bacterial preference exists whereby certain species of Bifidobacterium such a B. breve 
showed no growth with XOS (Wang et al., 2010) along with the majority of other 
Lactobacillus species studied (Crittenden et al., 2002). XOS has also been shown to be 
fermented by some Bacteroides isolates but not by classic pathogenic bacteria such as E. 
coli, Enterococcus, Clostridium difficile or Clostridium perfringens (Crittenden et al., 
2002). Another in vitro study found that B. adolescentis and L. brevis had the highest 
growth and fermentation of XOS compared to other strains (Moura, Patrícia et al., 2007), 
agreeing with the results from Crittenden et al. (2002) and Wang et al. (2010).  
 
Given that prebiotics differ in their structural composition logically means GIT bacterial 
species will have varying abilities to utilise different prebiotic substrates according to 
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their specific polysaccharide degrading machinery. When comparing the in vitro 
fermentation of both XOS and FOS by the same human inoculum, XOS showed the 
highest increases in numbers of Bifidobacterium whilst FOS produced the highest 
numbers of Lactobacillus (Rycroft et al., 2001). Moreover, another study showed that 
both short-chain FOS (DP 2-3) and XOS (DP 2-7) have previously shown no growth of 
Salmonella typhimurium (De Figueiredo et al., 2020). In addition, bacterial strains again 
showed preferences for different substrates such that Bifidobacterium breve and 
Lactobacillus brevis preferred XOS, disagreeing with the results from Wang et al. (2010) 
and agreeing with the results from Crittenden et al. (2002). Whilst Bifidobacterium lactis 
and Lactobacillus acidophilus preferred FOS (De Figueiredo et al., 2020). The only tested 
strain to grow on both XOS and FOS was B. longum whilst B. animalis was unable to 
ferment any of the substrates. This highlights the highly selective nature of GIT bacteria 
and explains the variability of results in the literature given that only a small number of 
targeted species are usually investigated in prebiotic studies. 
 
The DP of oligomers can influence bacterial substrate preference and utilisation. For 
example, B. adolescentis has been shown to mainly ferment XOS mixtures consisting of 
xylobiose, xylotriose and xylotetraose, with an increase in DP to 5-6 resulting in a 
reduction in the degree of fermentation (Moura, Patrícia et al., 2007). In contrast, L. brevis 
prefers short-chains where the XOS mixture mainly consisted of xylobiose (Moura, 
Patrícia et al., 2007). For fructans, in vitro fermentability studies have shown that short-, 
medium- and long-chain fructans are fermented by human (Hernot et al., 2009) and swine 
(Smiricky-Tjardes et al., 2003a) faecal inoculum. The growth of Lactobacillus increased 
similarly among fructan substrates of differing length, whilst the greatest increase in 
Bifidobacterium was seen with short-chain fructans (Hernot et al., 2009). To this point, it 
has previously been reported that the ability to simulate the growth of Bifidobacterium by 
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short-chain carbohydrates (DP 2-10) is approximately an order of magnitude higher than 
that of substrates with a DP > 10 (Roberfroid et al., 1998). Hence, the utilisation patterns 
of prebiotic substrates also depend on the bacterial preference for differing DP.  
 
The presence of bacterial species capable of utilising differing oligomers dictates the rate 
of fermentation and consequent location of GIT fermentation. For example, short-chain 
fructans are more rapidly fermented than those with a greater DP (Hernot et al., 2009; 
Van De Wiele et al., 2007). When investigating the in vitro fermentability of XOS with 
varying DP by piglet ileal, caecal and distal colonic digesta, short-chain (DP = 2-5), 
medium-chain (DP = 2-14) and long-chain (DP = 2-25) XOS were all extensively 
fermented (Moura, P. et al., 2008). However, the rate of fermentation of medium- and 
long-chain XOS in the ileum was reduced compared to short-chain XOS, indicating an 
improved fermentation efficiency of the foregut microbiota to utilise XOS with a low DP. 
In contrast, another study found that the rate of in vitro fermentation of short-chain XOS 
by swine faeces was slower when compared to GOS and soy solubles, leading to the 
conclusion that XOS was a good substrate for the distal portion of the GIT (Smiricky-
Tjardes et al., 2003a). However, there were differences in the studies, including different 
inoculum and different ages of pigs for sample collection. Moreover, another in vitro 
model showed that both FOS and INU stimulated LAB in the proximal and distal sections 
of the colon, with longer-chain INU having more pronounced beneficial effects in the 
colonic microbiota compared to short-chain FOS (Van De Wiele et al., 2007).  
 
Hence, in order to stimulate a wide range of probiotic bacteria it is evident that a mixture 
of different prebiotics is required. To this point, an in vitro study found that mixing FOS 
and INU together was effective at reducing the amount of gas produced whilst 
maintaining or increasing the growth of Bifidobacterium as the highest prebiotic index 
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was obtained with FOS alone and FOS and INU combined (Ghoddusi et al., 2007). Albeit, 
there has been minimal focus on investigating the effect of combining prebiotic substrates 
and their mode of action within the GIT. 
 
1.4.2.1.2 In vivo fermentation 
The effect of XOS and fructans on their ability to selectively promote the growth and 
activity of probiotic bacteria has been studied in vivo in many species. In rats, both XOS 
and FOS have been shown to increase the population of Bifidobacterium in the colon, 
with XOS having a greater effect than FOS (Hsu et al., 2004). In mice, XOS has been 
shown to increase Lactobacillus by 10-fold in the large intestine and produced the highest 
counts of Bifidobacterium, whilst also reducing Clostridium (Santos et al., 2006). Whilst 
another study showed that XOS was the preferential substrate for beneficial bacteria, 
mainly Bifidobacterium, in the caecum of broilers (Ribeiro et al., 2018).  
 
In vivo studies with weanling pigs have shown that supplementation of XOS decreased 
faecal E. coli counts and increased Lactobacillus (Liu, J. et al., 2018). Similarly, XOS has 
been shown to increase the abundance of the Lactobacillus genus in the ileum and caecum 
of piglets, whilst also reducing the level of Clostridium_sensu_stricto_1 and Escherichia-
Shigella (Chen, Y. et al., 2021). The effects of fructans on gut bacterial composition in 
pigs has been extensively reviewed by Csernus and Czeglédi (2020). Some studies have 
shown no effect of short-chain FOS (Farnworth et al., 1992) or long-chain INU (Branner 
et al., 2004) on the GIT bacterial profile of pigs. However, other studies have shown 
increases in levels of beneficial LAB when feeding fructans of differing lengths (Paßlack 
et al., 2012; Zhao et al., 2013; Xu, Z.R. et al., 2002). Hence, it is clear that both XOS and 
fructans of differing lengths promote the levels of beneficial LAB in many species.  
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1.4.2.2 Fermentation metabolites 
1.4.2.2.1 Short-chain fatty acids (SCFAs) 
Substrates that reach the hindgut are fermented into several metabolites by GIT bacteria, 
such as SCFAs primarily constituting of acetate, propionate and butyrate. These SCFAs 
generally occur in ratios ranging from 75:15:10 to 40:40:20 (Trachsel, 2017). Other 
SCFAs are also produced in small quantities like valerate and caproate, or are classed as 
metabolic intermediates like lactate and succinate as they are rapidly converted to other 
SCFAs by GIT bacteria (Trachsel, 2017). SCFAs are readily absorbed, and 95 % are 
absorbed by the colonocytes in the caecum and large intestine (den Besten et al., 2013). 
SCFA production is thought to provide ~10 % and ~30 % of human and swine daily 
energy requirements and colonocytes derive 60-70 % of their energy from SCFA 
oxidation, with butyrate being the preferential source (den Besten et al., 2013; Bergman, 
1990). Once absorbed, acetate acts as an energy source in the tricarboxylic acid cycle and 
is also utilised in the production of fats and lipids (Trachsel, 2017). Propionate is largely 
utilised as a substrate for gluconeogenesis in the liver but has also been shown to be an 
energy source for immune cells (Trachsel, 2017). Whilst the main role of butyrate is as 
an energy source for colonocytes, with any remaining butyrate being oxidised by 
hepatocytes to prevent toxic concentrations (Trachsel, 2017). Oxidising butyrate also 
consumes large amounts of oxygen which reduces the quantity of electron acceptors 
available for microbial respiration. This shift consequently favours species that use 
fermentative metabolism and prevents the overgrowth of facultative anaerobic bacteria 
like pathogenic Salmonella and E. coli. Butyrate has also been shown to induce 
transcriptional changes in the gut epithelium, for example by inducing expression of 
antimicrobial peptides in colonic mucosa (Campbell, Y. et al., 2012). Moreover, butyrate 
has been shown to increase the expression of tight junction proteins and decrease 
epithelial permeability, all of which contributes to improved gut barrier function. Butyrate 
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also plays important roles in anti-inflammatory effects whereby inflammation is reduced 
by down-regulating the activity of pro-inflammatory mediators such as interleukin-6 and 
interleukin-12 (Chang et al., 2014). Taken together, all of these butyrogenic effects have 
a positive effect on gut function and homeostasis.  
 
1.4.2.2.2 pH 
The presence of SCFAs in the GIT lumen creates an acidic environment such that the pH 
of the gut lumen decreases. A reduction in pH can alter the GIT bacterial community 
composition, prevent the overgrowth of pH-sensitive pathogenic bacteria like 
Enterobacteriaceae and Clostridium, and aid effective mineral solubilisation (den Besten 
et al., 2013; Csernus and Czeglédi, 2020). It has previously been shown that butyrate-
producing bacteria such as Roseburia spp. and Faecalibacterium prausnitzii occupy an 
environment around pH 5.5, whereas butyrate-producing bacteria almost disappear and 
acetate- and propionate-producing bacteria become dominate at ~ pH 6.5 (den Besten et 
al., 2013). Hence, the fermentation of prebiotic substrates that produce SCFAs and reduce 
pH, therefore promotes the growth of beneficial butyrate-producing bacteria. To this 
point, a lower pH in the ileum of weaner pigs has been demonstrated with the addition of 
FOS, along with an increase in propionic and lactic acid (Houdijk, J.G.M. et al., 2002). 
Whilst in vitro studies have confirmed production of SCFAs during the fermentation of 
XOS (Wang et al., 2010; Moura, P. et al., 2008) and fructans (Van De Wiele et al., 2007; 
Stewart et al., 2008; Houdijk, J.G.M. et al., 2002). Similarly, in vivo supplementation of 
XOS and FOS have been shown to increase the SCFA concentrations in the caecum of 





1.4.2.2.3 Lactate and bacterial-cross feeding 
Prebiotic effects can be enhanced by bacterial cross-feeding, which is defined as the 
metabolic product of one species which can be consumed by another (Davani-Davari et 
al., 2019). For example, bacterial species that are known to be involved in the 
fermentation of resistant starch include Bifidobacterium, Prevotella, and Mitsuokella 
(Trachsel, 2017). These organisms degrade resistant starch into small polysaccharides or 
other metabolic intermediates such as lactate, the latter of which then subsequently acts 
as a carbon source for other bacteria (Trachsel, 2017). Consequently, numbers of these 
bacteria, such as Veillonella, Megasphaera elsdenii, and Anaerostipes ceccae, naturally 
increase in order to utilise the lactate substrate (Muñoz-Tamayo et al., 2011; Duncan et 
al., 2004). Megasphaera elsdenii and Anaerostipes ceccae also produce butyrate by 
utilising the lactate, thus conferring additional benefits to the host, which highlights the 
importance of cross-feeding in butyrate production (Muñoz-Tamayo et al., 2011).  
 
The extensive fermentation of XOS and fructans by Bifidobacterium, Lactobacillus and 
Bacteroides likely leads to the accumulation of metabolic intermediates like lactate which 
become available for cross-feeding by non-degrading species (Santos et al., 2006). The 
conversion of lactate to other SCFAs has been demonstrated in the caecum of growing 
pigs whereby the content of lactate linearly decreased as concentrations of acetate, 
propionate and butyrate increased (Brestenský et al., 2017). Due to this rapid conversion, 
intermediate metabolites like lactate are seldom detected in the faeces of healthy subjects 
(Duncan et al., 2004). However, lactate has been shown to accumulate in the faeces up to 
~100 mM in individuals who have undergone gut resections (short-bowel syndrome; 
SBS) or who are sufferers of ulcerative colitis (Hove et al., 1994; Kaneko et al., 1997; 
Vernia et al., 1988). In SBS patients, an increased load of undigested carbohydrates leads 
to increased fermentation and production of metabolites like lactate which exceeds the 
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amount that can be metabolised or absorbed, hence an accumulation of lactate occurs and 
pH reduces (Kowlgi and Chhabra, 2015). The more acidic environment leads to further 
growth of lactate-producing species and contributes further to the lactate pool. Colonic 
infusions of donor human intestinal bacterial communities have been reported to 
permanently reverse the condition in certain cases, hence microbial balance is a likely 
contributing factor (Borody et al., 2003). To this point, an increase in the abundance of 
lactate-producing bacteria, and/or the reduction of lactate-utilising bacteria leads to 
lactate accumulation and is a potential risk for diarrhoea (Saunders and Sillery, 1982). 
Hence, bacterial lactate production in the GIT is mainly beneficial, providing the balance 
of lactate producers and utilisers are in equilibrium.  
 
1.4.2.3 Digestibility  
1.4.2.3.1 Nutrient digestibility  
Many studies have shown that the supplementation of prebiotics results in improved 
nutrient digestibility in pigs (Liu, J. et al., 2018; Liu, P. et al., 2008; Zhao et al., 2013; 
Zhao et al., 2012; Shim, 2005), whilst others have found no improvement in dogs 
(Swanson et al., 2002; Propst et al., 2003) or in pigs (Smiricky-Tjardes et al., 2003b). The 
reason for an improvement in nutrient digestibility is multi-factorial including an effect 
on host health via the stimulation of beneficial bacteria, reduction of pathogenic bacteria, 
improved intestinal morphology, lower intestinal pH, stimulation of mucosal immune 
system and bacterial enzyme production (Liu, J. et al., 2018).  
 
The villus height to crypt depth ratio in the small intestine is a useful indicator to estimate 
the capacity of nutrient absorption as it has been shown that maximal absorption in newly 
weaned pigs occurs as the villus height to crypt depth ratio is increased (Pluske et al., 
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1996). This is explained by a larger surface area for nutrient uptake which therefore leads 
to increased nutrient absorption, highlighting the benefit of feeding concepts that increase 
these gut morphology indicators. To this point, supplementation of XOS has been shown 
to increase the villus height and villus height to crypt depth ratio in the ileum of weanling 
pigs (Chen, Y. et al., 2021), whilst chito-oligosaccharides have shown the same effect in 
the ileum and jejunum (Liu, P. et al., 2008). This latter response was coupled with an 
increase in apparent total tract digestibility (ATTD) of dry matter (DM), gross energy 
(GE), crude protein, crude fat, calcium and phosphorus, as well as host growth (Liu, P. et 
al., 2008). Similar results have been seen in piglets with XOS supplementation whereby 
villus height to crypt death ratio increased in the jejunum as well as ATTD of DM, 
nitrogen and GE (Liu, J. et al., 2018). The authors attributed these results to increased 
beneficial and decreased pathogenic GIT bacteria, as well as an increased production of 
SCFAs by microbial fermentation causing a proliferation of enterocytes and hence 
increasing the absorption capacity in the gut. Increased epithelial cell proliferation is 
associated with decreased mucosal atrophy and accounts for increases in caecal and 
colonic weights (Hsu et al., 2004). Supplementation of XOS has been shown to increase 
the relative colonic wall and caecal wall weights of rats more effectively than FOS, 
indicating that XOS has a larger effect on epithelial cell proliferation than FOS (Hsu et 
al., 2004; Howard et al., 1995). 
 
1.4.2.3.2 Fibre digestibility 
Prebiotics like INU have been shown to increase the pre-caecal digestibility of crude 
fibre, indicating an increased degradation by the ileal bacterial communities (Böhmer et 
al., 2005). Similar results were also found by Kumprecht and Zobac (1998) whereby a 
combination of mannan-oligosaccharides (MOS) and Enterococcus faecium had the 
highest fibre digestibility compared to unsupplemented pigs. Moreover, trans-
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galactooligosaccharides (TOS) have been shown to increase the ATTD of non-detergent 
fibre and hemicellulose (Mountzouris, K. et al., 2006), whilst other studies have shown 
no effect of FOS or TOS on the apparent ileal digestibility (AID) or ATTD of crude fibre 
(Houdijk, J.G. et al., 1999).  
 
As previously discussed, XOS acts as a substrate for saccharolytic bacterial fermentation 
and produce SCFAs as main fermentation end-products. XOS has been shown to improve 
animal performance (+ 320g from day 0-42) by increasing feed digestion, feed intake and 
by stimulating the modulation of the bacterial community to a more favourable 
composition (Ribeiro et al., 2018). However, it has been demonstrated that the amount of 
substrate used to elicit these responses are relatively low (Courtin et al., 2008; Morgan, 
Natalie K et al., 2019; Ribeiro et al., 2018). An inclusion of 0.1 g/kg of XOS would equate 
to < 0.3 Kcal/kg, which even if converted to SCFAs with 100 % efficiency, would not be 
enough energy for the scale of performance response observed in broilers (Ribeiro et al., 
2018). Hence, the authors concluded that XOS acts as a signal to encourage xylan-
degrading bacteria to increase in activity, digest the xylan more efficiently and interact 
with the GIT in such a way that improves overall efficiency of digestion (Ribeiro et al., 
2018). This concept has recently been termed ‘stimbiotic’ and is defined as ‘fermentable 
additives that stimulate fibre fermentability but at a dose that is too low that a stimbiotic 
itself could contribute to a meaningful level of SCFA production’ (Cho et al., 2020). To 
further study this concept, the direct measurement of NSPs provides a good index of the 
plant cell-wall material present in samples and the gut. The procedure for measuring NSPs 
was developed by Englyst in 1994, and involves the enzymatic removal of starch and 
summation of the constituent sugars released from acid hydrolysis (Englyst, H.N. et al., 
1994). Individual monosaccharides can be measured by gas-liquid chromatography (GC) 
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or by high-performance liquid chromatography (HPLC), alternatively a single value for 
total sugars can be obtained using spectrophotometry (Englyst, H.N. et al., 1994).  
 
There is a clear effect of age on the ability of the GIT bacteria to hydrolyse fibrous 
fractions like NSP, with the hydrolysing ability increasing as age increases and a more 
developed bacterial community is established. A recent study has shown that AX 
solubilisation occurs in the small intestine of young broilers, and the ability of the hindgut 
microbiota to ferment the AX substrates increased as the broiler aged (Bautil et al., 2019). 
This was demonstrated by increased AID, caecal digestibility and ATTD, coupled with 
an increase in AX-degrading enzyme activity with age. Hence, this highlights a window 
of opportunity to speed up the fibre degrading capability of the bacteria and provide 
benefits to the host from a younger age. To this point, compared to control (CON) fed 
broilers, the addition of AXOS has been shown to increase the solubilisation of insoluble 
AX into soluble fractions in the ileum (Bautil et al., 2020). This effect was not associated 
with increases in AX-hydrolysing enzymes as expected, but caution was raised over the 
accuracy of the enzyme results. Furthermore, the ATTD of total-AX was increased when 
AXOS was supplemented, resulting in a greater ability of the intestinal microbiota to 
break down the insoluble AX fraction. It was therefore postulated that AXOS had a clear 
stimulating effect on the dietary fibre-degrading capacity of the hindgut bacterial 
community in young broilers. This kick-starter effect was likely due to a combination of 
a quicker emergence of an AX-degrading microbiota and a microbial-modulated effect of 
decreasing the digesta transit rate allowing for greater dietary fibre hydrolysation.   
 
As previously stated, provision of XOS can be direct via the addition of commercially 
produced oligomers or via the supplementation of XYL and production of AXOS and 
XOS in situ. Hence, XYL could exert similar kick-starter effects on increasing the fibre 
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degrading ability of the bacterial community. Both bran AXOS and XYL 
supplementation have been shown to improve feed utilisation in broilers, suggesting that 
the AXOS released in situ by the action of XYL contributes to the beneficial effects of 
feed supplemented XYLs (Courtin et al., 2008). Moreover, AXOS increased the 
abundance of caecal Bifidobacterium, an effect which was not seen with XYL addition, 
indicating that the mode of action of XYL and AXOS are not identical and suggests the 
latter has a larger microbiota-modulating effect. Another study investigated the effects of 
AXOS or AX plus XYL in broilers, results indicated that feed conversion ratio (FCR) 
was numerically lowest and metabolizable energy intake higher in birds fed the AXOS 
treatment (Morgan, N.K. et al., 2017). It was suggested that the depolymerisation of NSPs 
in situ was not instantaneous, hence AXOS generation in the gut via the use of enzymes 
was not as efficient as feeding AXOS directly. Taken together, these studies suggest that 
the kick-starter effects may be greater with XOS compared to in situ XYL-produced XOS, 
albeit the combination of XYL and XOS together has received little attention to date. One 
study that has investigated the effect of feeding both XYL and XOS together, showed a 
shift in the intestinal microbiome to favour fibre fermentation by increasing the 
abundance of fibrolytic species such as C. cellobioparum, B. crossotus, I. 
butyriciproducens, C. ruminocola, F. intestinalis, P. ruminis and F. prausnitzii (Cho et 
al., 2020). Although fibre fermentation was not measured it was stated that most of these 
bacterial species have genes encoding for XYL production, postulating that fibre 
digestion could have been increased.  
 
 
The ability to kick-start the metabolic activity of fibre-fermenting bacteria would be 
accompanied by an increase in activity of bacterial enzyme production. Little work has 
been done on this concept in vivo for stimbiotics. Yet, a combination of XOS and 
Saccharomyces cerevisiae has been shown to increase the microbial xylanolytic activity 
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in the small intestine of piglets, whilst feeding the additives alone increased the caecal 
cellulolytic activity (Marinho et al., 2007). This indicates a greater microbial activity and 
potential for increasing NSP digestibility. Moreover, the effect of insoluble AX fractions 
on the fermentability and modulation of gut bacterial hydrolase activity has been 
investigated in humans (Vardakou et al., 2008). When added to a pH-controlled anaerobic 
fermentation vessel, AX had a prebiotic index of 2.03, but when AX were pre-treated 
with XYL, the prebiotic index significantly increased to 3.48. This indicates that the 
XYL-treated AX provided shorter-chain oligomers that were better utilised by the gut 
bacteria compared to the longer-chain untreated AX. Moreover, addition of AX to a 24-
hour batch culture resulted in a 2-fold increase of bacterial XYL production, but a 120-
fold increase for XYL-treated AX. Thus, the production of XYL by GIT bacteria was 
induced by the addition of AX, but even more so by the shorter-chain XYL-treated 
substrates highlighting the potential of short-chain oligomers to kick-start fibre-
degradation. Furthermore, both FOS and TOS have been shown to increase the β-
galactosidase activity in the caeca of pigs, whilst TOS also showed increases in the colon 
and rectum compared to CON fed pigs (Mountzouris, K.C. et al., 2006). The production 
of microbial β-galactosidase hydrolyses products of plant glycosides and is usually 
produced by LAB like Bifidobacterium and Lactobacillus. Hence, this increase along the 
GIT suggests a stimulatory effect of TOS on LAB, their associated enzyme activity and 
potential for fibre hydrolysis.  
 
Overall, it is postulated that the provision of a highly fermentable fibre substrate that has 
structural similarities to the main dietary fibre source tends to train and imprint the 
metabolic activity of the hindgut bacterial communities enabling the hydrolysis and 
fermentation of fibre fractions (Bautil, 2020). However, it has also been shown that 
supplementing a different source of dietary fibre like β-glucans can also alter the digestion 
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of other fibre fractions (de Vries et al., 2016). Provision of β-glucans increased the ATTD 
of non-glucosyl polysaccharides (NGP) compared to CON diets, which was mainly 
attributed to the increased degradation of xylosyl-polysaccharides. The increased ATTD 
of NGP in diets containing corn distillers dried grains with solubles (DDGS) 
supplemented with β-glucans was attributed to a better degradability of barley NGPs 
rather than the NGPs from DDGS itself. However, ATTD of NGPs in rapeseed meal 
(RSM) diets were still increased by β-glucans even after correction for the presence of 
barley NGPs. This was explained by the presence of β-glucans potentially specifically 
stimulating the colonisation and activity of bacteria that are capable of degrading RSM 
NGPs, particularly xyloglucans. Hence, the fermentation of fibre substrates is not only 
due to fibre characteristics but also the presence of other fibres in the diet.   
 
Prebiotics selectively stimulate specific GIT bacteria; hence the bacterial community 
modulation effect will vary between different prebiotics along with their associated 
metabolic effects. This therefore indicates that the fibre degrading capacity of the GIT 
bacteria depends on which bacteria are stimulated. Taking the stimbiotic concept into 
account, addition of substrates like XOS should increase the abundance and metabolic 
activity of xylan-degrading bacteria leading to higher xylan digestibility, whilst 
supplementation of fructans should increase the digestibility of fructans. There is little 
evidence to date regarding the ability of substrates like XOS or FOS to increase the 
digestibility of other types of fibre fractions. However, the combination of prebiotics 
should theoretically broaden the number of different bacteria that are stimulated, leading 
to a wider range of microbial fibre-degrading capabilities, hence improving overall fibre 
digestion if the prebiotics work in synergy. Moreover, site of fermentation will play a 
role, for example it is unknown whether the provision of 2 short-chain oligomers would 
be preferential over 2 long-chain oligomers, or a combination of different chain lengths.  
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1.4.3 Animal performance  
All the above-mentioned functionalities of prebiotic substrates should theoretically lead 
to an improvement in host growth. Supplementation of a synthetic short-chain FOS 
mixture (Meioligo-P; GF2 = 40 %, GF3 = 50 %, GF4 = 7 %)) at 0, 2, 4 and 8 g/kg diet was 
investigated in broilers (Xu, Z. et al., 2003). Addition of 4 g/kg of FOS significantly 
increased average daily gain (ADG) of broilers, with a significant FCR improvement with 
2 and 4 g/kg addition. A similar study was conducted in growing pigs, where FOS was 
added at 0, 2, 4 and 6 g/kg of diet (Xu, Z.R. et al., 2002). Similar to the broiler study, 
supplementation with 4 and 6 g/kg diet of Meioligo-P FOS significantly improved ADG 
and FCR of pigs, as well as enhancing the growth of Bifidobacterium and Lactobacillus, 
and inhibiting E. coli and Clostridium (Xu, Z.R. et al., 2002). This agrees with Xu, C. et 
al. (2005) who found 4 g/kg of an alternative FOS product (GF2 = 47 %, GF3 = 39 %, GF4 
= 11 %) also improved piglet performance compared to a positive Auromycin CON. 
Regarding heavier pigs, supplementation of FOS at 2.5 g/kg, 5.0 g/kg, and 7.5 g/kg 
increased ADG by 4.0 %, 9.7 % and 10.7 % respectively, whilst 5.0 g/kg and 7.5 g/kg % 
also reduced FCR by 8.2 % and 7.6 % (Xu, Z.-r. and Hu, 2003). However, not all studies 
with short-chain FOS have shown beneficial effects. For example, addition of Jerusalem 
artichoke flour (GF1-2 = 33.3 %, GF3-4 = 46.4 % and GF>5 = 20.3 %) or Neosugar (GF2 = 
28 %, GF3 = 60 %, GF4 = 12 %) at 15 g/kg had no significant effect on weaning pig 
performance, SCFA production or bacterial composition, but there was a confounding 
replicate effect (Farnworth et al., 1992). Albeit, similar effects were seen in a weaned 
piglet study where supplementation of 5 g/kg FOS (Raftilose P95®) reduced growth and 
insulin-like growth factor I (Estrada et al., 2001). It is not clear why some studies show 
beneficial effects and other show neutral or negative effects of FOS on performance, but 
it is likely due to differences in inclusion rate, product concentration and composition, 
differing feed formulations and different aged pigs. However, from the above literature, 
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supplementation of a short-chain FOS mixture at 4 g/kg seems to be the optimum 
inclusion for piglets.  
 
Regarding longer chain linear INU, the literature reports both positive and neutral effects 
on weaner pig performance. In a weaner study, supplementation of INU in water and feed 
improved ADG and FCR compared to the CON (He et al., 2002). Similarly, 40 g/kg of 
dried artichoke or chicory powder supplementation has been reported to improve ADG 
and FCR (Grela et al., 2014). However, 80 g/kg of INU from chicory showed no effect 
on weaner pig performance (Halas et al., 2009). There is little in the literature on INU 
from agave which have a different linear and branched structure with β-(2,6)-linked 
fructose units. Yet one study used a synthetic mixture of FOS components with an average 
DP of 10 and β-(2,6)-linkages (Zhao et al., 2013). Results of this study showed that 
supplementation of 10 and 20 g/kg increased ADG, improved FCR and increased the 
ATTD of DM and GE in finishing pigs.  
 
The majority of research on XOS has been conducted in broilers, whereby promising 
effects with inclusions at 0.06 g/kg, 0.10 g/kg and 10 g/kg all showed improvements in 
broiler performance (Suo et al., 2015; Zhenping et al., 2013; Ribeiro et al., 2018). In 
weanling pigs, Liu, J. et al. (2018) showed a 17 % improvement in ADG and 14 % 
improvement in FCR when supplemented with 0.2 g/kg of XOS (50 % purity). Likewise, 
Chen, Y. et al. (2021) showed that 0.5 g/kg of XOS (95 % purity) increased ADG and 
improved FCR in weaned pigs compared to a CON diet. However, Yin, J. et al. (2019) 
found no performance benefits when using a lower inclusion rate of XOS at 0.1 g/kg (40 
% purity) in weaned piglets. Yet, there were differences between the studies such as diet 
raw material basis, piglet age and XOS purity. Taken together, these studies suggest 0.10 
– 0.48 g/kg of pure XOS improves the performance of young pigs and highlights that 0.04 
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g/kg of pure XOS may not be a high enough concentration to elicit performance benefits 
in piglets. 
 
Individually, the supplementation of fructans and XOS tends to improve the performance 
of monogastric animals. It is however unknown whether combining different prebiotics 
together would improve piglet performance above and beyond that of feeding them 
individually. Indeed, the combination of INU and FOS has been found to reduce gas 
production whilst maintain the growth of Bifidobacterium in a faecal batch culture, with 
the highest prebiotic index being achieved with FOS alone and a mixture of FOS and INU 
(Ghoddusi et al., 2007). However, to the author’s knowledge there is no literature 
focusing on the effect of combining prebiotic substrates in vivo. In theory, combining 
different prebiotics together could increase the substrate availability for a wider range of 
resident probiotic bacteria. In turn, this could increase fermentative activity, SCFA 
production, energy provision for the host and potential host growth. However, given the 
plasticity of the pig GIT bacterial community, it is unknown whether prebiotic 
combinations would create excessive competition in the GIT ecosystem and hence be of 
detriment to the host. Hence, further research in this area is required.  
 
1.4.4 Aims and objectives 
There is a lack of peer reviewed literature on the effects of XOS in pigs, with most of the 
research having been performed in poultry. Moreover, the effect of XOS alone or in 
combination with alternative additives in pigs is a new area of research which has not 






1. To determine the effect of XYL and XOS supplementation on grower pig 
performance and their impact on faecal bacterial community composition over 
time.   
2. To determine whether L-lactate could be detected in piglet faeces over the 
weaning period and whether concentrations changed with age. 
3. To determine how quickly a known concentration of L-lactate would be 
metabolised by pig faecal bacteria, and whether this differed between solutions, 
sample fractions or analytical methods. 
4. To evaluate titanium dioxide (TiO2) and intrinsic cellulose as inert markers for 
AID and ATTD of NSPs in piglets. 
5. To determine the effect of XOS with or without fructans on piglet performance 
and various GIT functions, including bacterial community composition, microbial 
endo-XYL activity, fermentation activity and NSP digestibility.  
 
Chapter 2 will investigate the effect of XYL and XOS supplementation on growth 
performance and faecal bacterial community composition in growing pigs. Following 
this, Chapter 3 will investigate if L-lactate can be detected in piglet faeces and if 
concentrations change with age. Moreover, the rate of metabolism of a known 
concentration of L-lactate by pig faecal bacteria will be explored. Chapter 4 will 
investigate the effect of XOS with or without fructans on growth performance, gut 
bacterial community composition and microbial endo-XYL activity in weaned piglets. 
Whilst Chapter 5 will evaluate TiO2 and intrinsic cellulose as inert markers for NSP 
digestibility. Using the results from Chapter 5, Chapter 6 will investigate the effect of 
XOS with or without fructans on gut bacterial fermentation activity and NSP digestibility 
in weaned piglets. Conclusions of the thesis will be made in Chapter 7.  
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Chapter 2   
Effect of xylanase and xylo-oligosaccharide supplementation on 
growth performance and faecal bacterial community composition 
in growing pigs 
2.1 Abstract  
Feeding concepts to improve pig health and performance are of upmost importance to the 
swine industry. This study was conducted to investigate the effects of XYL and XOS 
supplementation on the growth performance and faecal bacterial community composition 
in growing pigs over time. In this 35-day trial, a total of 464 grower pigs with an average 
initial body weight (BW) of 14.5 kg (Standard deviation; SD ±1.56 kg) were blocked into 
mixed sex pens of 4–5 pigs balanced for BW, sex and litter origin. Pens were randomly 
allocated to 1 of 4 dietary treatments in a 2 × 2 factorial treatment arrangement with 2 
levels of supplementary XYL (0 and 0.15 g/kg) and XOS (0 and 0.20 g/kg). Every week, 
pen feed intake and pigs were weighed to calculate pig performance. Faecal samples from 
32 male pigs were collected on days 1, 14 and 35 of the trial and analysed to profile the 
bacterial communities through 16S ribosomal ribonucleic acid (rRNA) sequencing of the 
V4 region on the MiSeq platform (Illumina). There was no effect of XYL on pig 
performance, nor was there an interaction between XYL and XOS. Pigs supplemented 
with XOS had a poorer gain to feed ratio (G:F) during the first week (Day 1–7) of the 
trial (P < 0.002). During the second week of the trial (Day 8–14), pigs fed XOS showed 
an improved ADG compared to those without XOS (P < 0.003), but there were no 
performance effects in the overall trial period (Day 1–35). Alpha diversity increased over 
time (P < 0.05), and as an index of bacterial community compositions, beta diversity also 
changed over time (P < 0.001), but there was no overall effect of treatment on alpha or 
beta diversity. Despite no overall treatment effect, certain operational taxonomic units 
(OTUs) associated with Muribaculaceae_ge and Prevotellaceae NK3B31 group were 
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higher in all 3 dietary treatments compared to the unsupplemented CON diet (P < 0.05). 
In summary, XYL and XOS had limited effect on pig performance in this trial. Faecal 
bacterial communities significantly changed over time but despite influencing certain 
OTUs, treatment had no overall effect on faecal bacterial community composition. 
Supplementation of XYL or XOS, individually or simultaneously, increased the 
abundance of OTUs belonging to the Muribaculaceae and Prevotellaceae families 
associated with carbohydrate metabolism, indicating that these bacteria are likely 
involved in the mechanistic pathways of XYL and XOS.  
 
2.2 Introduction 
The fibre component of cereals is primarily composed of complex carbohydrates found 
in plant cell walls called NSPs. The amount and type of NSPs vary among cereal grains, 
with xylans, β-glucans and cellulose being the most prominent (Choct, 1997). Cereals 
such as wheat and rye contain large amounts of soluble and insoluble NSPs, with the main 
soluble component being xylan (Choct, 1997). Within the GIT of monogastrics, 
solubilised xylans are anti-nutritive as they increase digesta viscosity which in turn 
reduces nutrient absorption and host growth (Olukosi, O.A. et al., 2007). Further to this, 
valuable nutrients are trapped within cells rendering them inaccessible to the host due to 
a lack of endogenous enzyme production to degrade plant cell walls (Masey O'Neill et 
al., 2014). Supplementation of exogenous β-1,4-XYL can alleviate these antinutritive 
effects by hydrolysing the xylan polysaccharide, thus decreasing digesta viscosity, 
releasing entrapped nutrients and improving the nutritive value of feed and host growth 
(Masey O'Neill et al., 2014). A less well-known mechanism of XYL and its benefits on 
performance, is the indirect provision of fermentable XOS from the hydrolysis of the 
xylan backbone (Masey O'Neill et al., 2014). These are short-chain xylo-oligomers that 
resist digestion and are fermented in the hindgut where they have prebiotic effects by 
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selectively stimulating beneficial bacteria like Bifidobacterium or Lactobacillus, and 
reducing pathogenic bacteria like E. coli (Hsu et al., 2004; Liu, J. et al., 2018). 
Furthermore, XOS can also be manufactured commercially via the hydrolysis of corncobs 
and can be formulated directly into the host's diet. As an emerging new-generation 
prebiotic, studies using XOS have shown promising improvements in performance, 
nutrient digestibility, gut structure and gut bacterial community composition in broilers 
and weanling pigs (Liu, J. et al., 2018; Ribeiro et al., 2018; Chen, Y. et al., 2021). 
However, little attention has been given to growing pigs; hence this study investigated 
the effect of XYL and XOS supplementation on the performance and faecal bacterial 
community composition of growing pigs over time.  
 
2.2.1 Study aims  
At present, there is a lack of information in the literature on the effect of XOS in growing 
pigs. Hence, this study aimed to determine the effect of XYL and XOS supplementation 
on grower pig performance and their impact on faecal bacterial community composition 
over time.   
 
2.2.2 Hypotheses 
• Hypothesis 1: XYL and XOS supplementation will improve grower pig 
performance compared to the CON. When XYL and XOS are fed in combination, 
the performance of grower pigs will be improved compared to when XYL and 
XOS are provided independently.  
• Hypothesis 2: Faecal bacterial community composition (alpha and beta diversity) 
will differ between dietary treatment and over time.   
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• Hypothesis 3: Compared to the CON, the supplementation of XYL and XOS, 
independently or in combination, will increase the abundance of beneficial 
bacteria like Bifidobacterium and Lactobacillus and decrease pathogenic bacteria 
such as Escherichia coli.  
 
2.3 Materials and methods 
Study protocols were approved by the University of Leeds Pig Research Centre and 
ethical approval was granted by the Animal Welfare and Ethical Review Body as 
described in Appendix A.1.   
 
2.3.1 Animals and housing 
At 7 weeks of age, 464 grower pigs ((Large White x Landrace females) x JSR Pietrain-
based Geneconverter 900 sire line) with an average initial BW of 14.5 kg (SD ±1.56 kg) 
were used in this randomised complete block design with 24 replicates and 4–5 mixed-
sex pigs per pen for a 35-day feeding study. All pigs were weighed at the start of the trial 
and blocked into pens balanced for litter origin, sex and BW. Pens within each replicate 
were randomly allocated to 1 of 4 dietary treatments described below. The trial was 
conducted over 2 batches with 12 replicates in each batch. Pigs were housed in 
conventional fully slatted weaner-grower facilities where each pen (155 × 129 cm) had 2 







2.3.2 Experimental design and dietary treatments 
Pigs were fed with a 1-phase feeding program from day 1–35 of the trial and had ad 
libitum access to pelleted feed and water. All dietary treatments were formulated to meet 
or exceed the National Research Council nutrient recommendations for 11–50 kg pigs 
(NRC, National Research Council. 2012). The basal diet was prepared as a single batch 
of feed at Roslin Nutrition Ltd. (Scotland) before additive addition and pelleting. Dietary 
treatment compositions with calculated and analysed nutrient concentrations are 
presented in Table 2.1. All diets included 0.10 g/kg phytase [Quantum® Blue, AB Vista, 
Marlborough, UK; 5000 phytase units (FTU)/g] to give an expected activity of 500 
FTU/kg of feed. Inclusion of XYL [endo-1,4-β-XYL, Econase® XT, AB Vista, 
Marlborough, UK; 160000 Birch Xylan Units (BXU)/g)] in the XYL and XYL + XOS 
dietary treatment groups provided an expected activity of 24000 BXU/kg of feed. The 
XOS product was manufactured from the hydrolysis of corncobs and had a DP of 2–7. 
Supplementation of XOS (XOS 35, 35 %, Longlive Biotechnology Corporation, China) 
in the XOS and XYL + XOS dietary treatment groups provided 0.07 g/kg of pure XOS 
in the feed. Inclusion rates of XYL and XOS were according to the supplier’s 
recommendations at the time of the trial. Dietary treatments were arranged in a 2 × 2 
factorial treatment arrangement with 2 concentrations of supplementary XYL (0 and 0.15 
g/kg) and 2 concentrations of XOS (0 and 0.20 g/kg) to give 4 experimental treatments; 
CON (0 g/kg XYL and XOS), XYL (0.15 g/kg), XOS (0.20 g/kg) and XYL + XOS (0.15 







Table 2.1 Dietary treatment composition with calculated and analysed nutrient 
levels.   
Raw material 
Control XYL a XOS b 
XYL + 
XOS 
Ingredient, g/kg     
Wheat 719.9 719.7 719.7 719.5 
Soybean meal  225.0 225.0 225.0 225.0 
Soya oil  19.8 19.8 19.8 19.8 
Dicalcium phosphate  11.1 11.1 11.1 11.1 
Vitamin-mineral premix c 5.0 5.0 5.0 5.0 
Limestone 4.5 4.5 4.5 4.5 
L-Lysine HCl, 784 g/kg 4.4 4.4 4.4 4.4 
Sodium bicarbonate 3.7 3.7 3.7 3.7 
Salt  3.6 3.6 3.6 3.6 
Threonine, 980 g/kg 1.3 1.3 1.3 1.3 
DL-Methionine, 980 g/kg 0.90 0.90 0.90 0.90 
XYL  0.00 0.15 0.00 0.15 
XOS  0.00 0.00 0.20 0.20 
Phytase d 0.10 0.10 0.10 0.10 
L-Tryptophan, 980 g/kg 0.07 0.07 0.07 0.07 
L-Valine, 965 g/kg 0.06 0.06 0.06 0.06 
Calculated nutrient composition 
Net energy (MJ/kg) 10.43 10.43 10.43 10.43 
Standardised ileal digestible lysine (g/kg) 11.0 11.0 11.0 11.0 
Apparent total tract digestible phosphorus (g/kg) 3.8 3.8 3.8 3.8 
Analysed nutrient composition  
Dry matter (g/kg) 875.0 873.0 876.0 876.0 
Ash (g/kg) 45.0 42.0 43.0 44.0 
Crude protein (g/kg) 183.0 188.0 187.0 187.0 
Crude fibre (g/kg) 26.0 23.0 23.0 21.0 
Calcium (g/kg) 6.30 5.90 5.70 6.20 
a XYL; xylanase - endo-1,4-β-xylanase, Econase® XT, AB Vista, Marlborough, UK. b XOS; xylo-
oligosaccharide - XOS 35, Longlive Biotechnology Corporation, China. c Vitamin premix, active substance 
per kg of diet: 10,000 IU Vitamin A (retinyl acetate), 2250 IU Vitamin D3 (cholecalciferol), 75 mg Vitamin 
E  (alpha tocopheryl acetate), 0.91 mg Vitamin K3 (menadione), 1.6 mg Vitamin B1 (thiamine 
mononitrate), 4 mg Vitamin B2 (riboflavin), 8.9 mg Pantothenic acid (calcium-D-pantothenate), 2.4 mg 
Vitamin B6  (pyridoxine hydrochloride), 25 ug Vitamin B12 (cyanocobalamin), 30 mg Nicotinic acid, 0.5 
mg Folic acid, 100 ug Biotin, 100 mg Iron (sulphate monohydrate), 15 mg Copper (sulphate pentahydrate), 
45 mg Manganese (sulphate monohydrate), 80 mg Zinc (sulphate monohydrate), 1 mg Iodine (calcium 
iodate anhydrous), 0.25 mg Selenium (selenite) and 1500 mg Magnesium phosphate. d Phytase; Quantum® 







2.3.3 Measurements and sampling 
2.3.3.1 Pig performance and health observations  
Every week (Days 1, 7, 14, 21, 28, 35) all pigs were weighed individually and ADG was 
calculated. Weekly feed disappearance was recorded on a pen basis and pen average daily 
feed intake (ADFI) was calculated. ADG and ADFI data were used to calculate the 
weekly average G:F ratio. The timing of any pig mortality or removal from the trial was 
recorded, along with the pig BW to allow for ADFI and G:F adjustments.  
 
Health condition as indicated by digestive function was assessed by recording daily pen 
faecal scores on a scale of 1–4 by the same personnel (1 = firm faeces, 2 = soft faeces, 3 
= mild diarrhoea, 4 = severe diarrhoea). Pen health scores were recorded daily on a scale 
of 1–4 by the same personnel (1 = no signs of ill health, 2 = some signs of ill health, 3 = 
clear indications of ill health, 4 = seriously ill pigs). Pen cleanliness scores were recorded 
daily on a scale of 1–4 by the same personnel (1 = clean pigs, 2 = light contamination 
with faecal material, 3 = contamination with faecal material, 4 = heavy contamination 
with faecal material).  
 
2.3.3.2 Faecal collection 
Faecal samples were collected from 1 individual male pig per pen on days 1, 14 and 35. 
Faeces were collected in a 30 ml universal container immediately after defecation and 
placed on ice before being stored frozen (–80°C) until analysis. Of the collected samples, 
32 were selected for bacterial community analysis (8 replicates per treatment). Those 
chosen for analysis had a BW close to that of the pen average, had not received antibiotic 





2.3.4.1 Phytase and XYL recovery  
Phytase and XYL recovery were determined at ESC (Ystrad Mynach, Wales, UK) 
according to the manufacturer’s enzyme-linked immunosorbent assay for Quantum® 
Blue and Econase® XT. All diets were analysed for standard nutrients at DM Scientific 
(East Lothian, Scotland, UK). 
 
2.3.4.2 Deoxyribonucleic acid (DNA) extraction and bacterial community analysis 
Total bacterial DNA was extracted from the faecal samples (ca 0.2 g) using the QIAamp 
DNA Stool Mini Kit (QIAGEN®, Hilden, Germany) as per the manufacturer’s protocol, 
with 2 modifications. To maximise cell lysis, the faecal samples underwent bead beating 
(Tissue Lyser LT, Qiagen; 0.2 g of 0.1 mm silica beads) for 5 min at a maximum speed 
of 50 rps and were incubated at a higher temperature of 95°C. Extracted DNA quantity 
and quality were measured spectrophotometrically (NanoDrop ND-1000). 
 
Extracted DNA was sent to the Environmental Genomics Facility at the University of 
Southampton for next-generation sequencing following the Illumina 16S Metagenomic 
sequencing library preparation protocol. Polymerase chain reactions (PCR) were used to 
amplify the V4 region of the bacterial 16S rRNA gene using the modified 515F (Parada 
et al., 2016) 
(TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGGTGYCAGCMGCCGCGGTAA) and 
806R  (Apprill et al., 2015) 
(GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGGACTACNVGGGTWTCTAAT) 
primer set (overhang sequences correspond to Illumina adapters shown in italics). The 25 
μl PCR reaction consisted of 2.5 μl microbial DNA (5 ng/ul), 5 μl forward primer (515 
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F), 5 μl of reverse primer (806R) and 12.5 μl KAPA HiFi HotStart ReadyMix. The 
amplification was performed using the following program: 95ºC for 3 min, 25 cycles of 
(30 s at 95ºC, 30 s at 55ºC, 30 s at 72ºC), 72ºC for 5 min, before being held at 4ºC. 
Amplification was confirmed using a Bioanalyser 1000 chip. AMPure XP beads were 
used to purify the 16S V4 amplicon away from the primers and primer dimer species. 
Nextera XT v2 index adaptors were attached using a further 8 cycles of PCR. AMPure 
XP beads were used to clean the final library before quantification. All AMPure clean-up 
steps and the setup of the indexing PCR were carried out on a liquid handling robot 
(Biomek 4000). Libraries were quantified by a fluorometric quantification method using 
double-stranded DNA binding dyes, normalised and pooled. Pooled libraries were 




Mothur (v.1.41.1) was used to process the sequence reads and the MiSeq standard 
operating procedure was followed (Kozich et al., 2013). Briefly, contigs were created by 
combining the forward and reverse reads, any ambiguous bases or contigs smaller or 
larger than 200–300 base pairs were removed. Duplicate sequences were merged, and 
unique sequences were aligned to the SILVA reference database (v.132). Only contigs 
that aligned between position 11894 and 25319 were selected with a maximum 
homopolymer length of 8. Sequences were pre-clustered, allowing for 1 difference in 
every 100 base pairs of sequence. Chimeras and sequences that aligned to Archaea, 
Eukaryota, chloroplasts or mitochondria were removed from the dataset. Sequences were 
clustered into OTUs with 97 % similarity, before quantifying the number of OTUs within 
each group and their taxonomy. A BIOM file was then created to transfer the data into R 
(v. 1.1.463).   
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2.3.5 Statistical analysis 
2.3.5.1 Pig performance and health observations 
The pen served as the experimental unit for all growth performance data (BW, ADG, 
ADFI, G:F). G:F ratio was calculated as a ratio of weight gain to feed intake according to 
the following equation: 
 
 
Data were tested for normality by visualisation of histograms and the Shapiro-Wilk test 
for normality, while the Levene’s test was used to assess the homogeneity of variance. 
Any data showing non-normal distribution or unequal variance were inversely 
transformed prior to analysis. Transformed data were back transformed for inclusion into 
the data tables. Performance data were analysed as a 2-way analysis of variance 
(ANOVA) using the statistical package JMP® (Version 14.1. SAS Institute Inc., Cary, 
NC, 1989 - 2019) (SAS, 2020). The statistical model included the fixed effects of XYL, 
XOS and their interaction, and replicate and batch as random variables. The initial BW 
of pigs was included as a covariate for BW and ADG analysis. Main effects were analysed 
individually when interactions were non-significant. Average pen faecal, health and 
cleanliness scores were analysed by the non-parametric Kruskal-Wallis one-way 
ANOVA. Significant differences were classed as P < 0.05 and trends as P < 0.10. 
 
2.3.5.2 Bacterial community composition analysis  
The software R was used to analyse the microbiome data (v. 1.1.463) statistically. 
Individual pigs served as the experimental unit for the bacterial community composition 
analysis. A general linear model was used to determine the effects of treatment and time 
𝐺𝑎𝑖𝑛 𝑡𝑜 𝐹𝑒𝑒𝑑 (𝐺: 𝐹) =
𝐴𝑣𝑒𝑟𝑎𝑔𝑒 𝑑𝑎𝑖𝑙𝑦 𝑔𝑎𝑖𝑛 (𝑘𝑔 𝑝𝑒𝑟 𝑑𝑎𝑦)
𝐴𝑣𝑒𝑟𝑎𝑔𝑒 𝑑𝑎𝑖𝑙𝑦 𝑓𝑒𝑒𝑑 𝑖𝑛𝑡𝑎𝑘𝑒 (𝑘𝑔 𝑝𝑒𝑟 𝑑𝑎𝑦)
 Equation 2.1 
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on bacterial abundance at the phylum and genus level. Post-hoc differences were 
identified using a Tukey’s test (JMP® v.14.1). The number of OTUs, Chao1 (Chao, 1984) 
and Shannon-Weiner (Shannon, 1948) alpha diversities were measured using the 
Phyloseq package (v.1.22.3) in R (McMurdie and Holmes, 2013). A general linear model 
(lme4) was used to determine the effects of treatment and time on alpha diversity and the 
number of OTUs. Models were reduced using analysis of deviance. Beta diversity was 
analysed using the packages Vegan (v.2.5.3) and DESeq2 (v.1.18.1). A permutational 
multivariate ANOVA (PERMANOVA - adonis) was used to assess community 
similarities across treatment and time. A non-metric multidimensional scaling (NMDS; 
axis = 2) plot using Bray-Curtis distances was used to plot beta diversity. DESeq2 
analysis identified the fold change of OTUs, which differed significantly between 2 
groups. DESeq2 was performed on un-rarefied data and P values presented were 















2.4.1 Phytase and XYL recovery 
The analysed phytase activity in the feed (FTU/kg) of the CON, XYL, XOS and XYL + 
XOS dietary treatments were 457, 658, 561 and 613, respectively. The analysed XYL 
activity in the feed (BXU/kg) in the CON, XYL, XOS and XYL + XOS supplemented 
diets were < 2000, 19700, < 2000 and 20800, respectively. Hence, the XYL dietary 
treatment had a recovery of 82 %, while the XYL + XOS treatment had a recovery of 87 
%. Recovery was lower than expected but similar in both XYL treatments. 
 
2.4.2 Pig performance and health observations 
Pig growth performance and health scores are presented in Table 2.2. There was no effect 
of XYL on any of the performance parameters throughout the trial, nor was there an 
interaction between XYL and XOS, hence only the main effects are presented. However, 
XOS supplementation increased ADFI (P < 0.010) and decreased G:F ratio (P < 0.002) 
during the first week of the trial (Day 1–7). During the second week of the trial (Day 8–
14), XOS supplementation increased ADFI compared to treatments without XOS (P < 
0.040), which led to a higher ADG (P < 0.003) and BW at day 14 (P < 0.040) but G:F 
ratio was not affected. There was also a trend for XOS supplemented pigs to have a higher 
ADFI between day 15–21 (P = 0.087). There was a trend for XYL fed pigs to have a 
higher G:F ratio between day 29–35 compared to those without XYL (P = 0.085). There 
were no significant main or interactive effects on overall performance (Day 1–35) of 
either XYL or XOS. There was no difference between treatments for average pen faecal, 





Table 2.2 Main effects of XYL and XOS on grower pig performance and health 
observations a 
    Treatments   P-Value 




XYL +  
XOS Inclusion (g/kg) 0.0 0.15 0.0 0.20   
BWd (kg)             
Day 1   14.5 14.6 14.5 14.6 0.31   0.470 0.640 0.360 
Day 7   17.2 17.2 17.3 17.2 0.08   0.590 0.220 0.630 
Day 14   20.7 20.6 20.5 20.8 0.17   0.620 0.040 0.800 
Day 21   24.9 24.6 24.6 24.9 0.22   0.210 0.180 0.480 
Day 28   29.8 29.2 29.4 29.6 0.31   0.130 0.590 0.290 
Day 35   35.6 35.2 35.2 35.6 0.32   0.310 0.390 0.640 
                 
ADGe (kg/d)                
Day 1–7   0.38 0.37 0.38 0.37 0.01   0.640 0.380 0.420 
Day 8–14   0.52 0.51 0.48 0.54 0.02   0.630 0.003 0.750 
Day 15–21   0.60 0.55 0.58 0.57 0.02   0.110 0.560 0.550 
Day 22–28   0.70 0.66 0.69 0.67 0.03   0.180 0.390 0.220 
Day 29–35   0.81 0.83 0.81 0.83 0.02   0.500 0.750 0.160 
Day 1–35   0.60 0.59 0.59 0.60 0.01   0.250 0.460 0.640 
                 
ADFIf (kg/d)                
Day 1–7   0.76 0.75 0.73 0.78 0.04   0.820 0.010 0.820 
Day 8–14   1.08 1.02 1.00 1.11 0.04   0.320 0.040 0.730 
Day 15–21   1.08 1.05 1.04 1.09 0.02   0.400 0.090 0.570 
Day 22–28   1.37 1.33 1.35 1.35 0.02   0.250 0.750 0.440 
Day 29–35   1.46 1.42 1.44 1.44 0.01   0.130 0.920 0.600 
Day 1–35   1.15 1.12 1.12 1.15 0.02   0.300 0.250 0.900 
                 
G:Fg                
Day 1–7   511 513 542 482 19.70   0.910 0.002 0.310 
Day 8–14   511 522 507 527 31.00   0.620 0.350 0.530 
Day 15–21   552 528 552 528 20.60   0.280 0.300 0.670 
Day 22–28   516 501 521 496 20.80   0.440 0.210 0.500 
Day 29–35   559 589 572 576 14.90   0.090 0.800 0.220 
Day 1–35   531 535 538 528 11.70   0.730 0.390 0.830 
                 
Faecal score - day 
1–35h 
  2.47 2.49 2.41 2.49 0.02   0.570 
Health score - day 
1–35i 
  0.10 0.10 0.08 0.11 0.01   0.920 
Cleanliness score – 
day 1–35j  
   1.13 1.14 1.16 1.17 0.01    0.590 
a Data are means of 24 replicate pens of 4–5 pigs. b XYL; xylanase. c XOS; xylo-
oligosaccharide. d BW; body weight. e ADG; average daily gain. f ADFI; average daily 
feed intake. g G:F; gain to feed ratio. h Faecal score; 1 = firm faeces, 2 = soft faeces, 3 = 
mild diarrhoea, 4 = severe diarrhoea. I Health score; 1 = no signs of ill health, 2 = some 
signs of ill health, 3 = clear indications of ill health, 4 = seriously ill pigs. j Cleanliness 
score; 1 = clean pigs, 2 = light contamination with faecal material, 3 = contamination with 
faecal material, 4 = heavy contamination with faecal material. k SEM: Standard error of 
the mean.  
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2.4.3 Bacterial community composition analysis 
Most faecal bacteria belonged to the phyla Firmicutes (51 %) and Bacteroidetes (40 %), 
jointly making up 91 % of the bacterial community (Table 2.3). Changes in the bacterial 
community over time and between dietary treatments were estimated at the phylum and 
genus level. There were 6 phyla with a relative abundance greater than 1 % in a minimum 
of one treatment or time group (Table 2.3). There was no effect of treatment on the relative 
abundance of OTUs at the phyla level, nor was there an interaction between dietary 
treatment and timepoint (TP; Table 2.3). There was a trend for the abundance of 
Tenericutes to be lowest in the CON group and highest in the XOS group (P = 0.059). 
The abundance of Tenericutes also decreased from day 1–14, and then preceded to 
increase from day 14–35 (P < 0.001). Spirochaetes tended to follow the same trend as 
that of Tenericutes over time (P = 0.091).  
 
There were 33 genera with a relative abundance greater than 1 % in a minimum of one 
treatment or time group (Table 2.3). Of the 33 genera, 17 were from the phylum 
Firmicutes, 11 from Bacteroidetes, 2 from Actinobacteria, 1 from Tenericutes, 1 from 
Spirochaetes and 1 from Epsilonbacteraeota. The abundance of 
Prevotellaceae_NK3B31_group was highest in the XOS group (P < 0.04). Of the 33 
genera, the abundance of 21 significantly changed over time (P < 0.05). Many genera 
decreased in abundance from day 1–14, namely, Phascolarctobacterium, 
Rikenellaceae_RC9_gut_group, Mollicutes_RF39_ge, Ruminococcaceae_unclassified, 
Prevotellaceae_NK3B31_group, Ruminococcaceae_NK4A214_group and Prevotella_1. 
Moreover, the abundance of many genera also increased from day 1–14, namely, 
Prevotella_7, Dialister, uncultured bacteria, Acidaminococcus, Mitsuokella, 






Table 2.3 The average relative abundance (> 1 %) at the Phyla and Genera level in pig faeces over time and between diets (n = 32). 
 




P Value  
Phylum1 Genus1 1 14 35 CONa XYLb XOSc XYL + XOS Day Diet Day × Diet  
Firmicutes 49.86 52.33 49.8 1.06 51.14 51.31 50 50.21 1.23 0.163 0.835 0.528 
Bacteroidetes 39.4 39.69 40.25 0.93 38.9 39.08 39.99 41.14 1.07 0.806 0.439 0.175 
Tenericutes 2.63a 1.59b 2.45a 0.21 1.8 2.24 2.73 2.12 0.24 <0.001 0.059 0.902 
Spirochaetes 2.11 0.96 1.78 0.38 1.47 1.97 2 1.02 0.43 0.091 0.338 0.779 
Proteobacteria 2.06 1.89 1.98 0.19 2.21 1.93 1.88 1.87 0.22 0.809 0.654 0.937 
Actinobacteria  1.62 1.9 1.17 0.67 1.75 1.74 1.22 1.55 0.31 0.155 0.593 0.356 
                         
Bacteroidetes Prevotella_9 12.59 14.04 11.25 0.92 12.43 13.42 10.56 14.09 1.06 0.107 0.109 0.904 
Firmicutes Lactobacillus 7.24 7.55 7.45 1.00 7.16 8.39 6.71 7.4 1.16 0.976 0.769 0.072 
Bacteroidetes Muribaculaceae_ge 6.54a 5.4a 8.60b 0.60 6.44 6.38 6.93 7.64 0.69 <0.001 0.544 0.854 
Firmicutes Lachnospiraceae_unclassified 5.69 5.26 4.28 0.50 5.54 4.36 5.28 5.12 0.58 0.130 0.511 0.680 
Firmicutes Megasphaera 5.46 6.02 6.27 0.60 6 6.6 5.83 5.24 0.69 0.616 0.579 0.987 
Firmicutes Phascolarctobacterium 4.17a 1.43b 1.63b 0.32 1.93 2.64 2.52 2.54 0.37 <0.001 0.529 0.682 
Bacteroidetes Rikenellaceae_RC9_gut_group 3.46a 1.68b 2.39c 0.21 2.6 2.46 2.72 2.25 0.24 <0.001 0.554 0.995 
Bacteroidetes Alloprevotella 2.91 3.9 2.98 0.36 3.44 3.19 3.01 3.42 0.42 0.103 0.874 0.616 
Tenericutes Mollicutes_RF39_ge 2.59a 1.56b 2.41a 0.21 1.77 2.21 2.67 2.1 0.24 <0.001 0.070 0.863 
Firmicutes Ruminococcaceae_UCG-002 2.56ab 1.85a 2.64b 0.22 2.02 2.22 2.85 2.3 0.25 0.020 0.116 0.950 
Firmicutes Ruminococcaceae_unclassified 2.35a 1.73b 2.05ab 0.13 2 1.88 2.25 2.04 0.15 0.004 0.369 0.928 
Firmicutes Subdoligranulum 2.3 2.38 1.6 0.24 2.08 2.41 1.8 2.08 0.27 0.040* 0.488 0.205 
Bacteroidetes Prevotella_7 2.28a 4.17b 3.70ab 0.44 2.94 3.37 3.83 3.39 0.51 0.010 0.678 0.614 










P Value  
Phylum1 Genus1 1 14 35 CONa XYLb XOSc XYL + XOS Day Diet Day × Diet  
Bacteroidetes Prevotellaceae_NK3B31_group 2.05a 0.92b 0.80b 0.19 1.09 1.04 1.83 1.08 0.22 <0.001 0.040* 0.182 
Firmicutes Dialister 2.01a 5.54b 3.70c 0.45 4.05 4.25 2.94 3.76 0.52 <0.001 0.297 0.488 
Bacteroidetes Prevotella_2 1.96 2.08 1.92 0.22 1.96 2.13 1.93 1.94 0.25 0.870 0.933 0.846 
Spirochaetes Treponema_2 1.9 0.76 1.59 0.36 1.24 1.74 1.81 0.88 0.42 0.077 0.353 0.726 
Firmicutes Ruminococcaceae_ge 1.88 1.81 2 0.17 1.8 1.95 1.96 1.88 0.19 0.702 0.932 0.063 
Firmicutes Ruminococcaceae_UCG-014 1.7 1.44 1.73 0.14 1.67 1.34 1.81 1.67 0.16 0.247 0.195 0.856 
Firmicutes Faecalibacterium 1.16ab 1.65a 0.89b 0.20 1.52 1.22 1.11 1.09 0.23 0.028 0.519 0.912 
Bacteroidetes Uncultured 1.06a 1.60b 1.17a 0.12 1.15 1.28 1.34 1.34 0.13 0.003 0.708 0.895 
Firmicutes Ruminococcaceae_NK4A214_group 0.87a 0.42b 0.58b 0.08 0.57 0.56 0.71 0.65 0.09 <0.001 0.611 0.605 
Bacteroidetes Bacteroidales_unclassified 0.86 0.8 0.97 0.18 1.05 0.75 1.05 0.65 0.21 0.783 0.395 0.272 
Actinobacteria Olsenella 0.82a 0.59ab 0.39b 0.10 0.65 0.78 0.39 0.58 0.12 0.014 0.117 0.240 
Firmicutes Acidaminococcus 0.79a 2.39b 2.28b 0.35 1.82 1.61 1.8 2.05 0.40 0.002 0.902 0.723 
Bacteroidetes Prevotella_1 0.79a 0.20b 0.42ab 0.11 0.58 0.44 0.46 0.42 0.13 <0.001 0.821 0.358 
Firmicutes Clostridiales_unclassified 0.71ab 0.45a 0.92b 0.10 0.74 0.49 0.84 0.69 0.12 0.007 0.207 0.873 
Firmicutes Mitsuokella 0.63a 2.15b 1.39ab 0.28 1.21 1.6 1.12 1.63 0.32 <0.001 0.581 0.712 
Firmicutes Oribacterium 0.53a 1.07b 0.75a 0.09 0.96 0.72 0.72 0.74 0.11 <0.001 0.323 0.152 
Epsilonbacteraeota Campylobacter 0.48 0.45 0.3 0.19 0.84 0.21 0.36 0.23 0.22 0.777 0.160 0.849 
Actinobacteria Collinsella  0.23 0.66 0.22 0.15 0.59 0.3 0.22 0.36 0.17 0.060 0.461 0.612 
Firmicutes Streptococcus 0.03a 0.74b 0.94b 0.15 0.84 0.3 0.64 0.49 0.17 <0.001 0.156 0.501 
a CON; Control. b XYL; Xylanase. c XOS; Xylo-oligosaccharides. 1Phyla and genera with > 1 % abundance in a minimum of one treatment or time group. 





The number of OTUs and alpha diversity (Chao1 and Shannon) are presented in Table 
2.4. The number of OTUs and Chao1 diversity was higher at day 35 compared to day 1 
and 14 (P < 0.001). Shannon indices were greater at day 35 than day 14, but not day 1 (P 
< 0.006). Dietary treatment did not affect the number of OTUs. However, XOS 
supplementation tended to have higher numbers of OTUs than the other dietary treatments 
(P = 0.078). Chao1 diversity was not significantly different between dietary treatments, 
but Shannon indices tended to be the lowest in the XYL treatment group and highest in 
the XOS treatment group (P = 0.089). There was no time × diet interaction for the number 
of OTUs or Shannon indices. However, there was a trend for Chao1 (P = 0.064), such 
that the CON and XYL treatments increased in diversity over time, whereas a reduction 
in diversity was observed at day 14, with a subsequent increase at day 35 for the XOS 
and XYL + XOS treatments. 
 
There was no diet × TP interaction for beta-diversity. The beta diversity of bacterial 
communities changed over time (P < 0.001; Figure 2.1) but was unaffected by treatment. 
An NMDS plot of the similarity of bacterial communities at each TP shows the 
divergence of day 14 samples from day 1 samples, whilst the samples at day 35 cluster 











Table 2.4 Number of OTUs and alpha diversity measures of bacterial community 






Day    
1 838.6a 1380.1a 4.6ab 
14 813.8a 1346.1a 4.5a 
35 940.8b 1572.1b 4.7 b 
     
Diet c    
CON  845.6 1389.4 4.6 
XYL 836.2 1387.2 4.5 
XOS 916.5 1505.8 4.7 
XYL + XOS 859.4 1448.7 4.6 
     
P value     
Day < 0.001 < 0.001 0.006 
Diet 0.078 0.115 0.089 
Day × Diet 0.262 0.064 0.975 
a-b Means within a column that do not share a common superscript are significantly 
different (P < 0.05). a Data are means of 8 replicates pigs. b OTU; operational Taxonomic 







Figure 2.1 Non-metric multidimensional scaling (NMDS) plot of Bray-Curtis 
similarity coefficients from 16S rRNA gene sequence data from individual pigs 
over time (n = 32, P < 0.001). 
 
 
Due to the significant effect of time on bacterial community composition, DESeq2 was 
used to identify individual OTUs which showed the greatest change in abundance 
between TP. Of interest, from day 1–14 (Figure 2.2), OTUs associated with Veillonella 
and Megamonas from the Veillonellaceae family increased by 24.2 and 10.0 log2 fold 
from a base mean of 17.61 and 74.12, respectively (base mean; mean counts of all samples 
normalised for sequencing depth; P < 0.001). The greatest decrease in abundance from 
day 1–14 was for OTUs associated with the genus Prevotella_2, where abundance 
decreased by 23.7 log2 fold from a base mean of 9.14. Of the top 10 decreases in 
abundance from day 1–14, all genera were from the Prevotellaceae, Muribaculaceae and 




Although there was no overall treatment effect for beta diversity, DESeq2 analysis 
between the CON group and the 3 dietary treatments was conducted to identify if specific 
OTUs were affected. Each dietary treatment (XYL, XOS and XYL + XOS) showed an 
increased abundance of OTUs associated with Muribaculaceae_ge (P < 0.05) and 
Prevotellaceae_NK3B31_group (P < 0.001) compared to the CON diet (Table 2.5). 
Moreover, all 3 dietary treatments showed a reduction in OTUs associated with 




























































































Increased from CONc to XYLd   Decreased from CON to XYL 
544 Prevotellaceae_NK3B31_group 20.9 20.26 <0.001   223 Prevotella_9 58.0 –27.08 <0.001 
270 Muribaculaceae_ge 2.9 14.89 0.022   452 Alloprevotella 5.3 –18.28 <0.001 
            4219 Ruminococcaceae_UCG-004 0.3 –16.27 0.034 
            428 Veillonellaceae_unclassified 14.9 –6.73 <0.001 
            41 Campylobacter 426.3 –2.53 0.039 
                      
Increased from CON to XOSe   Decreased from CON to XOS 
544 Prevotellaceae_NK3B31_group 20.9 22.93 <0.001   354 Prevotella_9 27.3 –25.58 <0.001 
317 Prevotella_7 10.2 22.79 <0.001   652 Prevotellaceae_NK3B31_group 9.3 –24.22 <0.001 
255 Prevotella_9 10.4 21.35 <0.001   408 Alloprevotella 5.1 –21.19 <0.001 
609 Dorea 6.3 21.28 <0.001             
270 Muribaculaceae_ge 2.9 15.14 0.002             
353 Treponema_2 27.7 10.97 <0.001             
                      
Increased from CON to XYL + XOS   Decreased from treatment CON to XYL + XOS 
544 Prevotellaceae_NK3B31_group 20.9 22.83 <0.001   286 Prevotella_7 33.3 –25.56 <0.001 
255 Prevotella_9 10.4 22.66 <0.001   698 Prevotella_9 9.2 –23.93 <0.001 
609 Dorea 6.3 21.86 <0.001   408 Alloprevotella 5.1 –21.35 <0.001 
317 Prevotella_7 10.2 21.61 <0.001   303 Bacteria_unclassified 47.2 –6.41 0.003 
270 Muribaculaceae_ge 2.9 21.37 <0.001             
a OTU; operational Taxonomic Unit. b Base mean; mean counts of all samples normalised for sequencing depth. c CON; Control diet. d XYL; Xylanase.  





2.5.1 Pig performance 
This study aimed to investigate the effects of XYL and XOS supplementation on the 
growth performance and faecal bacterial community composition of growing pigs over 
time. The nutritive value of cereals can be improved with XYL supplementation by 
increasing nutrient digestibility via the degradation of the plant cell walls and release of 
trapped nutrients and reducing digesta viscosity (Passos et al., 2015). Furthermore, the 
degradation of plant cell walls produces short-chain oligomers called XOS as an end-
product of xylan degradation in vivo. The oligomers produced during the hydrolysis of 
plant cell walls reach the hindgut and exert prebiotic effects by acting as substrates for 
selective bacteria, thus influencing the GIT bacterial community composition and 
subsequent energy provision for the host (Courtin et al., 2008; Ribeiro et al., 2018). 
Provision of XOS to the hindgut can be indirect via the supplementation of XYL or direct 
via the addition of commercially produced XOS into the diet. While it was expected that 
the supplementation of XYL, XOS and their combination would improve pig 
performance, there were no effects on overall growth performance in the current study.  
 
The effect of XYL supplementation on pig performance is inconsistent in the literature, 
most likely due to differences in the duration of the studies, age of pigs, XYL 
concentration and the type and quantity of dietary substrates (Barrera et al., 2004). A 
recent study found that 0.05 and 0.10 g/kg of XYL supplementation in a corn-soybean 
meal-based diet linearly increased ADG and G:F in weanling pigs (Lan et al., 2017). 
Moreover, others have found a higher concentration of XYL (0.50 g/kg) in a corn-soybean 
meal-based diet improved ADG and FCR in heavier pigs of 27–68 kg (Fang et al., 2007). 




week of the trial (Day 29–35), overall, pigs fed XYL supplemented diets showed a similar 
performance to those without XYL and therefore had no overall beneficial effects on 
growth performance. These findings agree with a study where weanling pigs (10–24 kg) 
receiving diets composed of corn, rye, wheat and soybean meal supplemented with 5 
different concentrations of a Bacillus circulans XYL between 0 and 32 000 U kg-1 did not 
show any improvements in growth performance (Olukosi, O.A. et al., 2007). Albeit, there 
were differences in the trials, for instance, the current study used a wheat-soybean meal 
diet and a Trichoderma reesei XYL. The age of the animal studied can also affect the pig 
performance response to XYL, for instance, including 0.10 g/kg of XYL in the first 2 
weeks post-weaning (3–5 weeks of age) has been shown to decrease BW, ADG and feed 
efficiency (Lu et al., 2019). However, XYL supplementation from 2 weeks post-weaning 
led to an improved final BW and overall ADG up to 6 weeks post-weaning (5–9 weeks 
of age). While the current study used pigs of 7–12 weeks of age, similar benefits of XYL 
inclusion were not shown despite this older age. 
 
The majority of research on XOS has been conducted in broilers where some studies have 
shown no effect on bird growth performance (Craig et al., 2019), while others have 
demonstrated beneficial effects on growth and immunity (Zhenping et al., 2013; Suo et 
al., 2015; Ribeiro et al., 2018). Despite this, there is a scarcity of research focusing on the 
effect of XOS in pigs. In the current study, XOS fed pigs had a higher ADFI but similar 
ADG compared to those without XOS, leading to a poorer G:F ratio in the first week of 
the trial (Day 1–7). However, during the second week of the trial from day 8–14, XOS 
increased ADFI by 0.11 kg/d which lead to an extra 60 g/d of growth and an increased 
BW of 0.35 kg at day 14, but this benefit was not maintained throughout the trial. It is 
sufficient to conclude that XOS had a limited effect on overall pig performance in the 




weanling pig study (Yin, J. et al., 2019) which reported no performance benefits when 
using a lower concentration of XOS at 0.10 g/kg (40 % purity XOS, 0.10 g/kg supplied 
0.04 g/kg of pure XOS). However, beneficial effects of XOS supplementation occurred 
in piglets where ADG increased by 17 % and G:F by 14 % compared to unsupplemented 
diets (Liu, J. et al., 2018). Likewise, another study showed XOS increased ADG and 
improved FCR in weaned pigs compared to a CON diet (Chen, Y. et al., 2021). However, 
there were considerable differences between the studies. For instance, the current study 
used a wheat-soybean meal diet, 7-week-old pigs and 0.20 g/kg of a 35 % XOS product 
supplying 0.07 g/kg of pure XOS. In comparison, a corn-soybean meal diet was used, 3‒
4 week-old piglets and either 0.20 g/kg of a 50 % purity XOS or 0.50 g/kg of a 95 % 
purity XOS product providing 0.10 or 0.48 g/kg of pure XOS (Liu, J. et al., 2018; Chen, 
Y. et al., 2021). Together, this indicates that a concentration of 0.10 ‒ 0.48 g/kg of pure 
XOS improves the performance of young pigs but highlights that concentrations of 0.04 
g/kg (Yin, J. et al., 2019) and 0.07 g/kg of pure XOS may not be a high enough 
concentration to elicit these benefits. Furthermore, the performance differences reported 
could be because the microbial community of the 7-week-old pigs in the current trial was 
more stable and less susceptible to change under the influence of XOS compared to a 
newly weaned pig with a more plastic microbiota, resulting in XOS having more of an 
effect in the younger pig.  
 
There was no difference between dietary treatments for average pen faecal, health or 
cleanliness scores from day 1–35. The average pen faecal score from day 1–35 across all 
treatments was 2.47, thus between the observations of ‘soft faeces’ and ‘mild diarrhoea’, 





2.5.2 Bacterial community composition  
To investigate the prebiotic effect of XYL and XOS in pigs, faecal bacterial community 
composition was studied by sequencing the V4 region of the 16S rRNA gene between 
dietary treatment groups and over time. Over 90 % of faecal bacteria belonged to the 
Firmicutes and Bacteroidetes phyla. Similar bacterial compositions to those found in this 
study have been observed in the literature (Kim, Hyeun Bum et al., 2011; Holman et al., 
2017). An interesting observation was the abundance of Tenericutes. The phylum 
Tenericutes consists of the class Mollicutes and are bacteria that lack a cell wall (Zhan et 
al., 2017). Tenericutes have been identified as an opportunistic phylum, and for example, 
a study showed that Tenericutes tended to increase with the inclusion of dietary flavonoid 
supplementation in dairy cows (Zhan et al., 2017). The abundance of Tenericutes was 
lower at day 14 compared to day 1 or 35 in the current study and showed a tendency to 
be lower in the CON group than the XOS group. Interestingly, Tenericutes were also one 
of the most dominant phyla after dietary XOS intervention for 6 months in pigs (Pan et 
al., 2019). At the genus level, most of these changes can be explained by the change in 
abundance of Mollicutes_RF39_ge which belongs to the Tenericutes phyla. This may 
indicate that the abundance of bacterial competitors of Mollicutes_RF39_ge was highest 
at day 14 and in the CON group, leading to the lower abundance observed. However, the 
functional roles of Mollicutes_RF39_ge remain unclear (Turnbaugh, 2017).  
 
Of the 33 genera identified to have an abundance > 1 %, the only genus affected by dietary 
treatment was the Prevotellaceae_NK3B31_group which was higher in the XOS group 
compared to the CON, XYL or XYL + XOS groups. Belonging to the Prevotellaceae 
family, the abundance of Prevotellaceae_NK3B31_group has been enriched in low FCR 
pigs compared to high FCR pigs (Quan et al., 2019), albeit there were no efficiency 




genera changed from day 1–14. These results may be explained by a change in diet since 
the pigs transitioned from a highly digestible weaner diet at day 1 to a more indigestible 
cereal-based grower diet, possibly explaining the flux in bacterial abundance while the 
bacterial community adjusted.  
 
Alpha diversity defines the diversity within a particular ecosystem and is commonly used 
as an indicator of species richness and evenness using Chao1 and Shannon indices 
measures, respectively (Pan et al., 2019). Disagreeing with hypothesis 2, dietary treatment 
had no significant effect on alpha diversity. This agrees with other studies investigating 
XOS (Pan et al., 2019; Pourabedin et al., 2017) and alternative prebiotics (Berding et al., 
2016; Li, 2017). XOS did show a trend for an increased number of OTUs and species 
evenness, indicating there is potential for XOS to increase alpha diversity. To this point, 
XOS has been shown to increase species richness (Chao1) in weanling pigs (Yin, J. et al., 
2019). Early bacterial colonisation and succession in the GIT are vital for establishing 
specific bacterial community compositions and subsequent host health. The age of the 
host has a notable effect on the diversity and bacterial community of the microbiome, 
with stability generally reached after 5 weeks of age (Thompson et al., 2008). Supporting 
this, in a trial with 3-month-old pigs, time had no effect on alpha or beta diversities over 
a 12-week sampling period, indicating that the bacterial communities had stabilised by 
this later age (Umu et al., 2015). Agreeing with hypothesis 2, the current study 
demonstrated that time influenced alpha diversity, particularly the number of OTUs and 
species richness, which was greater at day 35 compared to day 1 and 14. This indicates 





Beta diversity defines the heterogeneity of species composition between different 
communities along the environmental gradient, thus reflecting the species diversity 
between communities (Pan et al., 2019). In contrary to hypothesis 2, the beta diversity of 
bacterial community composition was not affected by dietary treatment; yet, it did change 
over time as hypothesised (no. 2). As shown in the NMDS graph, the communities at day 
14 diverged from day 1, while the communities at day 35 clustered more tightly, 
indicating a more homogenous bacterial community composition at the end of the trial. 
A change in diet may explain these results since the pigs transitioned from a highly 
digestible weaner diet at day 1 to a more indigestible cereal-based grower diet. These 
changes in raw material content could have altered the quantity and type of material that 
reached the hindgut, highlighting the importance of diet in shaping gut bacterial 
communities (Frese et al., 2015). This, in turn, likely disrupted the bacterial community. 
By day 35, it is likely the community had specialised in fermenting more indigestible 
materials. Similar results occurred in weanling pigs, where the composition of bacterial 
communities significantly diverged over two weeks after weaning, demonstrating 
bacterial community composition change over time irrespective of treatment (Looft et al., 
2012). Moreover, clustering tendencies have been observed between different doses of 
XOS in pigs. However, the growth stage at which XOS was added was postulated to have 
been more of a driving force to shape the gut microbiota structure than XOS dosage, 
which played a comparable insignificant role (Pan et al., 2019). 
 
To explore the time effect further, DESeq2 analysis was conducted to identify the greatest 
changes in abundance between day 1 and 14. Both Veillonella and Megamonas from the 
Veillonellaceae family increased with time. Veillonellaceae are gram-negative bacteria 
known for lactate fermentation (Bonder et al., 2016). Veillonellaceae is considered a pro-




syndrome increase their abundance (Gevers et al., 2014; Shukla et al., 2015), thus 
possibly indicating some gut dysfunction at day 14 in the current study. To this point, the 
abundance of the genera Megasphaera, Dialister and Mitsuokella which belong to the 
Veillonellaceae family were all identified as having a > 1 % relative abundance in the 
current study, with the latter 2 genera showing a significant increase in abundance at day 
14. With the primary function of the Veillonellaceae family being lactate utilisation (Daly 
et al., 2012), it is reasonable to assume that an increase of lactate could have been present 
in the gut at day 14, hence explaining the large increase in lactate-utilising bacterial 
abundance in the faeces. A potential reason for lactate presence could include an 
increased level of starch fermentation, whereby bacteria degrade starch into small 
polysaccharides or other metabolic intermediates such as lactate, thus increasing the 
abundance of lactate-utilising bacteria to prevent its accumulation (Trachsel, 2017; 
Duncan et al., 2004). Interestingly, the dietary switch from the digestible weaner diet to 
a more indigestible grower diet at day 1 resulted in a 28.6 % increase in dietary starch 
levels, from 350 to 450 g/kg. Most starch is usually digested in the upper GIT of 
monogastrics. Still, an overload of dietary starch into an immature digestive system or an 
increased level of resistant starch may lead to increased starch fermentation in the 
hindgut. Dissections and consequent GIT sample collection were not within the scope of 
this study. However, investigating starch digestion and lactate concentration along the 
GIT and its interplay with lactate-utilising bacteria and other metabolites in pigs would 
be interesting for future studies. This is of particular importance when considering cross-
feeding, as bacteria like Prevotella spp. or Bifidobacterium spp. may produce lactate as a 
metabolic intermediate of starch fermentation (Trachsel, 2017; Duncan et al., 2004), 
while species like Megasphaera elsdenii and Anaerostipes caccae utilise the lactate and 
produce butyrate, thus conferring additional health and energy benefits to the host 




Members of the Prevotellaceae, Muribaculaceae and Rikenellaceae families, which all 
belong to the order Bacteroidales, showed the greatest decline in abundance from day 1–
14. Prevotella spp. are adapted to metabolise a wide range of complex carbohydrates, and 
therefore provide benefits to the host via the production of SCFAs (Dou et al., 2017; De 
Filippo et al., 2010). Moreover, Muribaculaceae are involved in complex carbohydrate 
degradation (Lagkouvardos et al., 2019; Ormerod et al., 2016) and Rikenellaceae ferment 
carbohydrates and proteins (Su et al., 2014; Xin et al., 2019). As pigs age, the gut matures 
and becomes more efficient at degrading less digestible material. It is therefore expected 
that the abundance of bacteria capable of degrading complex carbohydrates would 
increase. With the change to a more indigestible cereal-based grower diet occurring at 
day 1, the microbiota was likely in a state of flux at day 14 while adapting to the change 
in quantity and different substrates reaching the hindgut.  
  
Although there was no overall treatment effect on bacterial community structure, 
disagreeing with hypothesis 3, there were some treatment effects worth mentioning. 
Supplementation of XYL decreased OTUs associated with Veillonellaceae_unclassified 
when compared to the CON group. Interestingly, similar results have also been reported 
in a weanling pig study (Lu et al., 2019). XYL decreased the abundance of 
Veillonellaceae and tended to decrease Megasphaera, both of which are members of the 
lactate-utilising Veillonellaceae family (Daly et al., 2012). This repeated observation may 
indicate that the mechanistic pathway of XYL could suppress the growth of 
Veillonellaceae families.  
 
Furthermore, OTUs classified as Prevotella_9 and Alloprevotella declined in all 3 dietary 




Muribaculaceae_ge and the Prevotellaceae NK3B31 group increased. 
Muribaculaceae_ge and the Prevotellaceae NK3B31 group belong to the 
Muribaculaceae and Prevotellaceae family, both of which have been associated with the 
degradation of complex carbohydrates, including xylan (De Filippo et al., 2010; Ormerod 
et al., 2016; Quan et al., 2019; Xin et al., 2019). This indicates that specific OTUs 
associated with both Muribaculaceae_ge and the Prevotellaceae NK3B31 group may be 
involved in the mechanistic pathways of XYL and XOS in the gut. Also, the combination 
of XYL and XOS would be expected to have an enhanced effect via a dual approach. The 
increase in Muribaculaceae_ge abundance (21.37 log2 fold) in the XYL + XOS treatment 
group was indeed higher than the increases seen in the single XYL and XOS treatment 
groups (14.89 and 15.14 log2 fold, respectively), albeit no performance benefits were 
seen. 
 
A series of experiments investigating the prebiotic activity of XOS in broilers showed 
improvements in bird performance and shifts in microbial populations in the upper GIT 
tract (Ribeiro et al., 2018). The authors postulated that even if all the supplemented XOS 
was converted to SCFAs at 100 % efficiency, this would not solely be responsible for the 
improvements observed. Hence, it is possible that XOS can act as a signal to the xylan-
degrading bacteria to increase in abundance and activity, thus improving xylan 
digestibility and efficiency of overall digestion. This stimulatory concept has been shown 
in broilers (Bautil et al., 2020) and described elsewhere in the literature (Bedford, Michael 
R, 2018; Petry and Patience, 2020). Despite the supplements in the current trial appearing 
to increase the abundance of some bacterial families associated with carbohydrate 
metabolism, xylan degradation along the GIT was not measured within this project's 
scope and no performance benefits were observed. A longer feeding period or an earlier 




communities would become xylan-degrading specialists and ultimately confer 
performance benefits to the host. 
 
2.5.3 Conclusion 
Overall, XYL and XOS supplementation had a limited effect on pig performance and 
faecal bacterial community composition. Results of this trial and comparison with the 
literature suggest a higher concentration of pure XOS (≥ 0.10 g/kg) in younger pigs may 
be necessary to observe performance benefits (assessed in Chapter 4). The degradation of 
xylan along the GIT coupled with bacterial community composition analysis would be of 









Chapter 3  
L-lactate concentration and metabolism in pig faeces  
3.1 Abstract  
Lactate is a metabolic intermediate that is quickly utilised by bacteria in the GIT, thus it 
is seldom detected in the faeces of healthy subjects or at low concentrations (< 3 mM). 
Accumulation of faecal lactate indicates the inability of the GIT bacterial community to 
clear hyper-lactate concentrations and could act as an indicator of bacterial imbalance and 
gut health status. This chapter presents a series of pilot studies with the aims of identifying 
(i) if L-lactate can be detected in piglet faeces and if concentrations change with age; and 
(ii) how quickly a known concentration of L-lactate is metabolised by pig faecal bacteria. 
In experiment 1, faecal samples from 5 piglets were collected on a weekly basis from a 
week before weaning until 20 days post-weaning for faecal L-lactate analysis, as well as 
4 grower and finisher samples at one point in time. Samples were thawed, deproteinised 
and L-lactate concentrations were measured using a colorimetric assay kit. In experiment 
2, a faecal sample was taken from a finisher pig and immediately aliquoted into 1 of 2 
extraction solution types, distilled water (n = 14) or phosphate buffer solution (PBS; n = 
14). The samples were then equally split between 2 sample fraction groups; ‘Whole’ 
unseparated samples or separated ‘Supernatant’ samples. Samples were then spiked with 
5 mM of L-lactate at 0 min, and L-lactate concentration was measured at 7 TPs; 0, 20, 
30, 60, 120, 240 and 360 min using a colorimetric assay or handheld L-lactate Scout 
(SCT) device. L-lactate concentrations were also measured with the SCT immediately 
before and after freezing to assess the effect of freeze-thawing. Data were analysed using 
repeated measures mixed analysis (JMP-v14). Experiment 1 showed that L-lactate 
concentrations were low or below the minimum detectable range of the assay (< 0.02 
mM) in piglet faeces, with only 20 % of samples having detectable concentrations, the 




or finishing pig faeces. Experiment 2 showed a 3-way interaction between TP, sample 
fraction and analytical method (P < 0.001). At 0 min, the SCT device correctly measured 
the spiked ~5 mM L-lactate concentration in both the ‘Whole’ and ‘Supernatant’ samples 
but the assay measured lower concentrations, suggesting elements within the faecal 
matrix may have interfered with the assay. L-lactate concentration in the ‘Whole’ samples 
decreased to ~0.60 mM after 360 min when measured by the SCT device and was 
undetectable after 120 min with the assay, indicating L-lactate metabolisation by pig 
faecal bacteria. L-lactate concentration in the ‘Supernatant’ samples, where bacteria were 
separated via centrifugation prior to lactate addition, remained stable over time when 
measured by both the SCT and assay. There was no effect of solution type on lactate 
concentrations (P > 0.050), and the freeze-thaw cycle reduced L-lactate concentrations 
(P < 0.020). In summary, L-lactate can be detected in piglet faeces albeit at low levels, 
whilst 5 mM of L-lactate was metabolised by pig faecal bacteria in 360 min. The SCT 
device is a suitable real-time method for measuring L-lactate concentrations compared to 
the colorimetric assay which failed to measure the spiked concentration. Faecal collection 
for L-lactate analysis must be rapid and the use of a buffer to halt microbial activity may 












3.2 Introduction  
GIT health, or gut health, is a key topic of interest in the animal nutrition field. The term 
‘gut health’ lacks clear definition in the scientific literature, although it is commonly used 
in both human medicine and in animal health (Bischoff, 2011). Gut health covers multiple 
aspects of the GIT, such as effective digestion and absorption of food, the absence of GIT 
illness, normal and stable intestinal microbiota, effective immune status and a state of 
well-being (Bischoff, 2011). The function of the GIT is not restricted to food digestion 
and nutrient absorption but is also integral to host health. The GIT communicates with 
bacteria that support digestion via their enzymatic capabilities (Blaut and Clavel, 2007) 
and regulate major immune functions vital for gut and general health (Chung and Kasper, 
2010). Moreover, the gut-brain axis transmits information from the GIT to the brain to 
feedback detection of dietary nutrients and other conditions that might affect mood and 
general well-being (Tsurugizawa et al., 2009). The assessment of gut health status is 
important but remains a challenge as it is difficult to evaluate the condition of the gut non-
invasively. Rapid, accurate and non-invasive diagnostics to assess intestinal condition on-
farm are required to act as a diagnostic tool and determine the effectiveness of potential 
treatments of gut disorders (Derikx et al., 2010).  
 
Various non-invasive markers of gut health have been studied but none provide 
instantaneous results and are not commercially practical, available or used. This is mainly 
due to the need for scientific or veterinary intervention, requirement of a home office 
license or impracticality in a farm setting. The measurement of lactate in faecal samples 
has the potential to act as a marker of microbial imbalance, albeit this is a new research 
area for the pig sector. Lactate is present in isoforms in the body, D- and L-lactate. 
Usually, lactate exists entirely in the L-lactate form as mammalian cells almost 




to pyruvate by L-lactate dehydrogenase (LDH) (Ewaschuk et al., 2005). In comparison, 
D-lactate is formed in miniscule concentrations from methylglyoxal via the glyoxalase 
pathway in mammalian organisms (Kowlgi and Chhabra, 2015). Mammals lack D-LDH, 
and instead it is thought to be metabolised to pyruvate by the enzyme D-α-hydroxy acid 
dehydrogenase, which metabolises D-lactate at about one-fifth of the rate that L-LDH 
metabolizes L-lactate (Ewaschuk et al., 2005).  
 
Both L- and/or D-Lactate can be produced by the bacterial communities in the GIT in 
varying amounts depending on the relative concentration and biological activity of 
different bacterial species (Kowlgi and Chhabra, 2015). L-lactate is the major 
fermentation end-product of LAB such as Lactobacillus, Bifidobacterium, Enterococcus 
and Streptococcus (Duncan et al., 2004). The lactate isomer produced by bacteria depends 
on the genus, species and strain as seen in Table 3.1 (Blake, 2017). The production of 
lactate and associated reduction in pH of the gut environment can be beneficial as it 
restricts the growth of potentially pathogenic bacteria like Escherichia coli and 
Clostridium perfringens (Bakker-Zierikzee et al., 2005). Furthermore, bacteria such as 
Megasphaera, Anaerostipes, Selenomonas and Veillonella are capable of utilising lactate 
and converting it mainly to acetate and propionate, and in the case of Megasphaera and 
Anaerostipes also butyrate (Counotte et al., 1981; Hashizume et al., 2003; Muñoz-
Tamayo et al., 2011). Butyrate acts as an energy source for gut epithelial cells and is 
generally deemed beneficial for host growth, gut health and inflammation (Guilloteau et 
al., 2010). Therefore, lactate plays important roles within the gut ecosystem and cross-






Table 3.1 Lactate isomers produced by bacteria in the gastrointestinal tract (Blake, 
2017). 
 































(Sheedy et al., 
2009) 
 
Lactate is rarely detected as a major fermentation product of mixed anaerobic bacterial 
communities in human faeces or gut contents due to its rapid utilisation by other bacterial 
species (Duncan et al., 2004). One study assessed the content of lactate and SCFA 
concentrations along the GIT of growing pigs and found a high lactate concentration at 
the start of the GIT in the jejunum (69.1 mM) and lower concentrations in the caecal 
digesta (36.3 mM) and faeces (2.5 mM) (Brestenský et al., 2017). Results showed that 
lactate concentration decreased linearly with an increasing content of other SCFAs, which 
is explained by the large microbial population in the caeca that metabolise lactate and 
convert it to other SCFAs. This utilisation means that faecal lactate concentrations are 
usually < 5 mM in healthy individuals (Duncan et al., 2004). Any lactate that is unused 
by bacteria is either absorbed by the host or excreted in the faecal matter (Blake, 2017). 
However, lactate can accumulate in the faeces up to ~100 mM in individuals who have 




1994; Kaneko et al., 1997; Vernia et al., 1988). Some report this to be due to poor 
carbohydrate digestion, increased fermentative activity and a relative increase in lactate-
producing species (Ewaschuk et al., 2005), whilst others suggest that once the pH reduces 
past a certain point (pH 5.2) lactate production is maintained but lactate utilisation 
decreases (Belenguer et al., 2007).  
 
In SBS patients where the small intestine is absent or reduced in length, an increased load 
of undigested carbohydrates reach the colon (Kowlgi and Chhabra, 2015). As a result, the 
number of metabolites produced exceeds the amount that can be metabolised or absorbed, 
leading to the accumulation of SCFAs and lactate, subsequently leading to a reduction in 
pH. As previously mentioned, a reduction in gut pH can be beneficial in restricting the 
growth of potentially pathogenic bacteria, yet the more acidic environment also favours 
the growth of lactate-producing species as they are acid-resistant. This results in a cascade 
where further lactate is produced, further decreases in pH are seen and more lactate 
accumulates (Kowlgi and Chhabra, 2015; Mayeur et al., 2013). In particular, the 
concentration of D-lactate accumulation in SBS patients can be serious and lead to 
neurotoxicity and cardiac arrythmia in humans (Chan et al., 1994; Vella and Farrugia, 
1998). This highlights the vital role of the GIT microbiota in the production and utilisation 
of lactate under disease conditions. In comparison, the mechanism of lactate 
accumulation and disease development of ulcerative colitis is uncertain. However, 
colonic infusion of donor human intestinal bacterial communities from healthy 
individuals has been reported to permanently reverse the condition in some cases, 





A rapid and large influx of readily fermentable substrates, such as starch, can induce 
lactate accumulation in the large intestine or faeces of non-ruminant mammals. In rats, 
the ingestion of certain oligosaccharides induced an accumulation of lactate and succinate 
up to ~70 mM in the caecum and reduced the pH to 5.5 (Hoshi et al., 1994). In pigs fed a 
low digestible diet, increased levels of undigested and unabsorbed food residues acted as 
substrates for fermentation by the GIT bacterial community which lead to increased faecal 
lactate concentrations (Etheridge et al., 1984). This could be caused by a rapid increase 
in abundance of amylolytic lactate-producing bacteria, and/or the reduction of lactate-
utilising bacteria. In the absence of lactate-utilising bacteria, lactate accumulation is rapid 
as it is very slowly absorbed by epithelial cells (Umesaki et al., 1979). An in vitro model 
of pig caecal fermentation showed that lactate accumulation can be avoided if digesta pH 
is maintained > 6 when oligosaccharides were provided as a substrate (Ushida and Sakata, 
1998). This is further supported by a dairy calf study which demonstrated the majority of 
high lactate concentrations were observed in faeces with a pH <  6 (Shimomura and Sato, 
2006).  
 
Luminal accumulation of lactate can lead to diarrhoea as it causes an osmotic pressure 
which results in water secretion from the mucosa into the large intestine (Saunders and 
Sillery, 1982). One study investigated pigs’ faecal organic acid profiles with pathogenic 
and non-pathogenic diarrhoea (Tsukahara and Ushida, 2001). While diarrhoetic piglets 
receiving antibiotic treatments and those with dyspepsia (non-pathogenic) exhibited high 
faecal lactate concentrations, this was not so for piglets with colibacillosis. It was 
concluded that the rapid quantitative analysis of lactate in diarrhoetic faeces would 
provide a possible method for differentiating between colibacillosis and non-pathogenic 
diarrhoea in piglets. Differing lactate isomers and concentrations have also been seen with 




seldom detected in faeces. The detection of lactate in faecal matter may therefore indicate 
a gut microbial imbalance where lactate has been able to accumulate either due to an 
increase in lactate-producing bacteria and/or a reduction in lactate-utilising bacteria. 
 
In a previous trial (Chapter 2), the abundance of bacteria from the Veillonellaceae family 
were shown to increase in pig faecal matter over time. Veillonellaceae are gram-negative 
lactate-utilising bacteria (Bonder et al., 2016). Although lactate was not measured, it is 
reasonable to assume that an increase of lactate could have been present in the gut, 
explaining the large increase in lactate-utilising bacteria abundance. This may have been 
due to a microbial imbalance or the dietary switch from a digestible weaner diet to a more 
indigestible grower diet that was accompanied by a 28.6 % increase in dietary starch and 
possible increase of starch fermentation. The overall aim of the research reported in this 
chapter is to determine if lactate can be measured in pig faeces and potentially act as a 
non-invasive and rapid marker of microbial imbalance. 
 
3.2.1 Study aims 
Coupled with the stress of weaning that encompasses abrupt dietary, social, bacterial and 
environmental changes, young piglets have an underdeveloped and immature GIT system 
making them vulnerable to diseases and dysbiosis. The dietary switch from easily 
digestible sows’ milk to a more indigestible solid feed has a large impact on the GIT 
bacterial community as it abruptly adapts to utilise different feed materials that reach the 
hindgut. Therefore, the piglet is at increased risk of lactate accumulation and inability to 





The aim of experiment 1 was to investigate whether L-lactate could be detected in piglet 
faeces over the weaning period using a colorimetric assay kit and to determine whether 
faecal concentrations changed with age. The aim of experiment 2 was to decipher how 
quickly a known concentration of L-lactate would be metabolised by pig faecal bacteria; 
this was compared between different testing solutions, sample fractions and using 
different analytical methods. The analytical methods tested were a colorimetric assay kit 
and a handheld L-lactate SCT device. The SCT device was tested for its suitability as an 
on-site real-time detection method, with the overall aim of determining best practise for 
measuring L-lactate as an indicator of gut health in pigs on farm. A series of pilot trials 
were conducted to assess the study aims. 
 
3.2.2 Hypotheses 
3.2.2.1 Experiment 1 
1. L-lactate will be detected in piglet faeces.   
2. Faecal L-lactate concentrations will be higher immediately after weaning than 
before weaning. 
3. After weaning, faecal L-lactate concentrations will decrease over time as the 
piglet ages and the GIT bacterial communities become more developed and 
established.  
3.2.2.2 Experiment 2 
4. Metabolism of L-lactate by faecal bacteria will be rapid and full utilisation of a 
known concentration will occur within 6 hours as seen in the literature.  
5. L-lactate will be metabolised when kept in contact with faecal bacteria (‘Whole’ 
samples), but to a lesser extent when the L-lactate is added to the ‘Supernatant’ 




6. L-lactate concentration will be similar when measured by the colorimetric assay 
or handheld L-lactate SCT device.  
7. L-lactate concentration will be similar before and after freeze-thawing. 
 
3.3 Materials and methods 
3.3.1 Animals  
The animals used in experiments 1 and 2 were from the University of Leeds’ Spen Farm 
breeding herd ((Large White × Landrace females) × JSR Pietrain-based Geneconverter 
900 sire line).  
3.3.1.1 Animals - experiment 1 
A week before weaning, 5 piglets were randomly selected from different sows in their 
respective farrowing crates for faecal sampling. They were followed throughout the 4-
week trial at Spen Farm, Leeds, UK. Faecal samples were taken weekly, starting from 7 
days before weaning until 20 days post-weaning, referred to as TP 1–5 as described 
below.  
• TP 1: 7 days before weaning 
• TP 2: Immediately post-weaning 
• TP 3: 7 days post-weaning  
• TP 4: 14 days post-weaning 
• TP 5: 20 days post-weaning 
 
Selected piglets were weighed at TP 1, 2 and 5 to determine piglet growth rate. In 
addition, at TP 1, 4 grower pigs (42 kg ± 3.3 kg) and 4 finisher pigs (106 kg ± 3.9 kg) 
were also randomly selected from the herd for faecal sampling to determine whether L-




3.3.1.2 Animals – experiment 2 
A finisher pig with a BW of 96 kg was randomly selected for faecal sampling from within 
the indoor finishing herd at Spen Farm, Leeds, UK.   
 
3.3.2 Sample collection and processing  
3.3.2.1 Sample collection and processing - experiment 1 
Faecal samples were collected immediately after defecation and placed on ice before 
further processing. A 2.5 g homogenised sub-sample of each faecal sample was weighed 
into a 15 ml falcon tube filled with 10 ml of distilled water [adapted protocol from 
(Shimomura and Sato, 2006)]. After thorough homogenisation by manual shaking, 
samples were centrifuged for 10 min at 2000 × g at room temperature. The supernatant 
(2 – 5 ml) was collected and immediately placed on dry ice. Samples were transferred to 
the laboratory and stored at –80 ºC until analysis. 
 
3.3.2.2 Sample collection and processing - experiment 2 
A schematic diagram for the methodology of experiment 2 is shown in Figure 3.1. A large 
faecal sample (ca 100 g) from the randomly selected finisher pig was collected 
immediately after defecation and placed on ice before further processing. Within minutes 
of collection, 2.5 g of the homogenised faecal sample was weighed into a 15 ml falcon 
tube containing either 10 ml of distilled water (n = 14) or 10 ml of PBS (n = 14) and 
thoroughly homogenised. The samples were equally split between 2 groups for processing 
(‘Whole’ or ‘Supernatant’; sample fraction).  
 
• ‘Whole’ samples (Water, n = 7; PBS, n = 7) were spiked with 5 mM of L-lactate 




360 min, the sample was centrifuged for 5 min at 2000 × g and the supernatants 
were collected before being immediately frozen on dry ice and transported to a –
80 ºC unit until analysis.  
 
• ‘Supernatant’ samples (Water, n = 7; PBS, n = 7) were first centrifuged for 5 min 
at 2000 × g and the supernatant collected into a new falcon tube. The supernatants 
were then spiked with 5 mM of L-lactate. Samples were kept at room temperature 
and then frozen on dry ice at each TP (as described for the ‘Whole’ samples above) 
and transported to a –80ºC unit until analysis. 
 
L-lactate concentrations were measured in duplicate at each TP using 2 analytical 
methods; a handheld L-lactate SCT device (EKF-Diagnostics) was used to measure real-
time L-lactate concentrations immediately before freezing on dry ice or a L-lactate 






Figure 3.1 Schematic methodology of experiment 2 (Timepoint, TP; L-lactate 










3.3.3 L-lactate analysis  
3.3.3.1 L-lactate analysis - experiment 1 
Samples were thawed and deproteinised prior to analysis using the Trichloroacetic acid 
(TCA) method according to the kit manufacturers’ protocol (Biovision, K823-200). 
Briefly, 100 µl of sample was mixed with 15 µl of cold (4 ºC) TCA in a 1.5 ml 
microcentrifuge tube. The sample was kept on ice for 15 min before centrifugation at 
12000 × g for 5 min and collecting the supernatant. To neutralise excess TCA, 10 µl of 
cold (4 ºC) neutralisation solution was mixed with the supernatant and placed on ice for 
a further 5 min. The resulting sample was used directly in the L-lactate assay.  
 
A colorimetric assay kit (Biovision, K627-100) was used to measure L-lactate 
concentration in the faecal samples according to the kit manufacturers’ protocol. To 
ensure the readings were within the standard curve range, 4 dilutions were tested 
including undiluted, 1:1, 1:10 and 1:20, of which the undiluted samples were the best fit. 
Test samples were prepared in duplicate at 50 µl/well. A reaction mix was prepared 
containing 46 µl of lactate assay buffer, 2 µl of lactate substrate mix and 2 µl of lactate 
enzyme mix. In addition, 2 samples were tested for nicotinamide adenine dinucleotide + 
hydrogen and nicotinamide adenine dinucleotide phosphate background levels in the 
absence of the lactate enzyme mix (adjusted 48 µl lactate assay buffer and 2 µl lactate 
substrate mix). The reaction mix was added to each well and incubated at room 
temperature for 30 min before being measured on a microplate reader at 450 nm. Sample 
concentrations were corrected for assay background levels, deproteinisation dilution 
(0.8), initial sample dilution (0.2) at collection and were calculated back to mM per g of 





3.3.3.2 L-lactate analysis - experiment 2 
Initial L-lactate concentrations were measured in duplicate using the SCT device 
immediately prior to freezing. The SCT device works by enzymatic amperometry where 
L-lactate oxidase coats the electrode and reacts with lactate, this produces hydrogen 
peroxide which then generates an electrical current that is proportional to the amount of 
L-lactate in the sample. L-lactate sensors were kept at 4 ºC and allowed to come to room 
temperature 20 min before use. As seen in Figure 3.2, to take a reading, a sensor was 
inserted into the handheld device and then placed into the media. This was repeated with 
a new sensor to take duplicate readings.  
 
 Figure 3.2: Handheld L-lactate Scout (SCT) device with sensor.  
 
After thawing, L-lactate concentrations were re-measured in all samples using the lactate 
SCT device to assess the impact of freeze-thawing. Following this, samples were 
deproteinised and L-lactate concentrations were measured in duplicate using a 
colorimetric assay, as per experiment 1 described above. To ensure the readings were 
within the standard curve range, 3 dilutions were tested according to the initial SCT 




at 1:10, whilst readings at < 2 mM were diluted at 1:1, and those with non-detectable 
readings below the 0.5 mM detection range of the SCT device were left undiluted. Sample 
concentrations were corrected for assay background levels, deproteinisation dilution (0.8) 
and sample dilutions as described above. SCT results were corrected for the constant 
automatic haematocrit adjustment made by the handheld device (0.2), as suggested by the 
supplier. Duplicate readings were averaged.  
 
3.3.4 Statistical analysis  
Statistical analysis was not possible on data from experiment 1 due to the small sample 
size and non-detectable concentrations. Data from experiment 2 were analysed using a 
repeated measure mixed analysis (JMP-v.14), with TP, analytical method (SCT and 
assay), sample fraction (‘Whole’ and ‘Supernatant’) and solution (Distilled water and 
PBS) as factors. The effect of freezing on L-lactate concentration in each sample fraction 
was assessed using a repeated measure mixed analysis (JMP-v.14), with TP and pre- or 
























3.4.1 Results - experiment 1 
The post-weaning growth performance of the study piglets was similar to the average 
performance of the unit, with an ADG of 0.35 kg/d (± 0.06 kg/d) from TP 2–5. All piglets 
remained healthy throughout the sampling period, had normal faecal consistency and 
received no antibiotics.  
 
Experiment 1 investigated whether L-lactate could be detected in piglet faeces and 
whether faecal concentrations changed with age. L-lactate concentrations were low or 
below the minimum detectable range of the assay (< 0.02 mM), as shown in Table 3.2. 
Only 20 % of samples showed concentrations that were detectable, ranging from 0.03 to 
0.34 mM per g of faeces, with the majority of these measurable concentrations being at 
TP 2, which was immediately post-weaning. L-lactate concentrations were undetectable 
at TP 4 and 5, or in the grower and finisher pig samples (data not shown).  
 
Table 3.2 L-Lactate concentration (mM per g of faeces) in piglet faeces over time. 
 
Piglet 
L-Lactate concentration (mM per g of faeces) 
TP 1a TP 2b TP 3c TP 4d TP 5e 
1 ND 0.18 ND ND ND 
2 ND 0.25 ND ND ND 
3 ND 0.16 0.03 ND ND 
4 ND ND ND ND ND 
5 0.34 ND ND ND ND 
ND: Non-detectable. a TP; Timepoint 1: 7 days before weaning. b TP 2: Immediately post-








3.4.2 Results - experiment 2 
Experiment 2 aimed to decipher how quickly a known concentration of L-lactate would 
be metabolised by pig faecal bacteria between different testing solutions, sample fractions 
and using different analytical methods. There was a significant 3-way interaction between 
TP, sample fraction and analytical method (Figure 3.3; P < 0.001). At 0 min (baseline), 
the SCT device correctly measured the spiked L-lactate concentration (~5 mM) in both 
the ‘Whole’ and ‘Supernatant’ samples. However, the colorimetric assay yielded 
concentrations much lower at the same TP in both the ‘Whole’ and ‘Supernatant’ samples. 
L-lactate concentration in the ‘Whole’ samples decreased to ~0.60 mM over 360 min 
when measured by the SCT device and was undetectable after 120 min with the 
colorimetric assay. L-lactate concentration in the ‘Supernatant’ samples remained stable 
over time when measured by both the SCT and assay. There was no significant effect of 
solution type (distilled water vs PBS) on L-lactate concentrations (P > 0.050).  
 
Figure 3.3 L-lactate concentration (mM) in pig faeces over time in different 
solutions, different sample fractions and measured by different analytical methods 





There was a significant effect of the freeze-thaw process on L-lactate concentrations in 
the ‘Whole’ samples (P < 0.020; Figure 3.4) and a trend for the ‘Supernatant’ samples (P 
= 0.053; Figure 3.5). Over time, the average L-lactate concentration in the ‘Whole’ 
samples in distilled water and PBS were –0.18 mM and –0.27 mM lower, respectively, 
after freeze-thawing compared to real-time analysis before freezing. Over time, the 
average L-lactate concentration in the ‘Supernatant’ samples in distilled water and PBS 
were –0.32 mM and –0.45 mM lower, respectively, after freeze-thawing compared to 
real-time analysis before freezing.  
 
 
Figure 3.4 L-lactate concentration (mM) over time in ‘Whole’ samples measured 
in real time (before freezing) and after freeze-thawing by the L-lactate Scout 






Figure 3.5 L-lactate concentration (mM) over time in ‘Supernatant’ samples 
measured in real time (before freezing) and after freeze-thawing by the L-lactate 

























Lactate is seldom detected in the faeces of healthy subjects as bacteria rapidly metabolise 
it in the GIT. However, lactate can accumulate in the faeces of individuals suffering from 
certain GIT disorders (Hove et al., 1994). Lactate accumulation can be caused by various 
gut disorders and an overload of undigested carbohydrates to the hindgut. An over-
production of lactate by lactate-producing bacteria or a reduction in lactate metabolism 
by lactate-utilising bacteria can cause lactate to accumulate in the GIT environment. For 
this reason, the measurement of lactate in pig faeces has the potential to act as a marker 
of microbial imbalance and an indicator of gut health.  
 
Experiment 1 investigated whether L-lactate could be detected in piglet faeces around 
weaning and whether faecal concentrations changed with age. Results showed that L-
lactate concentrations were low or below the minimum detectable range of the 
colorimetric assay, hence partially agreeing with hypothesis 1. Only 20 % of samples 
showed detectable concentrations, ranging from 0.03 – 0.34 mM per g of digesta. In 
faeces from healthy dogs, L-lactate concentrations were reported to be around ~0.60 mM 
(Blake, 2017). In growing pigs (~25 kg), faecal lactate concentrations of ~0.80 – 2.80 
mM have been reported, although it was not stated whether the D- or L- isomer was 
measured or if the values represented total lactate (Brestenský et al., 2017). The L- and 
D-lactate concentrations in the stomach, duodenum, ileum, caecum and colon of weanling 
pigs have also been investigated (Mathew et al., 1998). Although faecal lactate 
concentrations were not measured, L-lactate was not detectable in the colon of CON fed 
pigs, and D-lactate was only detectable at 0.10 – 0.30 mM, indicating that very low or no 
lactate would have been detected in faeces. Hence, the L-lactate concentrations found in 





Moreover, 3 of the detectable L-lactate readings were at TP 2, which were taken 
immediately post-weaning, partially supporting hypothesis 2. Weaning is an extremely 
stressful time for the piglet with abrupt changes to diet, social, bacterial and 
environmental life conditions (Kim, J. et al., 2012). These stressors can affect the gut 
microbiome, physiology and ultimately increase susceptibility to enteric disease (Pajarillo 
et al., 2014). The presence of faecal lactate around the weaning period is most likely 
multifactorial. Firstly, although not instantaneous, weaning is associated with marked 
changes to the histology and biochemistry of the small intestine such as villous atrophy 
and crypt hyperplasia, leading to an overall reduction in digestive and absorptive capacity, 
and subsequent increase in substrate fermentation (Pluske et al., 1997). Secondly, 
weaning stress causes abrupt changes to the microbiome often leading to dysbiosis in 
bacterial communities (Gresse et al., 2017). Suppose the GIT bacterial communities were 
in a state of flux and adaption. In that case, the abundance of lactate-producing and 
utilising bacteria may have been unbalanced leading to the presence of lactate in the 
faeces. By the week after weaning (TP 3), L-lactate was either non-detectable or had 
greatly reduced. This suggests either a possible increase in digestive and absorptive 
capacity leading to less substrate fermentation or stabilisation of the bacterial 
communities. L-lactate concentration did not show a decreasing relationship with age as 
expected, hence disagrees with hypothesis 3.   
 
Lactate concentration in faeces has been measured successfully over time in dairy calves 
(Shimomura and Sato, 2006). Elevated total faecal lactate concentrations were observed 
within the first 4 weeks of life but then remained low (~ < 5 mM) after this age 
(Shimomura and Sato, 2006). Lactate is considered the main anion in the immature gut 
flora of the colonic lumen in early life. It is thereafter replaced by replaced by SCFAs 




Sato, 2006). The processing of calf faeces involved homogenising 5 g of faeces with 20 
ml of water, separating the sample via centrifugation and freezing the supernatant before 
sample analysis (Shimomura and Sato, 2006). Before analysing D- and L-lactate 
concentrations with a UV method using an LDH assay kit, the thawed supernatant was 
deproteinized with zinc sulfate and potassium hydroxide. A similar methodology was 
used in the current study, but slightly adapted with half the faecal matter quantity due to 
the difference in animal size and amount of faeces produced in a single defecation. 
Furthermore, samples were deproteinised using the TCA method as recommended by the 
colorimetric assay kit used to measure L-lactate concentrations via LDH. In summary, 
experiment 1 showed that L-lactate can be detected in piglet faeces but at very low or 
non-detectable concentrations.  
 
 
Experiment 2 was designed to investigate the metabolism of L-lactate by pig faecal 
bacteria over time, and whether this differed between solutions and sample fractions. This 
experiment also compared a colorimetric assay with a real-time handheld device to 
determine its potential as an on-farm rapid analysis technique. The concentration of 
lactate in blood is one of the most commonly measured parameters taken during clinical 
exercise testing or performance analysis of athletes (Goodwin et al., 2007). Small 
handheld analysers like the SCT device that measure blood L-lactate are available on the 
marketplace and are used by athletes to monitor their blood lactate concentrations with 
the aim of improving their fitness and endurance training. When compared to a 
spectrophotometric analyser method, the SCT device has also proved a reliable alternative 
method when assessing blood L-lactate concentrations in dogs (Ferasin et al., 2007). 
Similar accurate and reliable blood L-lactate results using the SCT device have been 




Heuwieser, 2012; Rocha et al., 2015). The handheld analysers are based on enzymatic 
amperometry, whereby L-lactate oxidase coats an electrode and reacts with lactate, this 
produces hydrogen peroxide which then generates an electrical current that is 
proportional to the amount of L-lactate in the sample (Pang and Boysen, 2007; Allen and 
Holm, 2008). However, handheld L-lactate analysers like the SCT device are modified 
for use in blood and make automatic compensations for haematocrit levels (Blake, 2017), 
making their use sub-optimal in other biological samples unless the correction factor is 
known and adjusted for. To the authors knowledge, the SCT device has not previously 
been tested on faecal matter.  
 
Results showed that the SCT device correctly measured the spiked L-lactate 
concentration of ~ 5 mM at 0 min (baseline) in both the ‘Whole’ and ‘Supernatant’ 
samples, indicating the device can measure L-lactate in faecal matter. Regardless of 
solution, the initial SCT reading at 0 min in the ‘Supernatant’ samples was very close to 
the spiked concentration at 5.08 mM. In comparison, regardless of solution, in the 
‘Whole’ samples, the initial SCT reading at 0 min was 4.28 mM which was slightly lower 
than the 5 mM expected. This indicates that some L-lactate metabolism may have 
occurred during sample preparation. Similar results have been found in a study using 13C-
labeled lactate to study the butyrate formation from lactic acid by pig caecal bacteria 
(Ushida and Hoshi, 2002). Results highlighted the importance of Megasphaera elsdenii 
in lactate conversion in the pig caecum and demonstrated its ability to remove hyper-
lactate concentrations. Labelled lactate was introduced into incubation vessels to obtain 
20 mM as the final concentration after the inoculation of digesta. The labelled lactate was 
fully metabolised within 6 hours of incubation, with the concentration of acetate being 
highest amongst the produced acids, followed by propionate and butyrate. However, 




mM. This lower concentration was reported to be caused by the metabolism of lactate 
during the preparation of the samples. The authors stated that placing the samples in a 
crushed-ice bath followed by centrifugation was insufficient to stop fermentation 




Enzymatic assays are another method of lactate measurement, and have been used 
previously with human faeces (Mayeur et al., 2013), bovine faeces (Shimomura and Sato, 
2006) and murine faeces (Rul et al., 2011). An enzymatic assay for the measurement of 
D-, L- and total lactate has been tested and successfully established for canine faeces 
(Blake, 2017). Assays are a good option for lactate analysis and certain kits can 
distinguish between D- and L-lactate concentrations, albeit they do not produce 
instantaneous results. However, the results from the colorimetric assay used in this study 
generated lower concentrations than the expected spiked level (5 mM) at the same TP in 
both ‘Whole’ and ‘Supernatant’ samples. This may have been because certain elements 
within the faecal matrix interfered with the assay, despite sample deproteinisation. 
Supporting this proposition, a CON sample (without faecal matter) of distilled water or 
PBS spiked with 5 mM L-lactate was tested in the assay at the same time. Results showed 
that the L-lactate concentration was 4.5 mM in distilled water and 4.4 mM in PBS, further 
supporting the theory that elements within the faecal matter interfered with the assay. 
Furthermore, when the SCT device tested these samples, results were similar at 4.6 mM 
in distilled water and 4.4 mM in PBS. In summary, the results show that the specific assay 
used in this study was not a suitable method to measure L-lactate in faecal medium, 
whereas the SCT was, and this may have given false low readings in experiment 1. Hence, 





When faecal bacteria remained in contact with the L-lactate in the ‘Whole’ samples the 
majority of L-lactate was utilised by 360 min (~0.60 mM remained) when measured by 
the SCT, but L-lactate was undetectable after 120 min with the assay. This indicates that 
the faecal bacteria successfully metabolised the majority of the added L-lactate within 
360 min, thus agreeing with hypothesis 4. This is slower than in the referenced in vitro 
study (Ushida and Hoshi, 2002) whereby ~14 mM was metabolised within 360 min, but 
caecal digesta was used instead of faeces. The microbial community in faecal matter is 
likely to represent only a discrete population of the intestinal microbiota (Quan et al., 
2019). Moreover, the differences in microbiota distribution along the GIT suggests that 
different intestinal niches have different roles. This may explain the difference in the rate 
of lactate metabolism between the two studies (Gresse et al., 2019). As hypothesised (no. 
5), when L-lactate was added to the ‘Supernatant’ samples the concentration did not 
decrease over time and remained around the initial spiked level when measured by both 
the SCT and assay. These results demonstrate that centrifugation separated the majority 
of lactate-utilising bacteria as the L-lactate was not metabolised.  
 
Chemicals like sulfuric acid and ethanol can halt fermentation and help preserve samples 
for metabolite analysis (Ushida and Hoshi, 2002), although these can have undesired 
effects in further analysis. Prior to experiment 2 being conducted, faecal matter suspended 
in ethanol and spiked with 5 mM of L-lactate were tested on the SCT device. However, 
the SCT could not measure the L-lactate as the ethanol interfered with the enzymatic 
amperometric detection method. PBS was selected as an alternative solution as 
recommended for faecal analysis by a different Porcine LDH ELISA Kit (MBS042294). 
Homogenising the faecal matter in PBS instead of distilled water did not affect the 





The lactate SCT device can measure L-lactate concentrations in real-time, whereas the 
samples were frozen for preservation purposes before being thawed and analysed by the 
assay. The effect of the freeze-thaw process on L-lactate concentrations was assessed by 
analysing the samples in real-time before freezing compared to after freeze-thawing, both 
measured by the SCT device. Results showed that average L-lactate concentrations over 
time were significantly lower after freeze-thawing compared to real time analysis, such 
that ‘Whole’ samples in distilled water and PBS were –0.18 mM and –0.27 mM lower 
after freeze-thawing respectively. Moreover, ‘Supernatant’ samples in distilled water and 
PBS tended to be –0.32 mM and –0.45 mM lower after freeze-thawing than real-time 
analysis. This indicates deterioration of the L-lactate molecule during the freeze-thaw 
process, hence disagrees with hypothesis 7. These results highlight the importance of real-
time analysis as a loss of –0.18 to –0.45 mM is a large deterioration, especially if the 
concentration is already low such as in experiment 1. However, it has been shown that 
once deproteinised, lactate in faecal extracts from dogs can remain stable for 24 hours of 
storage at 4 ºC and 28 days of storage at –80 ºC (Blake, 2017). 
 
3.5.1 Conclusion 
To conclude, this series of pilot studies has highlighted various benefits and limitations 
of measuring lactate concentrations in pig faecal matter. Firstly, faecal L-lactate 
concentrations are generally low or undetectable in healthy piglets and growing/finishing 
pigs. The SCT device successfully measured the spiked L-lactate concentration whereas 
the assay failed to do so, indicating the specific assay used in this study was not a suitable 
method of L-lactate analysis in pig faeces and casts doubts on the results of experiment 




concentrations become a useful non-invasive gut assessment tool in the future, but the 
SCT is limited to the analysis of the L-lactate isoform and has a relatively high minimum 
detection limit of 0.50 mM. In comparison, the assay kit used in these trials was not 
suitable, but other kits have proved accurate for faecal analysis (Blake, 2017) and these 
should be further validated for pig faecal samples. Moreover, both D- and L-lactate 
isoforms can be measured in certain assays, but results are not instantaneous, and the 
freeze-thaw process may lead to lower results than true. When faecal bacteria remain in 
contact with the spiked L-lactate, the majority of L-lactate was utilised within 360 min, 
but when the bacteria were separated, the L-lactate was not metabolised. Lactate 
metabolism is relatively fast and the process of collecting and preparing faecal samples 
for lactate analysis must be rapid; the use of a buffer to halt microbial activity may be 
required to ensure true values are obtained. The freeze-thaw process has a negative effect 
on L-lactate concentrations, highlighting the benefits and importance of real-time analysis 
to prevent this deterioration. Further research and validation are required. 
 
Further research is required to establish the normal range of lactate concentrations in pig 
faecal matter at different ages in healthy and diseased individuals. Future work in this 
area could include the examination of faecal lactate and bacterial communities to 
investigate the interplay between the microbiota and metabolites. Furthermore, research 
on the D/L faecal lactate ratio is required as this has been described as the most relevant 
index for assessing imbalanced microbiota in SBS patients (Mayeur et al., 2013). It would 
be interesting to investigate faecal lactate concentrations in a variety of GIT diseases that 
have different characteristics and symptoms to obtain a broader understanding of the role 
of lactate in gut health. Finally, it would be interesting to assess the effect of feeding 
prebiotics that promote LAB and thus lactate production to young piglets and assess their 




If more lactate is present in the GIT when supplementing diets with prebiotics, the 
abundance of lactate-utilising bacteria should theoretically be increased and therefore the 















Chapter 4  
Investigating the effect of xylo-oligosaccharides with or without 
fructans on growth performance, gut bacterial community 
composition and microbial endo-xylanase activity in weaned 
piglets. 
4.1 Abstract  
Seeking suitable alternatives to antibiotics that promote gut health and prevent disease in 
pig production is of great importance for the sustainability and profitability of the 
industry. Compared to feeding a single prebiotic, feeding a combination of different 
prebiotics could upregulate the metabolic capability of a wider range of gut bacteria, 
hence improving overall fibre digestion if the prebiotics work in synergy. This study 
investigated the effect of XOS with or without short and long-chain fructans on growth 
performance, gut bacterial community composition and microbial endo-XYL activity in 
weaned piglets. In this 28-day trial, a total of 474 weaner piglets with an average initial 
BW of 7.88 (SD ± 1.51 kg) were blocked into mixed sex pens of 4‒5 piglets. Pens were 
randomly allocated to 1 of 6 dietary treatments in a 2 × 3 factorial treatment arrangement 
with 2 levels of XOS (0 and 0.286 g/kg) and 3 levels of fructans [(0 g/kg) and 6.50 g/kg 
of short-chain FOS and 4.08 g/kg of INU to supply 3.8 g/kg of pure fructans)]. Piglet BW 
and feed intake were recorded throughout the study to calculate piglet performance. At 
the end of the experiment, 48 piglets were euthanised for the collection of ileal and 
colonic digesta to profile the bacterial communities through 16S rRNA sequencing of the 
V4 region and colonic microbial endo-XYL activity. In the overall trial period, piglets 
supplemented with fructans (FOS and INU) had a lower ADFI compared to 
unsupplemented CON fed piglets. When supplemented alone, XOS also reduced ADFI 
compared to the CON, but intake increased to levels not different from the CON group 




interaction (P < 0.018). There was no overall effect of treatment on piglet ADG, but at 
the end of the trial piglet BW tended to follow a similar interaction pattern to ADFI (P = 
0.088). FCR tended to be higher when piglets were supplemented with FOS and INU 
compared to the CON (P = 0.086). Ileal and colonic bacterial diversity was lower for FOS 
fed piglets compared to the CON (P < 0.050), whilst overall bacterial community 
structure differed between treatments in the ileum (P < 0.026) but not the colon. In the 
ileum, XOS increased the abundance of OTUs associated with g__Helicobacter, 
g__Prevotella_7, g__Prevotella_9, g__uncultured (Prevotellaceae Family) and reduced 
g__Actinobacillus (P < 0.050). There was a XOS × fructan interaction for ileal abundance 
of OTUs associated with g__Lactobacillus, whereby supplementation of XOS alone 
increased abundance above all treatment groups apart from the FOS group (P < 0.038). 
There was no effect of treatment on colonic microbial endo-XYL activity (P > 0.050). In 
summary, prebiotic supplementation supressed overall ADFI, whilst fructans tended to 
increase FCR. Bacterial community structure differed with prebiotic supplementation in 
the ileum but not the colon. Despite the enrichment of beneficial Lactobacillus abundance 
in the ileum with XOS, no overall performance benefits were seen, likely because of the 
reduction in ADFI and the need for a longer feeding period.  
 
4.2 Introduction 
The GIT constitutes an environment for the activity and development of the largest 
microbiota population in the body and has been the subject of study for many years due 
to its importance in the health and well-being of animals and humans (Barszcz et al., 
2016; Isaacson and Kim, 2012). The GIT bacterial community confers a range of benefits 
to the host including improved disease resistance, GIT function, health status and animal 
performance (Isaacson and Kim, 2012; Barszcz et al., 2016). For this reason, research 




modulation of the GIT microbiota is timely. One such strategy is the supplementation 
with feed additives such as prebiotics.   
Prebiotics are defined as ‘non-digestible food ingredients that survive digestion and reach 
the large intestine, where they act as substrates for selective bacteria, consequently 
influencing their growth and activity which provides health benefits to the host’(Gibson 
and Roberfroid, 1995). Prebiotics selectively stimulate beneficial bacteria like 
Bifidobacterium or Lactobacillus, and reduce pathogenic bacteria like Escherichia coli 
(Hsu et al., 2004; Liu, J. et al., 2018). The consequent shift in the bacterial community 
composition is associated with improved overall health, increased SCFA production, and 
reduced gut infection and inflammation (Macfarlane et al., 2006). The most commonly 
studied prebiotics include GOS and fructans such as FOS and INU. However, new-
generation prebiotics like XOS are gaining attention for monogastric nutrition. Fructan 
supplementation, in the form of FOS (Xu, C. et al., 2005; Xu, Z.R. et al., 2002) and INU 
(Grela et al., 2014; He et al., 2002) can improve pig performance and gut health 
parameters. Similarly, supplementation of XOS has shown promising improvements in 
growth performance, gut structure, and gut bacterial community composition in broilers 
and weaner pigs (Liu, J. et al., 2018; Ribeiro et al., 2018; Chen, Y. et al., 2021). 
 
Fructans occur naturally in many plants and are mainly extracted from sources such as 
the agave plant, chicory root or Jerusalem artichoke for commercial production (Grela et 
al., 2014). Fructose units are linked together by β-(2-1) glycosidic bonds which are 
resistant to endogenous digestive enzymes, hence survive transit to the distal portion of 
the GIT (Grela et al., 2014). INU extracted from chicory roots typically have a DP of 3‒
60 (Van De Wiele et al., 2007), whereas for native Jerusalem artichokes the average DP 
is ~6 (De Leenheer, 1994). Moreover, short-chain FOS can be produced by enzymatic 




consists of 2‒7 xyl units linked by β-(1-4) linkages and can be commercially produced 
via the hydrolysis of corncobs (Aachary and Prapulla, 2008).  
The site of fermentation of prebiotics in the GIT depends on a multitude of factors 
including the sugar composition, the DP, the type of linkages, the structure complexity, 
as well as the presence of substrate specific degrading bacteria and access to the substrate 
itself within the GIT (Houdijk, Jos, 1998). Measuring the metabolic activity of substrate 
specific degrading bacteria, like microbial endo-XYL activity, is key to understanding 
the mode of action of prebiotics. Substrates with a longer DP are fermented at a slower 
rate than those with a shorter DP due to the number of linkages that need to be broken 
(Roberfroid et al., 1998; Houdijk, Jos, 1998). To this point, fructans like FOS with a DP 
< 10 have been shown to be fermented approximately twice as quickly in vitro as those 
such as INU that have a longer DP  (Roberfroid et al., 1998). Therefore, the rate of 
fermentation naturally dictates the location of fermentation along the GIT, such that 
longer chains with a higher DP are more resistant to saccharolytic activity and 
fermentation takes place more slowly and distally in the GIT (Hughes and Rowland, 
2001). However, differences in rate of fermentation still exist between prebiotics with a 
similar DP, such that short-chain FOS and GOS have been shown to be rapidly fermented 
so likely function as a substrate in the terminal small intestine and proximal large intestine 
(Smiricky-Tjardes et al., 2003a). In comparison, short-chain XOS are slowly fermented 
and may be more suitable substrates for bacterial communities inhabiting the distal large 
intestine (Smiricky-Tjardes et al., 2003a). Hence, a complex relationship exists between 
substrate structure and fermentative activity.  
 
Furthermore, the bacterial community composition along the GIT varies by location 
(Kim, H B and Isaacson, 2015), thus, the location of prebiotic fermentation will influence 




benefits to the host. The ability of different prebiotics to selectively stimulate different 
bacteria may provide further benefits to the host if fed in combination. An in vitro study 
confirmed the resistance of FOS and XOS to GIT enzymes and gastric juices, and the 
ability of Lactobacillus and Bifidobacterium to ferment these substrates (De Figueiredo 
et al., 2020). However, preferences for FOS or XOS were shown between different strains 
of bacteria, such that Bifidobacterium breve and Lactobacillus brevis preferred XOS, 
whilst Bifidobacterium lactis and Lactobacillus acidophilus showed a preference for 
FOS. These differences highlight a potential synergy between the prebiotics if fed in 
combination to stimulate a more representative population of beneficial GIT bacteria. In 
this study, we investigated the difference in prebiotic activity between short-chain (low 
DP) and long-chain (high DP) fructans, and their synergy with XOS compared to without 
XOS. Both the effects on piglet performance and bacterial community composition in the 
ileum and colon were assessed, along with the microbial endo-XYL activity in the colon. 
 
4.2.1 Study aims  
There is a lack of information in the literature on the fermentative activity and potentially 
synergistic effects of feeding different prebiotics in combination. The aim of this study 
was to determine the effect of XOS with or without short-chain (low DP) and long-chain 
(high DP) fructans on piglet performance, bacterial community composition and 
microbial endo-XYL activity.  
 
4.2.2 Hypotheses 
1. Supplementation of prebiotics will improve piglet performance; those fed FOS, 




whilst piglets fed FOS or INU in combination with XOS will outperform both the 
CON and individual prebiotic supplementation.  
2. Supplementation of FOS will increase alpha diversity and alter bacterial 
community composition in the ileum of piglets.  
3. Supplementation of XOS or INU will increase alpha diversity and alter bacterial 
community composition in the colon of piglets.  
4. Addition of FOS and XOS together will increase alpha diversity and alter bacterial 
community composition in the ileum and colon of piglets, whilst addition of XOS 
and INU together will affect the colon.  
 
4.3 Materials and methods 
Study protocols were approved by the University of Leeds Pig Research Centre and 
ethical approval was granted by the Animal Welfare and Ethical Review Body as 
described in Appendix A.1. 
 
4.3.1 Animals and housing 
At an average age of 26 days (SD ± 1.6 days), 474 weaner piglets with an average initial 
BW of 7.88 kg (SD ± 1.51 kg) were weaned on this 28-day feeding trial (day 0‒27) until 
~54 days of age. All piglets were weighed at the start of the trial (day 0) and blocked into 
mixed-sex pens of 4‒5 piglets, balanced for litter origin, sex and BW. Pens within each 
of the 16 replicates were randomly allocated to 1 of 6 dietary treatments and piglet weight 
difference between pens was kept to a minimum (< 0.3 kg). The trial was conducted over 
2 batches, with 234 piglets in batch 1 and 240 piglets in batch 2 (8 replicates per 
treatment). Piglets were housed in conventional weaner-grower accommodation as 




4.3.2 Experimental design and dietary treatments 
Piglets were fed with a 2-phase feeding program from day 0 to day 27 of the trial and had 
ad libitum access to pelleted feed and water. The first phase diet was fed from day 0‒12, 
whilst the second phase diet was fed from day 13‒27. Diets were formulated to meet or 
exceed the National Research Council (NRC, National Research Council. 2012) nutrient 
recommendations for 7‒11 kg and 11‒25 kg pigs. Basal dietary treatment compositions 
with calculated and analysed nutrient concentrations (Sciantec, York, UK) are presented 
in Table 4.1.  
 
All diets included 5 g/kg of TiO2 as an indigestible marker and 0.10 g/kg phytase 
[Quantum® Blue, AB Vista, Marlborough, UK; 5000 phytase units (FTU)/g] to give an 
expected activity of 500 FTU/kg of feed. Supplementation of XOS (XOS 35, 35 % purity, 
Longlive Biotechnology Corporation, China; same product as in Chapter 2) at 0.286 g/kg 
in the XOS dietary treatment groups provided 0.10 g/kg of pure XOS in the feed. A short-
chain FOS product (58.7 % purity; BETAFOS60 provided by Betalia, part of Azucarera, 
Spain) was included at 6.50 g/kg to provide 3.82 g/kg of pure FOS. The FOS product 
contained differing amounts of fructans attached to a terminal glu unit, whereby 39.2 % 
was GF2, 18.4 % was GF3 and 1.15 % was GF4, hence had a DP of 2‒4. The FOS product 
was extracted by an enzymatic process from sugar beet at a temperature of 50‒60ºC. A 
long-chain INU product (93.5 % purity; Orafti® IPS provided by Beneo, Germany) was 
included at 4.08 g/kg to provide 3.82 g/kg of pure long-chain INU. The INU product had 
a DP of 2‒60, with ~40 % having a DP < 10 and 60 % with a DP > 10. Orafti® IPS was 
produced by a hot-water extraction process from chicory roots, whereby crude chicory 





Dietary treatments were arranged in a 2 × 3 factorial arrangement with 2 levels of XOS 
(0 and 0.286 g/kg) and 3 levels of fructans [(0 g/kg) and 6.50 g/kg of short-chain FOS 
and 4.08 g/kg of INU to supply 3.8 g/kg of pure fructans)] to give 6 dietary treatments, 
as follows: 
• CON, 0 = CON without XOS 
• FOS, 0 = Short-chain FOS without XOS 
• INU, 0 = Long-chain INU without XOS 
• CON, 1 = CON with XOS 
• FOS, 1 = Short-chain FOS with XOS 
• INU, 1 = Long-chain INU with XOS 
 
The basal diets were weighed, mixed and prepared as a single batch of meal at Target 
Feeds Ltd (Shropshire, UK) before being split into 6 separate dietary batches for additive 
addition. Analysis of fructans or XOS recovery in feed was not possible at the time of the 
study, therefore the products were mixed with TiO2 to act as a carrier and marker before 
being added to the basal diet. The meal was pelleted at Primary Diets (Ripon, UK) and 












Table 4.1 Basal dietary treatment composition with calculated and analysed 
nutrient levels. 







Ingredient, g/kg     
Barley  100.0 100.4 
Wheat 205.5 502.4 
Micronised wheat meal  100.0 0.0 
Micronised oats 100.0 0.0 
Wheatfeed 0.0 36.7 
Fishmeal (69 %) 72.5 25.1 
Soybean meal  159.9 228.1 
Full fat soybean meal 30.0 25.1 
Vitamin and mineral premix a 5.0 5.0 
Dried skimmed milk  40.0 0.0 
Whey powder 114.1 36.4 
L-Lysine HCL, 785 g/kg 3.2 3.7 
DL-Methionine, 990 g/kg 1.82 1.43 
L-Threonine, 980 g/kg 1.87 1.63 
L-Tryptophan, 980 g/kg 0.31 0.00 
L-Valine, 965 g/kg 0.69 0.45 
Vitamin E 0.31 0.21 
Phytase b 0.10 0.10 
Flavouring  0.15 0.15 
Dicalcium phosphate 1.00 7.83 
Salt  0.00 3.18 
Titanium dioxide 5.00 5.00 
Soya oil  58.50 17.07 
Calculated nutrient composition     
Net energy (MJ/kg) 11.44 10.20 
Standardised ileal digestible lysine (g/kg) 14.00 12.40 
Apparent total tract digestible phosphorus (g/kg) 4.50 4.00 
Analysed nutrient composition      
Dry matter (g/kg) 903.0 887.5 
Ash (g/kg) 53.9 50.7 
Crude protein (g/kg) 219.8 209.5 
Crude fibre (g/kg) 20.2 27.3 
Calcium (g/kg) 6.6 5.4 
a Vitamin premix per kg of diet: 12,500 IU Vitamin A, 2000 IU Vitamin D3, 250 mg 
Vitamin E, 4.2 mg Vitamin B1, 5.6 mg Vitamin B2, 5.0 mg Vitamin B6, 50 ug Vitamin 
B12, 4.4 mg Vitamin K hetrazeen, 40 mg Nicotinic acid, 20 mg Pantothenic acid, 1 mg 
Folic acid, 150 ug Biotin, 250 mg Choline Chloride, 200 mg Iron, 62 mg Manganese, 140 
mg Copper, 100 mg Zinc, 2.2 mg Iodine, 0.35 mg Selenium. b Phytase; Quantum® Blue, 





4.3.3 Measurements and sampling 
4.3.3.1 Piglet performance and health observations  
Individual piglet weights were recorded on days 0, 13 and 27 of the trial to determine 
average pen BW and ADG. Feed troughs were weighed back daily for the first stage diets 
and second stage diets from day 0‒20 to determine ADFI per pen. Diets were weighed 
back on day 20 at trough changeover and again at the end of the trial on day 27 to calculate 
pen ADFI. These measurements were used to calculate weekly pen FCR. Faecal, health 
and cleanliness scores were recorded by the same personnel daily, as described in section 
2.3.3.1.  
 
4.3.3.2 Digesta collection 
At the end of the experiment, in accordance with the Animals (Scientific Procedures) Act 
1986, 48 mixed-sex piglets from 8 replicates (24 piglets per batch) (20.44 kg ± SD 3.0 
kg) were killed via captive bolt penetration, followed by exsanguination to confirm death 
(schedule 1 method). Dissections took place over 2 consecutive days for sample 
collection (days 28 and 29). Selected piglets had a BW close to the pen average, were 
littermates within a replicate and had received no antibiotic treatment. The order of 
slaughter was random within and between replicates. 
 
A ventral incision was made into the piglets’ abdomen and the GIT was identified. The 
start of the GIT was clamped at the pyloric junction where the stomach connected to the 
duodenum and the end of the GIT was clamped ~10‒15 cm prior to the end of the rectum, 
before removing the GIT from the body cavity. Clamps were placed at various points 
along the GIT to prevent movement of digesta. For digesta collection, the terminal ileum 




as ~30 cm after the caecum. Digesta were gently squeezed from each section into 30 ml 
universal containers, then apportioned and used in immediate further processing or stored 
frozen (-80 ºC) pending further analysis. Apportioned digesta samples were freeze dried 
under vacuum at -35ºC for 24 hours before being ground and homogenised using a pestle 
and mortar.  
 
4.3.4 Analysis 
4.3.4.1 DNA extraction and bacterial community analysis 
Total bacterial DNA was extracted from the ileal and colonic samples (ca 0.2 g) using the 
QIAamp Fast DNA Stool Mini Kit (QIAGEN®, Hilden, Germany). The manufacturers 
protocol was followed, with minor modifications as described in section 2.3.4.2. 
 
Extracted DNA was sent to Novogene (China) for next generation sequencing on the 
Ilumina platform. PCR (200ng DNA) was used to amplify the V4 region of the bacterial 
16S rRNA gene using the 515F (5′-GTGCCAGCMGCCGCGGTAA-3′) and 806R (5′-
GGACTACHVGGGTWTCTAAT-3′) primer set. Each primer set was ligated with a 
unique barcode set. All PCR reactions were conducted with Thermo Scientific Phusion 
High-Fidelity PCR Master Mix (New England Biolabs). PCR products were purified 
using the Qiagen Gel Extraction Kit (Qiagen, Germany). The same amount of PCR 
product from each sample was pooled, end polished, A-tailed, and ligated with adapters. 
Sequencing libraries were generated using NEBNext ® Ultra™ IIDNA Library Pre-Kit 
(Cat No. E7645) for Illumina following the manufacturers recommendations and index 
codes were added. The library quality was assessed on the Qubit@ 2.0 Fluorometer 




sequenced on the NovaSeq 6000 SP flowcell Illumina platform and 250 bp paired-end 
reads were generated. 
 
4.3.4.2 Bioinformatics 
Paired-end reads were assigned to samples based on their unique barcode and truncated 
by cutting off the barcode and primer sequence. Paired-end reads were merged using 
FLASH (v1.2.7) (Magoč and Salzberg, 2011) and then filtered according to the QIIME 
process (v1.7.0) (Caporaso et al., 2010). Unique sequences were aligned to the 
GreenGene Database (v.2.2). Chimeras and sequences that aligned to Archaea, 
Eukaryota, chloroplasts or mitochondria were removed from the dataset. Sequences were 
clustered into OTUs with 97 % similarity, before quantifying the number of OTUs within 
each group and their taxonomy. A BIOM file was then created to transfer the data into R 
(v. 1.3.1093).   
 
4.3.4.3 Microbial endo-XYL activity  
There was not enough material to analyse microbial endo-XYL activity in the ileum, 
hence this analysis was only conducted on colonic samples. Microbial endo-XYL activity 
of the colonic samples were analysed using a Megazyme endo-XYL assay (Megazyme, 
Bray, Ireland; Kit XylX6-2V) and the kit protocol was followed with a few alterations. 
The principle of the assay was based on a colorimetric substrate (XylX6) and β-
xylosidase. Incubation with the endo-XYL in the samples generated a colorimetric 
oligosaccharide that was rapidly hydrolysed by the β-xylosidase to quantitatively release 
4-nitrophenol. The reaction was then terminated, and the absorption of the colorimetric 
group released was measured at 400 nm. The rate of release of 4-nitrophenol was 




One unit of activity was defined as the amount of enzyme required to release 1 micromole 
of 4-nitrophenol from the XylX6 substrate in 1 minute. Endo-XYL activities were 
expressed as endo-XYL units (EU) per g of DM.  
 
The endo-XYL was extracted and diluted from freeze-dried colonic samples by adding 
0.2 g of sample to 10 ml of 100 mM phosphate extraction/dilution buffer (pH 6.5) and 
gently stirred until dispersed. The solution was clarified by centrifugation (4000 × g) for 
10 min. For analysis, 0.05 ml aliquots of XylX6 reagent solution were added to 2 ml 
microcentrifuge tubes. To each tube containing the XylX6 solution, 0.05 ml of endo-XYL 
solution was added and vortexed before incubation at 40ºC for 30 min. After incubation, 
1.5 ml of stopping reagent was added and mixed. The absorbance of the reaction solution 
and the reagent blank were read at 400 nm on a benchtop spectrophotometer.  
 
4.3.5 Statistical analysis 
4.3.5.1 Piglet performance and health observations 
The pen served as the experimental unit for all growth performance data (BW, ADG, 
ADFI, FCR). FCR was calculated as a ratio of feed intake to weight gain according to the 
following equation: 
 
𝐹𝑒𝑒𝑑 𝑐𝑜𝑛𝑣𝑒𝑟𝑠𝑖𝑜𝑛 𝑟𝑎𝑡𝑖𝑜 (𝐹𝐶𝑅) =  
𝐴𝑣𝑒𝑟𝑎𝑔𝑒 𝑑𝑎𝑖𝑙𝑦 𝑓𝑒𝑒𝑑 𝑖𝑛𝑡𝑎𝑘𝑒 (𝑘𝑔 𝑝𝑒𝑟 𝑑𝑎𝑦)




Normality of data was tested by visualisation of histograms and the Shapiro-Wilk test, 
whilst homogeneity of variance was assessed using the Levene’s test. Any data showing 




Transformed data were back-transformed for inclusion into the data tables. The statistical 
package JMP® (Version 15.1. SAS Institute Inc., Cary, NC, 1989 - 2019) (SAS, 2020) 
was used to analyse the performance data as a 2-way ANOVA. The statistical model 
included the fixed effects of XOS, fructans and their interaction, and replicate and batch 
as random variables. The initial BW of piglets was included as a covariate for BW and 
ADG analysis. When interactions were not significant, main effects were analysed 
individually. A 2-way ANOVA was used to analyse the colonic microbial endo-XYL 
activity data. A non-parametric Kruskal-Wallis one-way ANOVA was used to analyse 
average pen faecal, health and cleanliness scores. Significant differences were classed as 
P < 0.05 and trends as P < 0.10. 
 
4.3.5.2 Bacterial community composition analysis  
The software R was used to statistically analyse the microbiome data (v. 1.3.1093). 
Individual piglets served as the experimental unit for the bacterial community 
composition analysis. A general linear model was used to determine the effects of XOS 
and fructans on bacterial abundance at the level of the phylum and genus, with all data 
meeting the necessary assumptions. Post-hoc differences were identified using a Tukey’s 
test (JMP® v.15.1). Number of OTUs, Chao1 (Chao, 1984) and Shannon-Weiner 
(Shannon, 1948) alpha diversities were measured using the Phyloseq package (v.1.22.3) 
in R (McMurdie and Holmes, 2013). To determine the effects of XOS and fructans on 
alpha diversity and number of OTUs, a general linear model was used (lme4) and models 
were reduced using analysis of deviance. The package Vegan (v.2.5.7) was used to assess 
beta diversity. To determine community similarities between XOS and fructan groups, a 
PERMANOVA was used. An NMDS plot (axis = 2) plot using Bray-Curtis distances was 





4.4.1 Piglet performance and health observations 
The effect of fructans and XOS on piglet growth performance are presented in Table 4.2. 
There was a trend for an interaction between XOS and fructans on day 13 piglet BW (P 
= 0.052) and ADG between day 0‒13 (P = 0.054), whilst there was a significant 
interaction for ADFI between day 0‒13 (P < 0.017). A similar interaction pattern was 
seen across all 3 key performance indicators and was driven by ADFI (Figure 4.1). Piglet 
ADFI between day 0‒13 was lower with fructan (FOS and INU) supplementation 
compared to the CON fed piglets. When XOS was supplemented alone or in combination 
with INU, ADFI was also reduced compared to the CON, but not dissimilar from the FOS 







Table 4.2 Effect of XOS and fructans (FOS and INU) on piglet growth performance a 
 
  Fructan 
SEM 
 XOSe   CON FOS INU CON FOS INU 
SEM 
 P value 
  CONb FOSc INUd  0 1 SEM  0 0 0 1 1 1  Fructan XOS 
Fructan 
× XOS 
BWf (kg)                     
Day 0  7.91 7.86 7.85 0.003  7.87 7.88 0.003  7.90 7.84 7.85 7.86 7.92 7.86 0.130  0.954 0.979 0.998 
Day 13 10.16 9.99 10.03 0.078  10.08 10.03 0.064  10.29 9.93 10.04 9.92 10.07 10.10 0.111  0.628 0.549 0.052 
Day 27 18.18 17.70 17.68 0.184  17.94 17.77 0.150  18.52 17.67 17.63 17.68 17.77 17.84 0.260  0.263 0.402 0.088 
                     
ADGg (kg/d)                     
Day 0‒13  0.172 0.163 0.167 0.006  0.169 0.166 0.005  0.185 0.157 0.165 0.158 0.169 0.170 0.008  0.605 0.647 0.054 
Day 14‒27 0.572 0.548 0.543 0.010  0.558 0.550 0.008  0.586 0.550 0.539 0.554 0.547 0.549 0.015  0.169 0.480 0.329 
Day 0‒27 0.380 0.364 0.363 0.007  0.372 0.366 0.006  0.394 0.362 0.360 0.363 0.366 0.368 0.010  0.235 0.424 0.104 
                      
ADFIh 
(kg/d) 
                    
Day 0‒13 0.210 0.204 0.202 0.005  0.207 0.204 0.004  0.224a 0.198b 0.202b 0.197b 0.211ab 0.202b 0.007  0.437 0.414 0.017 
Day 14‒27 0.652 0.652 0.657 0.012  0.652 0.655 0.010  0.675 0.645 0.643 0.629 0.659 0.674 0.017  0.902 1.000 0.060 
Day 0‒27 0.439 0.433 0.433 0.007  0.435 0.435 0.006  0.457a 0.424b 0.427b 0.421b 0.442ab 0.441ab 0.011  0.818 0.842 0.018 
                      
FCRi                     
Day 0‒13 1.24 1.29 1.24 0.015  1.26 1.25 0.013  1.21 1.29 1.28 1.26 1.29 1.21 0.022  0.271 0.967 0.336 
Day 14‒27 1.15a 1.19b 1.21b 0.008  1.18 1.19 0.007  1.15 1.18 1.19 1.14 1.21 1.23 0.012  0.001 0.264 0.362 
Day 0‒27 1.16 1.19 1.19 0.008  1.17 1.19 0.007  1.16 1.18 1.19 1.16 1.21 1.20 0.865  0.086 0.261 0.578 
a Data are means of 16 replicate pens of 4‒5 piglets. b CON; Control. c FOS; Fructo-oligosaccharides.d INU; Inulin. e XOS; Xylo-oligosaccharides, 0 = 
No XOS; 1= XOS. f BW; Body weight. g ADG; Average daily gain. h ADFI; Average daily feed intake. I FCR; Feed conversion ratio. a-b Means within a 






Figure 4.1 Effect of xylo-oligosaccharides (XOS) and fructans (Fructo-
oligosaccharides (FOS)) and (Inulin (INU)) on day 13 body weight (BW; P = 
0.052), day 0‒13 average daily gain (ADG; P = 0.054) and day 0‒13 average daily 
feed intake (ADFI; P < 0.017).  
 
As for the first 2 weeks of the trial, a similar interaction trend was observed for day 27 
piglet BW (P = 0.088) and ADFI between days 14‒27 (P = 0.06). Piglet BW and ADFI 
tended to be lower with FOS and INU inclusion compared to the CON. When 
supplemented alone XOS tended to reduce ADFI and BW, but they increased when XOS 
was fed in combination with FOS and INU. There was no effect of treatment on ADG 
between days 14‒27 (P > 0.05). FCR was higher between days 14‒27 (P < 0.001) when 





There was a significant interaction between fructans and XOS on ADFI for the overall 
trial period between days 0‒27 (P < 0.018; Figure 4.2). Again, ADFI was lower with FOS 
and INU inclusion compared to the CON fed piglets. When supplemented alone, XOS 
also reduced ADFI compared to the CON, but intake increased to levels not dissimilar 
from the CON fed piglets when XOS was fed in combination with FOS and INU. There 
was no effect of treatment on ADG between days 0‒27 (P > 0.05). FCR tended to be 
higher between days 0‒27 when piglets were supplemented FOS and INU compared to 
the CON (P = 0.086; Figure 4.2). 
 
 
Figure 4.2 Effect of xylo-oligosaccharides (XOS) and fructans (Fructo-
oligosaccharides (FOS)) and (Inulin (INU)) on day 0‒27 average daily feed intake 
(ADFI; P < 0.018) and main effect of fructans on FCR (P = 0.086). 
 
 
There were no effects of treatment on health, faecal or cleanliness scores throughout the 
trial (Table 4.3; P > 0.05). There was a trend for an increased health score value (more 
observations of ill health) between days 0‒13 of the trial, whereby both INU treatments 





Table 4.3 Effect of XOS and fructans (FOS and INU) on average piglet faecal, 
health and cleanliness scores.   
 




Fructan CONa FOSb INUc CON FOS INU  
XOSd 0 0 0 1 1 1  
          
Faecal scoree          
Day 0‒13 2.17 2.17 2.25 2.13 2.20 2.16  0.071 0.174 
Day 14‒27 2.13 2.11 2.15 2.19 2.10 2.08  0.051 0.634 
Day 0‒27 2.15 2.14 2.20 2.16 2.15 2.12  0.047 0.276 
           
Health scoref          
Day 0‒13 0.05 0.12 0.26 0.09 0.08 0.22  0.077 0.063 
Day 14‒27 0.03 0.05 0.11 0.10 0.04 0.06  0.058 0.523 
Day 0‒27 0.04 0.08 0.18 0.09 0.06 0.14  0.055 0.199 
          
Cleanliness 
scoreg 
         
Day 0‒13 1.03 1.06 1.04 1.03 1.05 1.07  0.029 0.647 
Day 14‒27 1.12 1.15 1.1 1.14 1.17 1.10  0.055 0.842 
Day 0‒27 1.07 1.10 1.07 1.09 1.11 1.09  0.032 0.816 
a CON; Control. b FOS; Fructo-oligosaccharides.c INU; Inulin. d XOS; Xylo-
oligosaccharides, 0 = No XOS; 1= XOS. e Faecal score; 1 = firm faeces, 2 = soft faeces, 
3 = mild diarrhoea, 4 = severe diarrhoea. f Health score; 1 = no signs of ill health, 2 = 
some signs of ill health, 3 = clear indications of ill health, 4 = seriously ill pigs. g 
Cleanliness score; 1 = clean pigs, 2 = light contamination with faecal material, 3 = 
contamination with faecal material, 4 = heavy contamination with faecal material. 
 
4.4.2 Bacterial community analysis 
4.4.2.1 Ileal bacterial community composition  
The majority of ileal bacteria belonged to the phyla Firmicutes (72.7 %), Bacteroidetes 
(13.2 %) and Proteobacteria (9.68 %), which jointly make up 95.6 % of the bacterial 
community (Table 4.4). Changes in the bacterial community between dietary treatments 
were estimated at the phylum and genus level. There were 5 phyla with a relative 
abundance greater than 1 % in a minimum of 1 sample. There was no effect of fructans 




fructans and XOS (P > 0.050). There was a trend for the abundance of Bacteriodetes to 
be higher (P = 0.094) and Proteobacteria to be lower (P = 0.070) when XOS was included. 
The abundance of Epsilonbacteraeota was higher when XOS was included (P < 0.019).  
 
There were 29 genera with a relative abundance greater than 1 % in a minimum of 1 
sample and the inclusion of fructans and XOS affected the abundance of several genera. 
Supplementation of XOS significantly decreased the abundance of g__Actinobacillus and 
increased the abundance of g__Helicobacter, g__Prevotella_7, g__Prevotella_9 and 
g__uncultured (Prevotellaceae Family) in the ileum (P < 0.050). There was a trend for an 
interaction between fructans and XOS on the abundance of g__Escherichia-Shigella in 
the ileum (P = 0.084), whereby the abundance was similar with and without XOS in the 
CON and INU groups but was higher without XOS and lower with XOS in the FOS group 
(Figure 4.3). There was a significant interaction between fructans and XOS on the 
abundance of g__ Lactobacillus in the ileum (P < 0.038), whereby the abundance in the 
XOS group was higher than all other treatment groups but was not dissimilar from the 
FOS group (Figure 4.3). There was a significant interaction between fructans and XOS 
on the abundance of g__Terrisporobacter in the ileum (P < 0.020), whereby the 
abundance was similar with and without XOS in the FOS and INU groups but was higher 













Figure 4.3: Effect of xylo-oligosaccharides (XOS) and fructans (Fructo-
oligosaccharides (FOS)) and (Inulin (INU)) on the relative abundance of 
g_Escherichia_shigella (P = 0.084), g__ Lactobacillus (P < 0.038), 







Table 4.4 Effect of XOS and fructans (FOS and INU) on average relative abundance (> 1 %) at the Phyla and Genera level in the ileal digesta 
of piglets.  
 
Ileal relative abundance (%) 
Fructan  XOSd  CON FOS INU CON FOS INU  P value 
CONa FOSb INUc SEM 0 1 SEM 0 0 0 1 1 1 SEM Fructan XOS 
Fructan 
× XOS 
Phylum1                  
p__Firmicutes 74.56 71.32 72.21 3.797 73.15 72.24 3.101 71.21 72.74 75.51 77.92 69.90 68.91 5.370 0.824 0.837 0.450 
p__Bacteroidetes 11.66 13.94 15.40 1.936 11.75 15.58 1.581 12.04 11.06 12.17 11.29 16.83 18.63 2.738 0.397 0.094 0.357 
p__Proteobacteria 11.48 9.07 8.48 3.190 13.10 6.25 2.605 15.47 13.87 9.98 7.49 4.28 6.99 4.512 0.782 0.070 0.749 
p__Epsilonbacteraeota 1.75 5.19 3.44 1.372 1.53a 5.39b 1.120 0.70 1.95 1.95 2.80 8.43 4.93 1.940 0.219 0.019 0.496 
Other 0.54 0.47 0.47 0.046 0.46 0.53 0.038 0.58 0.39 0.41 0.51 0.55 0.54 0.066 0.46 0.16 0.17 
Genus1                  
g__Acidaminococcus 0.25 0.35 0.24 0.060 0.23 0.32 0.049 0.21 0.35 0.15 0.29 0.34 0.33 0.089 0.366 0.219 0.510 
g__Actinobacillus 6.04 2.87 6.73 2.361 8.19a 2.25b 1.958 11.58 3.15 9.82 0.51 2.59 3.64 3.542 0.470 0.034 0.293 
g__Alloprevotella 2.53 2.39 2.56 0.356 2.12 2.86 0.295 2.65 1.80 1.92 2.40 2.98 3.20 0.534 0.935 0.081 0.244 
g__Anaerovibrio 0.45 0.39 0.42 0.060 0.37 0.48 0.050 0.47 0.30 0.33 0.43 0.49 0.50 0.090 0.804 0.118 0.344 
g__Campylobacter 0.11 0.12 0.82 0.478 0.05 0.65 0.396 0.07 0.03 0.06 0.16 0.21 1.58 0.717 0.489 0.283 0.498 
g__Clostridium_sensu_stricto_1 23.81 26.71 30.36 4.017 26.25 27.67 3.331 23.69 24.04 31.03 23.94 29.39 29.70 6.025 0.515 0.759 0.828 
g__Dialister 0.76 0.84 0.93 0.121 0.73 0.95 0.101 0.73 0.76 0.71 0.78 0.91 1.15 0.182 0.608 0.132 0.509 
g__Escherichia-Shigella 4.87 5.74 1.58 2.157 4.88 3.25 1.788 3.24 10.53 0.86 6.51 0.95 2.30 3.235 0.361 0.516 0.084 
g__Faecalibacterium 0.65 0.67 0.71 0.112 0.58 0.77 0.093 0.69 0.51 0.54 0.60 0.82 0.88 0.168 0.917 0.154 0.322 
g__Helicobacter 1.72 5.25 2.60 1.362 1.52a 4.86b 1.129 0.67 1.97 1.93 2.77 8.52 3.28 2.043 0.172 0.039 0.352 







Ileal relative abundance (%) 
Fructan  XOSd  CON FOS INU CON FOS INU  P value 
CONa FOSb INUc SEM 0 1 SEM 0 0 0 1 1 1 SEM Fructan XOS 
Fructan 
× XOS 
g__Lactobacillus 24.84 16.46 15.07 4.052 15.84 21.73 3.359 13.65b 20.12ab 13.76b 36.03a 12.79b 16.39b 6.077 0.191 0.213 0.038 
g__Megasphaera 0.45 0.68 0.57 0.112 0.47 0.65 0.093 0.41 0.67 0.34 0.49 0.68 0.79 0.167 0.359 0.174 0.346 
g__Phascolarctobacterium 0.26 0.35 0.23 0.101 0.22 0.34 0.084 0.28 0.20 0.19 0.25 0.50 0.26 0.152 0.677 0.316 0.504 
g__Prevotella_2 1.09 1.22 1.53 0.208 1.16 1.40 0.173 1.19 1.13 1.14 0.98 1.31 1.92 0.312 0.307 0.307 0.245 
g__Prevotella_7 0.37 0.59 0.62 0.100 0.40a 0.64b 0.083 0.34 0.57 0.31 0.40 0.61 0.92 0.150 0.169 0.046 0.087 
g__Prevotella_9 4.08 6.68 6.94 1.121 4.38a 7.42b 0.930 4.02 4.84 4.28 4.13 8.52 9.60 1.682 0.145 0.023 0.252 
g__Prevotellaceae_NK3B31_group 0.84 0.73 0.78 0.137 0.68 0.88 0.114 0.91 0.54 0.60 0.77 0.92 0.96 0.205 0.853 0.213 0.319 
g__Rikenellaceae_RC9_gut_group 0.76 0.52 0.53 0.108 0.60 0.61 0.089 0.92 0.40 0.48 0.60 0.65 0.57 0.162 0.206 0.969 0.162 
g__Romboutsia 2.40 1.52 1.48 0.650 1.90 1.70 0.539 2.11 1.43 2.17 2.69 1.62 0.79 0.975 0.528 0.783 0.531 
g__Ruminococcaceae_UCG-002 0.38 0.40 0.32 0.055 0.33 0.40 0.046 0.40 0.33 0.27 0.35 0.47 0.38 0.083 0.605 0.273 0.455 
g__Ruminococcaceae_UCG-014 0.36 0.37 0.38 0.049 0.35 0.39 0.040 0.38 0.35 0.32 0.34 0.39 0.44 0.073 0.974 0.436 0.525 
g__Sarcina 0.54 2.43 0.76 1.253 2.18 0.30 1.039 0.94 4.37 1.23 0.13 0.49 0.29 1.880 0.506 0.199 0.618 
g__Streptococcus 0.90 0.73 4.96 2.043 3.55 0.84 1.694 0.92 0.47 9.26 0.87 1.00 0.66 3.064 0.263 0.255 0.219 
g__Subdoligranulum 0.53 0.47 0.52 0.067 0.44 0.57 0.056 0.57 0.33 0.43 0.49 0.61 0.62 0.101 0.783 0.105 0.159 
g__Terrisporobacter 14.38 15.35 12.08 1.988 16.61a 11.26b 1.649 21.79a 15.39ab 12.66ab 6.97b 15.31ab 11.51ab 2.982 0.495 0.024 0.020 
g__uncultured (Prevotellaceae 
Family) 
0.45 0.51 0.53 0.068 0.42a 0.58b 0.056 0.43 0.48 0.34 0.47 0.55 0.72 0.102 0.681 0.041 0.170 
g__uncultured_Porphyromonadaceae 
_bacterium 
0.53 0.47 0.50 0.080 0.46 0.53 0.066 0.59 0.41 0.39 0.47 0.52 0.61 0.120 0.845 0.449 0.303 
Other 5.57 5.19 5.25 0.533 4.99 5.68 0.442 5.975 4.52 4.46 5.17 5.86 6.03 0.799 0.860 0.261 0.228 
1Phylum and genus with > 1 % abundance in a minimum of 1 sample. a CON; Control. b FOS; Fructo-oligosaccharides. c INU; Inulin. d XOS; Xylo-





4.4.2.2 Colonic bacterial community composition  
The majority of colonic bacteria belonged to the phyla Bacteroidetes (56.7 %) and 
Firmicutes (37.8 %), jointly making up 94.5 % of the bacterial community (Table 4.5). 
There were 7 phyla with a relative abundance greater than 1 % in a minimum of 1 sample. 
There was no effect of fructans or XOS on the relative abundance of OTUs at the phyla 
level.  
There were 44 genera with a relative abundance greater than 1 % in a minimum of 1 
sample and the inclusion of fructans and XOS affected the abundance of several genera 
(Table 4.5). FOS reduced the abundance of OTUs associated with g_(Muribaculaceae 
Family) (P  < 0.048) and g__Oscillospira compared to the CON group but not the INU 
group (P < 0.025). The abundance of OTUs associated with 
g__Prevotellaceae_NK3B31_group (P = 0.060), g__Prevotellaceae_UCG-003 (P = 
0.061) and g__uncultured_rumen_bacterium (P = 0.054) tended to be lowest in the FOS 
group. The abundance of OTUs associated with g__Clostridium_sensu_stricto_1 (P = 
0.055) and g__Terrisporobacter (P = 0.081) tended to be highest in the FOS group. The 
abundance of OTUs associated with g__Phascolarctobacterium (P = 0.094) tended to be 
highest in the INU group. The abundance of OTUs associated with g__Mitsuokella (P < 
0.016) and g__Ruminococcaceae_UCG-014 (P < 0.039) were lower in the XOS group 
compared to the CON group, whilst g__Subdoligranulum tended to be higher in the XOS 
group compared to the CON group (P = 0.085). The abundance of OTUs associated with 
g__Sphaerochaeta were no different with or without XOS in the FOS and INU groups 
but were higher without XOS and lower with XOS in the CON group (P < 0.038). There 
was a trend for an interaction between fructans and XOS on the abundance of OTUs 
associated with g__Romboutsia (P = 0.089). There was no difference in the CON group, 








Table 4.5 Effect of XOS and fructans (FOS and INU) on average relative abundance (> 1 %) at the Phyla and Genera level in the colonic 
digesta of piglets. 
 
Colonic relative abundance (%) 
Fructan   XOSd   CON FOS INU CON FOS INU   P value  
CONa FOSb INUc SEM 0 1 SEM 0 0 0 1 1 1 SEM Fructan XOS 
Fructan × 
XOS 
Phylum                                    
p__Bacteroidetes 58.85 55.23 55.89 1.909 57.03 56.28 1.559 59.29 58.13 53.67 58.40 52.33 58.11 2.700 0.370 0.737 0.178 
p__Firmicutes 35.46 39.45 38.43 1.762 37.60 37.96 1.438 35.32 36.98 40.52 35.60 41.92 36.35 2.491 0.262 0.862 0.200 
p__Proteobacteria 3.34 3.34 3.45 0.362 3.19 3.56 0.296 2.97 3.05 3.55 3.71 3.63 3.35 0.512 0.970 0.378 0.615 
p__Epsilonbacteraeota 0.86 0.89 0.56 0.167 0.64 0.89 0.136 0.67 0.75 0.50 1.04 1.02 0.61 0.236 0.314 0.199 0.850 
p__Spirochaetes 0.81 0.45 0.95 0.172 0.80 0.68 0.141 0.93 0.41 1.06 0.69 0.49 0.85 0.244 0.119 0.550 0.769 
p__Tenericutes 0.23 0.20 0.21 0.059 0.24 0.19 0.048 0.29 0.27 0.16 0.17 0.13 0.27 0.083 0.903 0.475 0.246 
Other 0.46 0.45 0.50 0.047 0.50 0.44 0.038 0.54 0.41 0.55 0.38 0.48 0.46 0.066 0.670 0.243 0.229 
Genus                                   
g__(Muribaculaceae Family) 0.84
a 0.28b 0.75ab 0.166 0.51 0.73 0.138 0.75 0.29 0.49 0.93 0.27 1.00 0.249 0.048 0.252 0.520 
g__ (Mollicutes_RF39 Order) 0.17 0.19 0.20 0.058 0.20 0.18 0.048 0.17 0.27 0.14 0.16 0.12 0.25 0.087 0.932 0.760 0.298 
g__Acidaminococcus 0.88 1.00 0.83 0.239 1.02 0.78 0.198 0.89 1.34 0.84 0.86 0.66 0.82 0.359 0.876 0.384 0.531 
g__Actinobacillus 0.59 0.82 0.54 0.167 0.50 0.79 0.138 0.51 0.54 0.45 0.66 1.10 0.62 0.250 0.440 0.134 0.611 
g__Alloprevotella 11.98 11.46 12.22 1.380 11.05 12.73 1.144 10.00 11.37 11.79 13.97 11.56 12.66 2.070 0.923 0.297 0.587 
g__Anaerovibrio 1.28 1.20 1.56 0.245 1.42 1.27 0.203 1.46 1.27 1.54 1.11 1.12 1.58 0.367 0.557 0.585 0.849 
g__Asteroleplasma 0.28 0.14 0.16 0.079 0.24 0.16 0.066 0.42 0.14 0.14 0.15 0.14 0.18 0.119 0.393 0.386 0.335 
g__Campylobacter 0.21 0.24 0.16 0.073 0.17 0.24 0.060 0.22 0.21 0.07 0.19 0.26 0.25 0.109 0.744 0.401 0.576 
g__Clostridium_sensu_stricto_1 4.42 7.01 5.00 0.776 5.24 5.71 0.643 4.43 5.89 5.41 4.42 8.13 4.59 1.164 0.055 0.601 0.356 
g__Desulfovibrio 0.48 0.35 0.54 0.071 0.46 0.45 0.059 0.46 0.38 0.56 0.50 0.33 0.53 0.106 0.163 0.905 0.883 
g__Dialister 2.37 3.64 2.19 0.530 2.67 2.79 0.440 2.23 3.36 2.41 2.50 3.91 1.96 0.795 0.118 0.843 0.789 
g__Erysipelotrichaceae_UCG-004 0.44 0.31 0.35 0.061 0.38 0.35 0.050 0.45 0.28 0.40 0.42 0.33 0.30 0.091 0.316 0.695 0.668 
g__Escherichia-Shigella 0.95 0.83 0.78 0.206 0.81 0.90 0.171 1.03 0.83 0.57 0.86 0.84 1.00 0.309 0.849 0.722 0.583 
g__Faecalibacterium 1.61 1.89 1.98 0.254 1.85 1.80 0.211 1.69 1.95 1.90 1.53 1.82 2.05 0.381 0.574 0.880 0.890 
g__Helicobacter 0.76 0.75 0.45 0.160 0.55 0.75 0.133 0.54 0.62 0.49 0.97 0.87 0.41 0.241 0.326 0.281 0.525 
g__Lactobacillus 3.91 4.85 4.35 0.668 4.07 4.67 0.554 3.54 4.04 4.63 4.28 5.67 4.07 1.002 0.607 0.435 0.510 







Colonic relative abundance (%) 
Fructan   XOSd   CON FOS INU CON FOS INU   P value  
CONa FOSb INUc SEM 0 1 SEM 0 0 0 1 1 1 SEM Fructan XOS 
Fructan × 
XOS 
g__metagenome 0.24 0.12 0.23 0.053 0.24 0.16 0.044 0.30 0.16 0.27 0.19 0.09 0.19 0.080 0.228 0.156 0.973 
g__Mitsuokella 0.30 0.43 0.36 0.062 0.45
a 0.27b 0.051 0.40 0.56 0.39 0.20 0.30 0.32 0.093 0.316 0.016 0.565 
g__Oscillospira 0.71
a 0.34b 0.57ab 0.092 0.46 0.62 0.077 0.63 0.34 0.43 0.79 0.35 0.71 0.139 0.025 0.156 0.592 
g__Phascolarctobacterium 0.79 0.62 1.11 0.158 0.85 0.83 0.131 0.61 0.67 1.28 0.98 0.57 0.95 0.238 0.094 0.913 0.293 
g__Prevotella_1 1.22 1.10 0.90 0.195 1.10 1.05 0.161 1.26 1.11 0.94 1.19 1.10 0.86 0.292 0.495 0.815 0.992 
g__Prevotella_2 5.64 6.29 6.01 0.759 6.27 5.68 0.630 6.42 6.55 5.84 4.86 6.03 6.17 1.139 0.831 0.506 0.677 
g__Prevotella_7 2.20 2.24 2.35 0.441 2.21 2.32 0.366 2.23 2.63 1.78 2.18 1.86 2.92 0.662 0.971 0.837 0.312 
g__Prevotella_9 24.86 27.59 23.26 2.003 27.02 23.45 1.661 25.80 29.69 25.58 23.92 25.49 20.94 3.004 0.310 0.128 0.871 
g__Prevotellaceae_NK3B31_group 6.77 2.49 5.28 1.263 4.50 5.19 1.047 8.02 2.65 2.83 5.53 2.33 7.72 1.895 0.060 0.635 0.116 
g__Prevotellaceae_UCG-003 0.57 0.29 0.55 0.091 0.39 0.54 0.076 0.51 0.26 0.42 0.64 0.32 0.67 0.137 0.061 0.165 0.771 
g__Rikenellaceae_RC9_gut_group 2.72 1.98 2.74 0.481 2.39 2.58 0.399 2.45 1.75 2.96 2.99 2.22 2.52 0.721 0.452 0.732 0.722 
g__Romboutsia 0.45 0.55 0.53 0.123 0.51 0.51 0.102 0.45 0.36 0.73 0.45 0.74 0.33 0.185 0.831 0.974 0.089 
g__Roseburia 0.30 0.26 0.46 0.094 0.29 0.39 0.078 0.34 0.20 0.33 0.26 0.31 0.59 0.141 0.283 0.376 0.422 
g__Ruminococcaceae_UCG-002 1.11 0.81 1.22 0.142 1.12 0.98 0.118 1.13 0.91 1.32 1.10 0.72 1.11 0.213 0.118 0.391 0.884 
g__Ruminococcaceae_UCG-005 0.59 0.36 0.63 0.095 0.50 0.55 0.079 0.58 0.38 0.55 0.60 0.34 0.71 0.143 0.107 0.672 0.750 
g__Ruminococcaceae_UCG-014 0.63 0.59 0.66 0.048 0.68
a 0.57b 0.039 0.69 0.67 0.70 0.57 0.50 0.63 0.071 0.511 0.039 0.770 
g__Sphaerochaeta 0.25 0.11 0.19 0.057 0.20 0.17 0.047 0.38
a 0.11b 0.11b 0.13b 0.11b 0.28ab 0.086 0.239 0.702 0.038 
g__Streptococcus 0.73 0.71 0.96 0.333 0.90 0.70 0.277 0.57 0.71 1.43 0.90 0.72 0.48 0.500 0.848 0.600 0.380 
g__Subdoligranulum 1.36 1.15 1.49 0.129 1.20 1.46 0.107 1.25 1.16 1.20 1.48 1.13 1.77 0.194 0.177 0.085 0.266 
g__Succinivibrio 0.38 0.63 0.26 0.194 0.36 0.49 0.161 0.17 0.61 0.30 0.59 0.65 0.23 0.292 0.401 0.564 0.637 
g__Sutterella 0.39 0.39 0.48 0.052 0.38 0.46 0.043 0.42 0.33 0.40 0.36 0.44 0.56 0.078 0.374 0.213 0.310 
g__Terrisporobacter 3.06 4.90 3.58 0.585 3.73 3.96 0.485 2.68 4.36 4.16 3.43 5.44 3.00 0.878 0.081 0.740 0.351 
g__Treponema_2 0.66 0.39 0.93 0.202 0.71 0.61 0.168 0.68 0.34 1.10 0.65 0.44 0.75 0.303 0.183 0.686 0.715 
g__uncultured 2.13 2.00 2.27 0.314 2.26 2.01 0.260 2.43 1.91 2.44 1.83 2.09 2.10 0.471 0.834 0.486 0.674 
g__uncultured_Porphyromonadaceae 
_bacterium 
2.58 1.67 2.55 0.348 2.11 2.43 0.288 2.22 1.53 2.57 2.94 1.81 2.53 0.521 0.118 0.430 0.743 
g__uncultured_rumen_bacterium 0.55 0.31 0.83 0.146 0.56 0.57 0.121 0.41 0.34 0.92 0.69 0.29 0.73 0.219 0.054 0.935 0.508 
Other 5.98 4.93 6.03 0.362 5.83 5.46 0.301 6.52 4.95 6.03 5.44 4.91 6.04 0.544 0.061 0.381 0.488 
1Phylum and genus with > 1 % abundance in a minimum of 1 sample. a CON; Control. b FOS; Fructo-oligosaccharides. c INU; Inulin. d XOS; Xylo-




4.4.2.3 Alpha and Beta diversity  
The number of OTUs and alpha diversity (Chao1 and Shannon) are presented in Table 
4.6. There was no significant interaction between fructans and XOS on alpha diversity 
measures in the ileum or colon (Table 4.6). The number of OTUs (P < 0.026) and Chao1 
diversity (P < 0.027) indices in the ileum were significantly lower with FOS inclusion 
compared to the CON, but not the INU treatment. Dietary treatment did not affect the 
Shannon-Wiener diversity index in the ileum (P > 0.05). The number of OTUs were 
significantly lower in the colon with FOS inclusion compared to the CON and INU 
treatments (P < 0.017). The Chao1 diversity index was significantly lower in the colon 
with FOS inclusion compared to the INU treatment, but not the CON treatment (P < 
0.038). The Shannon-Wiener diversity index was significantly lower in the colon with 















Table 4.6 Effect of XOS and fructans (FOS and INU) on number of OTUs, Chao1 diversity and Shannon-Weiner diversity in the ileum and 
colon of piglets. 
 
  
Fructan   XOSd   CON FOS INU CON FOS INU   P value  
CONa FOSb INUc SE 0 1 SE 0 0 0 1 1 1 SE Fructan XOS 
Fructan 
× XOS 
Ileum                                    
Number of OTUse 623a 562b 602ab 15.91 597 596 12.85 640 567 585 606 556 619 23.24 0.026 0.858 0.294 
Chao1 diversity 678a 613b 658ab 17.24 652 650 13.92 692 620 643 664 605 674 25.18 0.027 0.851 0.431 
Shannon-Weiner diversity 2.98 2.83 2.99 0.10 2.85 3.02 0.08 3.00 2.80 2.76 2.96 2.87 3.21 0.14 0.439 0.150 0.171 
  
                 
Colon                  
Number of OTUs 691a 643b 697a 13.81 677 677 11.28 702 646 683 681 640 710 19.53 0.017 0.996 0.459 
Chao1 diversity 743ab 699b 750a 14.82 730 731 12.10 751 699 740 736 698 760 20.96 0.038 0.943 0.703 
Shannon-Weiner diversity 4.08a 3.82b 4.02ab 0.06 3.92 4.02 0.05 4.10 3.79 3.88 4.06 3.85 4.17 0.09 0.011 0.148 0.159 
a CON; Control. b FOS; Fructo-oligosaccharides. c INU; Inulin. d XOS; Xylo-oligosaccharides. e OTUs; Operational taxonomic units. a-b Means within a 






There was a significant interaction between fructans and XOS on beta diversity in the 
ileum (P < 0.026). An NMDS plot of the similarity of bacterial communities in each 
treatment group is shown in (Figure 4.4). When looking at the effect of fructans on 
bacterial community structure with and without XOS, there was no difference between 
fructans in the absence of XOS (CON vs FOS, CON vs INU and FOS vs INU), but in the 
presence of XOS, both FOS and INU were different to the CON (CON vs FOS + XOS, 
and CON vs INU + XOS) but not each other (FOS + XOS vs INU + XOS). When looking 
at the effect of XOS on each fructan, bacterial community structure differed when XOS 
was included compared to the CON (CON vs CON + XOS), but there was no effect on 
FOS (FOS vs FOS + XOS) or INU (INU vs INU + XOS) with or without XOS. There 
was no effect of fructan and XOS on beta diversity in the colon (P > 0.05).  
 
 
Figure 4.4 Non-metric multi-dimensional scaling (NMDS) plot of the bacterial 
community composition between xylo-oligosaccharides (XOS) and fructans 




4.4.3 Microbial endo-XYL activity 
There was no effect of treatment on colonic microbial endo-XYL activity (Figure 4.5; P 
> 0.05).  
 
Figure 4.5: Effect of xylo-oligosaccharides (XOS) and fructans (Fructo-
oligosaccharides (FOS)) and (Inulin (INU)) on piglet colonic microbial endo-















4.5.1 Piglet performance 
There is increasing demand to find alternative feeding concepts to improve gut health, 
enhance disease resistance and support growth performance in pigs. This study aimed to 
investigate the effect of short or long DP fructans with or without XOS on piglet 
performance, bacterial community composition and microbial endo-XYL activity. In the 
absence of XOS, piglets receiving the FOS and INU treatments had a reduced ADFI. In 
the presence of XOS alone, piglet ADFI was similar to that of the FOS and INU fed 
piglets, yet when XOS was fed in combination with FOS and INU, ADFI increased to a 
level similar to the CON treatment. The interaction between fructans and XOS on ADFI 
resulted in similar interaction trends for BW. Similar results have been reported in the 
literature whereby FOS was shown to reduce ADFI and ADG in young growing pigs 
(Houdijk, JGM et al., 1998). In contrast, FOS has also been shown to have no effect on 
ADFI, but increase ADG and improve FCR in both weaning piglets and growing pigs 
(Xu, C. et al., 2005; Xu, Z.R. et al., 2002). Improvements in pig growth performance with 
INU supplementation have been reported up until 84 days of age, but, INU was in fact 
shown to reduce ADFI and subsequent ADG immediately after weaning (Grela et al., 
2014), agreeing with the current trial results. Moreover, the reduction in ADFI and growth 
performance when XOS was supplemented independently disagrees with other studies 
whereby a significant improvement in ADG was observed in the first 2- (Liu, J. et al., 
2018) and 4 weeks after weaning (Chen, Y. et al., 2021), and an increased ADFI was seen 
from 7‒8 weeks of age (Chapter 2).    
 
A possible reason for the reduction in ADFI and consequent reduction in BW observed 
with FOS, INU and XOS supplementation could be partially due to the ileal brake 




their microbial fermentation products stimulate the release of peptides from the GIT 
epithelium which affect digestion and ultimately influence feed consumption (Dunshea, 
F.R. et al., 2018). The release of GIT hormone peptides such as peptide tyrosine tyrosine 
(PYY) and glucogon-like peptide 1 creates a feedback mechanism which slows gastric 
emptying, gastric acid production and the intensity of peristaltic contractions, all of which 
reduce feed intake (Black et al., 2009). Commencement of the ileal brake mechanism via 
GIT nutrient infusion has been shown to reduce feed intake by up to 60 % in humans and 
rodents (Dunshea, F.R. et al., 2018). In pigs, feeding albus lupins that are high in 
oligosaccharide content reduced feed intake by ~15‒25 % and subsequently reduced 
ADG (Dunshea, F. et al., 2001), with similar results found by Moore et al. (2021). 
Throughout the current trial, the largest reduction in ADFI was 12 % in XOS fed piglets 
within the first 2 weeks of the trial (day 0‒13), hence are not dissimilar from the levels 
reported in the literature. Interestingly, other studies have shown a reduction in ADFI 
with both INU and FOS supplementation in young pigs when initially fed. However, the 
reduction was only temporary and was compensated for in later growth stages (Grela et 
al., 2014; Houdijk, JGM et al., 1998). The current trial was concluded at 28 days post-
weaning, hence data past this point was not obtainable.  
 
The extent of the ileal brake mechanism and its consequent effect on ADFI tends to 
increase relative to the amount of stimulating substrate within the GIT (Meyer et al., 1998; 
Van Avesaat et al., 2015). To this point, it would be expected that feeding XOS in 
combination with either FOS or INU would have a larger ileal brake effect due to 
increased fermentation and SCFA production, thus have a greater reduction on ADFI 
compared to when fed independently.  In fact, the results of this trial showed the opposite, 
such that in the last 2 weeks of the trial the combination of XOS + INU somewhat 




explained by a lower level of fermentative activity whereby less microbial fermentation 
products were produced, hence less GIT hormones were released to initiate the ileal brake 
mechanism. This therefore would have lessened the effect on reducing feed intake, thus 
explaining the higher ADFI observed. This theory is supported by the fermentative 
activity data (pH and lactate concentration) reported in section 6.4.1, whereby lactate 
concentration was lower, and pH was higher with XOS + INU compared to when INU 
was fed alone. This suggests that XOS and INU stimulate lactate-producing bacteria 
which somehow compete with each other when combined.   
 
Despite the interaction effect of fructans and XOS on ADFI, there was no overall effect 
on BW or ADG, hence disagrees with hypothesis 1. One possible reason for the lack of 
growth response is that the piglets were of a good weight at weaning (7.88 kg) and 
observations of performance benefits were therefore less likely, hence is a limitation of 
this study. Piglets fed the CON diet tended to have a higher BW at the end of the trial 
compared to all test treatments. The ADG of XOS fed piglets was reduced numerically 
by 14.6 % in the first 2 weeks of the trial, but only by 5.5 % in the last 2 weeks of the 
trial. This indicates the piglets were able to cope better with XOS as they aged, suggesting 
a longer feeding period may have been required to observe benefits in performance. 
Furthermore, supplementing fructans (FOS and INU) increased piglet FCR in the final 2 
weeks of the trial (day 14‒27) and tended to have the same effect in the overall trial period 
(day 0‒27). This reduction in efficiency is explained by a similar feed intake but lower 
ADG. Overall, there was no beneficial effect of fructans and XOS on piglet performance, 
hence disproving the initial hypotheses. This agrees with another study that investigated 
the effect of FOS and TOS whereby lower ADFI and ADG were reported compared to 
the CON (Houdijk, JGM et al., 1998). Furthermore, increased observations of ill health 




with and without XOS tended to have a higher score compared to the other treatments, 
suggesting incompatibility of INU within the first 2 weeks post-weaning. This could have 
been due to INU favouring the growth of undesirable bacteria in this particular study.  
 
4.5.2  Bacterial community analysis 
4.5.2.1 Ileal bacterial community composition 
To investigate the prebiotic effect of fructans and XOS, ileal bacterial community 
composition was studied by sequencing the V4 region of the 16S rRNA gene between 
dietary treatment groups. Over 95 % of the ileal bacteria belonged to the phyla Firmicutes, 
Bacteroidetes and Proteobacteria, agreeing with other studies (Isaacson and Kim, 2012; 
Holman et al., 2017). The increase in the abundance of the phylum Epsilonbacteraeota in 
the ileum of XOS fed piglets was explained by an increased abundance of OTUs 
associated with g__Helicobacter at the genus level. Helicobacter is a genus of gram-
negative curved rod bacteria which thrive in the acidic environment of the stomach 
(Christakopoulos et al., 2003). The most well-known species of this genus is Helicobacter 
pylori which causes chronic gastritis and stomach ulceration in humans, thus thrives in 
the very acidic and low pH environment of the stomach (Ansari and Yamaoka, 2017). 
Encouragingly, XOS has been reported to show antimicrobial activity against H. pylori 
in vitro (Christakopoulos et al., 2003). The current study showed an increase in the 
abundance of OTUs associated with g__Helicobacter with XOS fed piglets, albeit the 
species was unknown. Given that the ileal pH was 6.75 (section 6.4.1) it is unlikely that 
the Helicobacter species measured in the current study was H. pylori, suggesting XOS 





Moreover, the tendency for the abundance of Proteobacteria to decrease in the ileum of 
XOS fed piglets can be explained by a reduction in the abundance of OTUs associated 
with g__Actinobacillus at the genus level. Proteobacteria are a major group of bacteria 
including a wide variety of pathogens such as Escherichia and Salmonella. Species of the 
Actinobacillus genus, family Pasteurellaceae, are gram negative facultative anaerobic 
bacteria that range from commensal species to pathogenic members (Vanni et al., 2012). 
One well known species is Actinobacillus pleuropneumoniae which causes 
pleuropneumonia, a severe respiratory disease in pigs (Vanni et al., 2012). Although the 
species was unknown in the current study, XOS reduced the relative abundance of OTUs 
associated with g__Actinobacillus. To the author’s knowledge, this effect of XOS has not 
been reported in the literature to date, but the abundance of Lactobacillus has been shown 
to have a significant negative correlation with the abundance of Actinobacillus in piglet 
ileal digesta (Tian et al., 2019). This agrees with the current study whereby an increase in 
the abundance of Lactobacillus and a reduction in the abundance of Actinobacillus was 
seen in XOS fed piglets.  
 
Furthermore, the tendency for the abundance of Bacteroidetes to increase in XOS fed 
piglets can be explained by an increase in the abundance of OTUs associated with 
g__Prevotella_7, g__Prevotella_9 and g__uncultured (Prevotellaceae Family) at the 
genus level. Prevotella species are known to possess genes for cellulose and xylan 
hydrolysis (Ivarsson et al., 2014), hence the presence of XOS in the ileum seemed to 
stimulate the increase in abundance of OTUs associated with the Prevotellaceae family 
and carbohydrate metabolism. Unfortunately, the analysis of microbial endo-XYL 
activity in the ileum was not possible in the current study which would have supported 
this theory. However, similar results were found in Chapter 2, whereby an increase in the 




Prevotella_9 were seen in the faeces of XOS fed piglets compared to the CON. Hence, 
this family of bacteria are likely involved in the mechanistic pathways of XOS. It is 
important to note that there was a trend for an interaction between XOS and fructans on 
the abundance of OTUs associated with g__Prevotella_7, whereby increases with XOS 
were only seen in the INU group. This indicates the significant main effect stemmed 
mostly from this trend for an interaction in the INU group.  
 
The abundance of OTUs associated with g__Escherichia-Shigella in the ileum tended to 
be similar with and without XOS in the CON and INU groups but were higher without 
XOS and lower with XOS in the FOS group. This suggests a potential advantage of 
feeding XOS and FOS in combination to prevent the growth of pathogenic 
g__Escherichia-Shigella in the ileum. The supplementation of XOS alone has been 
shown to reduce faecal Escherichia coli counts in weanling pigs (Liu, J. et al., 2018), and 
similarly, FOS has been to shown to reduce Escherichia coli in the caecum (Liu, L. et al., 
2020). However, to the author’s knowledge, the combination of XOS and FOS on the 
abundance of Escherichia coli in the ileum has not been reported elsewhere and is likely 
due to competitive exclusion.  
 
Lactobacillus is the largest genus of LAB and mainly prominent in the small intestine 
(Yu et al., 2018). Lactobacillus have been shown to affect intestinal physiology, regulate 
the immune system and maintain intestinal homeostasis of the host, all of which improves 
overall health and growth performance (Valeriano et al., 2017). In the current study, the 
abundance of OTUs associated with g__ Lactobacillus in the ileum was highest in the 
XOS group compared to all other treatment groups but was not dissimilar to the FOS 




fermentation taking place in the ileum. XOS has been shown to increase the abundance 
of Lactobacillus in the ileum and caecum (Chen, Y. et al., 2021), colon (Pan et al., 2019) 
and faeces (Liu, J. et al., 2018) of pigs, hence supports the current trials results. An in 
vitro study suggested that the slower rate of XOS fermentation compared to GOS or soy 
solubles may indicate that XOS is a better substrate for bacteria in the distal portions of 
the GIT such as the transverse and descending regions of the large intestine (Smiricky-
Tjardes et al., 2003a). However, given the clear effect of XOS on Lactobacillus in the 
ileum in the current study, coupled with the absence of a similar effect in the colon, 
indicates that XOS is a  readily fermentable substrate for the bacteria in the small intestine 
and perhaps the caecum (not measured) in vivo. Hence, the hypothesis of XOS mainly 
being fermented in the lower gut is rejected. Moreover, piglets with a ‘good’ ADG have 
been found to have higher abundance of Lactobacillus and unclassified Prevotellaceae 
compared to piglets with a poor ADG (Gaukroger et al., 2020). However, despite the 
increase in abundance of beneficial Lactobacillus and unclassified Prevotellaceae in XOS 
fed piglets in the current study, this did not translate into a performance benefit for the 
host and in fact the opposite was observed.   
 
Furthermore, the abundance of OTUs associated with g__Terrisporobacter was similar 
with and without XOS in the FOS and INU groups but was higher without XOS and lower 
with XOS in the CON group. Similar results have been found in the ileum and caecum of 
weaner pigs, whereby the abundance of Terrisporobacter was lower with XOS than 
without (Chen, Y. et al., 2021). In humans, infants that were fed on a formula diet showed 
the lowest microbial diversity and highest relative abundance of Terrisporobacter 
compared to those fed other diets (Cai et al., 2019). Moreover, correlation network 
analysis revealed that the abundance of Terrisporobacter was positively correlated with 




reduction in abundance of OTUs associated with g__Terrisporobacter in XOS fed piglets 
could indicate the potential for XOS to reduce oxidative stress.  
 
4.5.2.2 Colonic bacterial community composition 
Over 94 % of the colonic bacteria belonged to the phyla Bacteroidetes and Firmicutes, 
which agrees with other studies (Isaacson and Kim, 2012; Holman et al., 2017). The 
abundance of OTUs associated with an unknown genus from the Muribaculaceae family 
and g__Oscillospira were reduced in FOS fed piglets compared to the CON but not the 
INU group. Little has been reported on the role of these bacteria in animals, but 
supplementing raw potato starch, a form of resistant starch, in pigs also reduced the 
relative abundance of OTUs associated with Oscillospira and S24-7 group (now known 
as Muribaculaceae), possibly indicating similarities between the mode of action of 
resistant starch and FOS  (Sun et al., 2015). Furthermore, a meta-analysis of 5 microbiota 
human studies revealed a significant reduction in the abundance of Oscillospira in 
patients suffering with inflammatory bowel conditions like Crohn’s disease (Walters et 
al., 2014), indicating a possible association with a degree of dysbiosis in FOS fed piglets. 
 
Compared to the CON group, XOS fed piglets had a lower abundance of OTUs associated 
with g__Mitsuokella and g__Ruminococcaceae_UCG-014. In the ileum of XOS fed 
piglets, the abundance of OTUs associated with lactate producing g__ Lactobacillus 
increased, hence it was expected that lactate utilising bacteria like Mitsuokella (Newman 
et al., 2018) would increase in abundance to utilise the free lactate. However, this was not 
the case and a reduction in the abundance of g__Mitsuokella was seen in the colon of 
XOS fed piglets compared to the CON. This indicates that the majority of lactate was 




lactate was present in the colonic samples, hence explaining the reduction of lactate 
utilising bacteria. Moreover, species in the Ruminococcaceae family are known for 
having XYL and cellulase gene activity, thus are well equipped to break down plant 
material (Biddle et al., 2013). As seen in the ileum with members of the Prevotellaceae 
family, it was expected that the presence of XOS in the colon would stimulate the 
abundance of xylan-degrading bacteria and their activity. However, a reduction in the 
abundance of g__Ruminococcaceae_UCG-014 was seen in the colon. Moreover, there 
was no difference in the colonic microbial endo-XYL activity, hence disagrees with 
hypotheses 2-4. The reduction of lactate utilising g__Mitsuokella and xylan degrading 
g__Ruminococcaceae_UCG-014 abundance in the colon, coupled with a large increase 
in the abundance of g__ Lactobacillus and members of the Prevotellaceae family in the 
ileum suggests that the fermentative activity of XOS is mainly in the ileum, hence further 
up the gut than initially expected.  
 
Finally, g__Sphaerochaeta belong to the family Spirochaetaceae; little is known about 
this genus, but isolates have been found in freshwater sediments and from the hindgut 
contents of termites (Ritalahti et al., 2012). One study showed that the abundance of 
Sphaerochaeta in the duodenum were increased in low FCR pigs compared to high FCR 
pigs (Tan et al., 2018). This somewhat agrees with the current study, as the colonic 
abundance was highest in the CON fed piglets which had the lowest FCR, whilst the 
abundance was lowest in the FOS and INU group which had significantly higher FCRs. 
Albeit, the location along the GIT was different and it does not explain the increase in 
abundance when XOS and INU were fed in combination. Furthermore, there was a trend 
for an interaction between XOS and fructans on the abundance of OTUs associated with 
g__Romboutsia. Again, little is known about this bacterial genus but it has been shown 




as having genes encoding for the specific carbohydrate degrading enzymes (Gerritsen, 
2015). Despite this, no difference was seen in the colonic endo-XYL activity with 
treatment, although other enzyme activities like arabinofuranosidase were not studied. 
With the caecum being a highly active fermentation site, average caecal levels of endo-
XYL activity (7.41 EU/g DM) have been reported to be 18 times that of the average 
activity in the ileum of broilers (0.43 EU/g DM) (Bautil, 2020). In the current study, the 
average colonic activity was 1.77 EU/g DM, hence in between the ileal and caecal figures 
reported for broilers. With dietary treatment having a larger effect on bacterial community 
composition in the ileum compared to the colon in the current study, a difference in endo-
XYL activity with treatment would have been more likely in the ileum than the colon. 
This effect was seen in piglets, whereby XOS increased the xylanolytic activity in the 
ileum but not the caecum or colon (Marinho et al., 2007).  
 
4.5.2.3 Alpha and Beta diversity 
Alpha diversity was estimated based on the Chao1 index as an indicator of species 
richness, whilst the Shannon-Wiener index was measured as an indicator of species 
evenness (richness and abundance). There was no effect of XOS on alpha diversity in the 
ileum or colon, which disagrees with hypothesis 3 and a study where XOS increased 
Chao1 and Shannon index (Chen, Y. et al., 2021), albeit XOS was included at a higher 
inclusion rate (0.50 g/kg) than the current study. Contrary to hypothesis 2, lower numbers 
of OTUs and species richness were found in the ileum of piglets supplemented with FOS 
compared to those fed the CON diet, but not the INU diet. One study found no effect of 
FOS on species richness in the ileal digesta or mucosa of broiler chickens (Shang et al., 
2018), whilst another found no effect of alternative prebiotics like GOS on alpha diversity 
(Berding et al., 2016; Tian et al., 2019). A high diversity is generally considered beneficial 




challenge (Konopka, 2009; Chen, L. et al., 2017). Alpha diversity tends to increase with 
age as the bacterial community becomes more developed (Chen, L. et al., 2017). 
However, it has been shown to reduce immediately after stressful events and periods of 
reduced growth such as after weaning (Hu et al., 2016). Others have shown low alpha 
diversity to be associated with bacterial community instability, as less diverse 
communities are more prone to the introduction of foreign species due to a lesser coverage 
of ecological niches (Frost et al., 2021). A good example of how low bacterial diversity 
can negatively affect the gut bacterial balance is Clostridium difficile, whereby the 
proliferation of this pathogenic bacteria increases when co-cultured with a low diverse 
dysbiotic microbiota compared to a healthy community (Horvat and Rupnik, 2018). 
Supporting this, in the current study, FOS fed piglets tended to have a higher abundance 
of OTUs associated with g__Clostridium_sensu_stricto_1 in the colon, coupled with a 
low alpha diversity. The reduction in alpha diversity when piglets were supplemented 
with FOS indicates a degree of bacterial community imbalance which may explain the 
poorer efficiency of the FOS fed piglets.  
 
There was a significant interaction between fructans and XOS on beta diveristy in the 
ileum, but not the colon hence disagreeing with hypothesis 3-4. Despite the lower ileal 
bacterial diversity of FOS fed piglets, there was no difference in ileal bacterial community 
structure between fructans or compared to the CON in the absence of XOS. However, in 
the presence of XOS, both FOS and INU were different to the CON. There was weak 
visual clustering in the NMDS plot, yet the FOS and INU samples were higher up the 
NMDS2 axis compared to the CON samples in the presence of XOS. Similarly, although 
no clear visual clustering was seen, the bacterial community structure differed when XOS 




bacterial community structure in the ileum. Similarly, clustering tendencies have been 
observed with different doses of XOS (Pan et al., 2019).  
 
4.5.3 Conclusion 
Overall, supplementation of XOS with or without short and long-chain fructans had no 
beneficial effect on piglet growth performance, likely because of the large reduction in 
ADFI. The ADG of XOS fed piglets was reduced in the first 2 weeks of the trial, but to a 
much lesser extent in the last 2 weeks of the trial, suggesting piglets adjusted to XOS with 
age and a longer feeding period may have been required to observe performance benefits. 
Bacterial community structure differed with prebiotic supplementation in the ileum but 
not the colon, indicating the fermentation of the products may be more suitable for 
bacteria inhabiting the distal small intestine compared to the large intestine. Dietary 
treatment had no effect on colonic microbial endo-XYL activity. Positive bacterial 
abundance changes were observed with XOS supplementation, for example the 
stimulation of beneficial Lactobacillus in the ileum. Hence, despite the lack of 
performance benefits observed, the bacterial modulation effect of XOS was positive and 
the piglets likely needed longer for these benefits to reflect in increased growth 
performance. In summary, results of the current study and comparison with the literature 
suggest a longer feeding period may be necessary to allow the gut bacteria a longer time 






Chapter 5  
Evaluation of titanium dioxide and intrinsic cellulose as inert 
markers for non-starch polysaccharide digestibility.  
5.1 Abstract  
The accuracy of the inert marker technique for digestibility studies relies on the marker 
being homogenously distributed throughout the digesta with the nutrients to facilitate 
calculation of accurate and precise digestibility values. However, numerous studies have 
shown separation of inert markers and digesta when investigating fibre fraction 
digestibility, resulting in negative or unexpectedly high digestibility values. Hence, this 
study aimed to evaluate TiO2 and intrinsic cellulose as inert markers for NSP digestibility 
in piglets. A total of 474 weaner piglets (7.88 ± 1.51 kg) were blocked into mixed sex 
pens of 4‒5 piglets and assigned to 1 of 6 dietary treatments in a 2 × 3 factorial treatment 
arrangement. Diets contained 2 levels of XOS (0 and 0.286 g/kg) and 3 levels of fructans 
[(0 g/kg) and 6.50 g/kg of short-chain FOS and 4.08 g/kg of INU to supply 3.8 g/kg of 
pure fructans)]. TiO2, cellulose and NSP concentrations of the feed, ileal digesta and 
faeces were determined to calculate the AID and ATTD of NSPs using both TiO2 and 
cellulose as comparative inert markers. Results showed highly negative AID of NSP 
when using TiO2 as an inert marker, indicating separation of the marker and NSP. In 
contrast, using cellulose as an inert marker yielded more realistic, less negative and less 
variable AID of NSP. There was a negative correlation between AID of total NSP when 
using TiO2 as a marker compared to cellulose (P < 0.021). At the faecal level, positive 
and more similar ATTD of NSPs were observed between the markers compared to AID, 
but no positive correlation was seen between the markers. Post-ileal cellulose degradation 
caused the average ATTD for total NSPs, obtained using cellulose as a marker,  to be 15.1 
% lower compared to when using TiO2 as a marker, and cellulose fermentation was also 




unsuitable inert marker for AID of NSPs, with cellulose yielding more realistic initial 
results. In contrast, TiO2 should be used for ATTD of NSPs, as post-ileal cellulose 
degradation rendered the use of cellulose as an inert marker infeasible.  
 
5.2 Introduction 
Digestibility studies are an important method of evaluating the nutritive value of feed 
materials or additives in monogastric nutrition. The digestibility of diets can be measured 
by total collection of faeces after a known quantity of feed has been consumed or by using 
an inert marker substance (Kavanagh et al., 2001). The marker method allows digestibility 
to be calculated using the ratio of inert marker to the nutrient of interest in the feed and 
digesta/excreta, and is a more efficient and less laborious method than total collection (de 
Vries, 2014). Chromic oxide (Cr2O3) is commonly used as an inert marker and has shown 
good recovery rates in some studies (Bakker and Jongbloed, 1994), but low recoveries in 
other studies (Yin, Y.-L. et al., 2000; Jagger et al., 1992). Likewise, TiO2 is also 
commonly used as a marker with good recovery rates and is suggested as the most 
appropriate inert marker for digestibility studies (Jagger et al., 1992).  
 
The accuracy of the marker technique relies on the marker being homogenously 
distributed throughout the digesta with the nutrients to facilitate calculation of accurate 
and precise digestibility values (Choct et al., 1996). The most common inert markers are 
insoluble and associated with the solid phase of the digesta throughout the GIT, but 
separation of the solid and liquid phase of the digesta can occur which complicates 
digestibility results (Choct et al., 1996; Van der Klis and Van Voorst, 1993). For example, 
peristaltic and anti-peristaltic contractions cause pressure at the ileocaecal junction, which 




(Fenna and Boag, 1974). Cr2O3 is a fine particulate material and is likely transported with 
the liquid phase at a higher rate than larger solid components, with differences in water 
intake only increasing the discrepancy (Van der Klis and Van Voorst, 1993). To this point, 
Oberleas et al. (1990) found that Cr2O3  was carried more readily by the liquid rather than 
the solid phase of the digesta in rats, hence concluded that it was a more useful marker 
for studying the flux of water rather than dietary DM. In a well digested diet, transit times 
are fairly short in the lower ileum and the distribution of nutrients and marker are 
relatively uniform, but the presence of large amounts of soluble NSPs can exacerbate 
differences in transit times and separation of nutrients (Choct et al., 1996). As such, the 
suitability of traditional inert markers for calculating digestibility in high fibre diets is 
questionable and the basal diet components should be considered (Prawirodigdo et al., 
2019; Prawirodigdo et al., 2021). To this point, numerous studies have shown negative or 
unexpectedly high digestibility values for fibre fractions using Cr2O3 (Jamroz et al., 2002; 
Brenes et al., 2003) or TiO2 (Bautil et al., 2019) with the overall concluding reason being 
that this was due to separation of the indigestible marker and digesta. When estimating 
the AID of NGP with Cr2O3, separation of the marker and digesta resulted in 
unrealistically high estimates (54 to 66 %) in broilers, infeasibly exceeding ATTD values 
by 16 to 42 % units (de Vries, 2014). This further supports that the marker method can 
yield erroneous results, especially in high fibre diets, ultimately leading to mis-estimation 
and confounded digestibility results.  
 
Minimal work has been conducted in finding suitable alternatives to the traditional 
markers for use in digestibility studies on fibre, but an ideal marker would be intrinsic to 
the diet and have a similar structure to fibre. Intrinsic, naturally occurring, acid-insoluble 
ash (AIA) has been examined and deemed a reliable marker for energy and DM 




crates for pigs (Kavanagh et al., 2001). However, it cannot simply be applied to analyse 
the digestibility of other dietary components, like fibre fractions. Cellulose is not 
hydrolysed by endogenous enzymes and is therefore considered relatively indigestible 
prior to the hindgut, making it a possible candidate as an inert marker for ileal 
digestibility. Any fermentation of cellulose by the GIT bacterial community mainly 
occurs in the distal part of the colon, hence using cellulose as a marker in the small 
intestine is theoretically plausible, whilst its use at the faecal level would require 
correction (Jha and Berrocoso, 2015). Indeed, indigestible cellulose has been shown to 
provide a better estimate of organic matter digestibility over AIA in ruminants (Penning 
and Johnson, 1983). By comparison, there is a lack of data in the monogastric field. This 
study aimed to evaluate TiO2 and intrinsic cellulose as inert markers for AID and ATTD 
of NSPs in piglets.  
 
5.2.1 Study aims 
A number of studies have shown separation of inert markers and digesta when 
investigating fibre fraction digestibility, resulting in negative or unexpectedly high 
digestibility values. This study therefore aimed to evaluate TiO2 and intrinsic cellulose 
that has a more similar structure to NSPs, as inert markers for AID and ATTD of NSPs 
in piglets.  
 
5.2.2 Hypotheses 
1. As seen in the literature, separation of TiO2 and digesta will occur in the ileum 
leading to mis-estimation of AID of NSPs, whereas cellulose will not separate 




2. Fractionation of the markers and digesta will be corrected at the faecal level, 
leading to a positive correlation between ATTD of NSPs using TiO2 or cellulose 
as inert markers.  
 
5.3 Materials and methods 
Study protocols were approved by the University of Leeds Pig Research Centre and 
ethical approval was granted by the Animal Welfare and Ethical Review Body as 
described in Appendix A.1. 
 
5.3.1 Animals, housing, experimental design and dietary treatments 
The animals, housing, experimental design and dietary treatments used in this study were 
as described in (section 4.3.1 and 4.3.2).  
 
5.3.2 Measurements and sampling 
5.3.2.1 TiO2 analysis  
TiO2 in the feed, ileal digesta and faecal samples were analysed according to the method 
of Short et al. (1996). Briefly, a known weight (~ 0.2 g) of freeze-dried (section 4.3.3.2) 
sample was weighed into a 28 ml glass tube and ashed at 580 ºC for 13 hours. Once 
cooled, 10 ml of 7.4 M sulphuric acid was added to the ash, and the tubes were transferred 
to a hot plate at 150 ºC for 1 h to enable ash dissolution. The cooled tube contents were 
poured into a small beaker containing 10 ml of deionised water before filtration through 
Whatman 541 filter paper into a 100 ml volumetric flask. 10 ml of hydrogen peroxide were 
added, and the solution was brought up to 100 ml with deionised water. A yellow/orange 




were transferred into a 96 well plate and the absorbance was measured at 408 nm using a 
spectrophotometer. The concentration of TiO2 in each sample was calculated by plotting the 
absorbance value on a calibration curve of known standards.  
 
5.3.2.2 Carbohydrate content 
5.3.2.2.1 Total NSP, NSP constituent sugars and cellulose analysis 
Total NSP, NSP constituent sugars, and cellulose content of the feed, ileal digesta, and 
faeces were determined in duplicate by GC following the methods of Englyst, H.N. et al. 
(1994) at Englyst Carbohydrates Ltd, Southampton, UK. Briefly, starch was dispersed 
with dimethylsulfoxide and enzymatically hydrolysed before being removed along with 
sugars by washing with either 80 % ethanol or pH 7 buffer for the total and insoluble NSP 
fractions respectively. The dried residues were treated with 12 M sulphuric acid at 35 ºC 
to disperse the cellulose followed by 2 M sulphuric acid treatment at 100 ºC to complete 
the hydrolysis of the neutral sugar cell-wall polysaccharides to their constituent 
monosaccharides and de-sulphate them.  
 
A portion of the hydrolysate was buffered to pH 4.5 and pectinase was added to complete 
the hydrolysis of pectin to galacturonic acid (galA). The neutral sugars were reduced to 
their alditols, and uronic acids to their aldonic acids with alkaline sodium borohydride. 
The aldonic acids were converted to their lactones by heating in acidified ethanol and 
derivatised with propylamine to their propylaldonamides. All sugars were then acetylated 
with acetic anhydride in the presence of methylimidazole as catalyst. A GC system with 
flame ionization detection (GC2010, Shimadzu, Japan) was used to measure the resulting 
alditol acetates of the neutral sugars and N-acetyl propylaldonamides of the uronic acids.  




(man), galactose (gal), glu, glucuronic acid (glcA) and galA. Total NSP content was 
calculated according to the sum of the constituent sugars as shown in Equation 5.1. 
Cellulose was calculated by the difference between total NSP glu and non-cellulosic 
polysaccharide (NCP) glu, as shown in Equation 5.2. 
 
𝑇𝑜𝑡𝑎𝑙 𝑁𝑆𝑃 = 𝑟ℎ𝑎 + 𝑓𝑢𝑐 + 𝑎𝑟𝑎 +  𝑥𝑦𝑙 + 𝑚𝑎𝑛 + 𝑔𝑎𝑙 + 𝑔𝑙𝑢








5.3.2.3 Inert marker ratios and apparent NSP digestibility  
The TiO2 : cellulose ratio in the feed, ileal digesta and faeces was calculated by dividing 
the concentration of TiO2 by the concentration of cellulose in each medium. The AID and 
ATTD of NSPs were calculated according to Equation 5.3 and Equation 5.4 respectively 
with each of the inert markers tested, TiO2 and cellulose. The ATTD of cellulose was 





𝐴𝐼𝐷 = 1 −  (
𝐹𝑒𝑒𝑑 𝑖𝑛𝑒𝑟𝑡 𝑚𝑎𝑟𝑘𝑒𝑟 (%) ×  𝐼𝑙𝑒𝑎𝑙 𝑛𝑢𝑡𝑟𝑖𝑒𝑛𝑡 (%)





𝐴𝑇𝑇𝐷 = 1 − (
𝐹𝑒𝑒𝑑 𝑖𝑛𝑒𝑟𝑡 𝑚𝑎𝑟𝑘𝑒𝑟 (%)  ×  𝐹𝑎𝑒𝑐𝑎𝑙 𝑛𝑢𝑡𝑟𝑖𝑒𝑛𝑡 (%)






5.3.3 Statistical analysis 
The individual piglet served as the experimental unit for all data in this chapter. Normality 
of data and homogeneity of variance were assessed as per section 2.3.5.1. The statistical 
package JMP® (Version 15.1. SAS Institute Inc., Cary, NC, 1989 - 2019) (SAS, 2020) 
was used to analyse marker concentrations, marker ratios, AID and ATTD of NSP data 
as a 2-way ANOVA. The statistical model included the fixed effects of XOS, fructans 
and their interaction. A linear regression was used to assess the relationship between AID 
and ATTD of NSPs using different inert markers. Significant differences were classed as 












5.4.1 Marker concentration in diet, ileum and faeces 
Analysed TiO2 concentrations in the experimental diets were close to the expected added 
marker concentrations (0.50 %; Table 5.1). The analysed cellulose concentrations and 
calculated TiO2 : cellulose ratio in the experimental diets were not different between the 
dietary treatments. There was a trend for an interaction between XOS and fructans on the 
ileal concentration of TiO2, whereby compared to the CON, concentrations were higher 
in the FOS and INU groups without XOS, but not different with XOS (Table 5.1; P = 
0.060). There was no effect of XOS, fructans or their interaction on the cellulose 
concentration or the TiO2 : cellulose ratio in the ileum, nor on the TiO2 or cellulose 
concentration in the faeces (P > 0.05). There was an interaction between XOS and 
fructans on the TiO2 : cellulose ratio in the faeces, whereby the CON diet had a lower 







Table 5.1: Effect of XOS and fructans (FOS and INU) on feed, ileal digesta and faecal concentrations of TiO2, cellulose and TiO2 : cellulose 
ratios a.  
  Fructan 
SEM 
  XOSe     CON FOS INU CON FOS INU 
SEM 
  P value 
  CONb FOSc INUd   0 1 SEM   0 0 0 1 1 1   Fructan XOS 
Fructan 
× XOS 
Diet                                  
TiO2f (g/100g DM) 0.51 0.49 0.50 -   0.50 0.49 -   0.50 0.48 0.52 0.51 0.49 0.48 -   - - - 
Cellulose (g/100g DM) 1.87 1.90 1.89 -   1.93 1.84 -   1.94 1.97 1.87 1.79 1.83 1.91 -   - - - 
TiO2 : Cellulose 0.27 0.26 0.27 -   0.26 0.27 -   0.26 0.24 0.28 0.28 0.27 0.25 -   - - - 
Ileum                                          
TiO2 (g/100g DM) 1.26 1.38 1.54 0.083   1.36 1.42 0.067   1.11 1.32 1.67 1.42 1.44 1.41 0.113   0.072 0.552 0.060 
Cellulose (g/100g DM) 6.95 6.72 6.40 0.379   6.65 6.73 0.306   6.51 6.76 6.69 7.40 6.69 6.10 0.553   0.572 0.860 0.372 
TiO2 : Cellulose 0.19 0.23 0.26 0.024   0.21 0.23 0.019   0.18 0.21 0.25 0.20 0.24 0.26 0.034   0.132 0.532 0.941 
Faeces                                          
TiO2 (g/100g DM) 3.20 3.26 3.31 0.113   3.23 3.29 0.092   2.98 3.32 3.40 3.43 3.20 3.23 0.159   0.791 0.658 0.111 
Cellulose (g/100g DM) 9.04 8.60 8.57 0.240   8.92 8.55 0.196   9.48 8.57 8.72 8.59 8.64 8.41 0.340   0.311 0.182 0.369 
TiO2 : Cellulose 0.36 0.38 0.39 0.014   0.37 0.39 0.012   0.32b 0.39a 0.40a 0.40a 0.37ab 0.39a 0.020   0.308 0.222 0.029 
a Data are means of 8 replicate samples per treatment. bCON; Control. cFOS; Fructo-oligosaccharides.d INU; Inulin. e XOS; Xylo-oligosaccharides, 0 = 
No XOS; 1= XOS. f TiO2; Titanium dioxide. 




5.4.2 AID of NSPs using TiO2 and cellulose as inert markers 
When using TiO2 as an indigestible marker for NSP digestibility profiling, highly 
negative AID values were obtained, indicating proportionately higher NSP levels in the 
ileum to the feed compared to their TiO2 content (Table 5.2 and Figure 5.1a + b). In 
comparison, when using cellulose as an inert marker for NSP digestibility profiling, the 
AID values were mainly positive and much less variable (Table 5.2 and Figure 5.1a+b). 
There was a negative correlation between AID of total NSP when using TiO2 as a marker 
compared to cellulose (P < 0.021; Figure 5.1c). Dietary treatment effects are discussed in 








Table 5.2: Effect of XOS and fructans (FOS and INU) on the AID of NSP constituent sugars and total NSP using TiO2 and cellulose as inert 
markers a. 
  Fructan 
SEM 
  XOSe     CON FOS INU CON FOS INU 
SEM 
  P value 
  CONb FOSc INUd   0 1 SEM   0 0 0 1 1 1   Fructan XOS 
Fructan × 
XOS 
AIDf of NSPg using TiO2h (%)                                 
Ara -44.97 -27.66 -12.04 9.862   -31.16 -25.29 7.883   -50.52 -31.70 -11.27 -39.43 -23.63 -12.80 13.947   0.069 0.601 0.890 
Fuc -97.56 -75.64 -91.62 16.120   -80.93 -95.62 12.885   -95.56 -62.90 -84.32 -99.57 -88.38 -98.92 22.797   0.601 0.425 0.892 
Gal -31.17 -16.23 -6.34 9.189   -17.04 -18.79 7.345   -33.27 -16.06 -1.78 -29.06 -16.41 -10.90 12.995   0.163 0.867 0.869 
GalA -1.85 11.32 18.90 8.439   8.57 10.34 6.745   -0.29 8.34 17.64 -3.41 14.29 20.15 11.934   0.217 0.853 0.927 
Glu -34.95b -16.08ab 2.00a 10.107   -18.18 -14.51 8.079   -36.88 -20.43 2.78 -33.02 -11.72 1.22 14.294   0.042 0.750 0.934 
Man -6.01 -0.68 -5.21 6.818   0.76 -8.69 5.449   -17.13ab 3.17ab 16.25a 5.101b -4.53ab -26.66b 9.642   0.830 0.227 0.006 
Rha -16.34 -18.88 1.48 10.000   -1.90 -20.59 7.995   -8.86 -2.65 5.81 -23.83 -35.10 -2.85 14.145   0.283 0.107 0.671 
Xyl -47.53b -28.54ab -6.36a 10.130   -35.06 -19.89 8.097   -54.18 -42.53 -8.48 -40.88 -14.56 -4.23 14.327   0.021 0.193 0.692 
Total NSP -38.02 -20.64 -5.08 9.381   -24.11 -18.37 7.499   -42.09 -26.34 -3.92 -33.95 -14.94 -6.23 13.267   0.053 0.592 0.857 
AID of NSP using cellulose (%)                                 
Ara 5.74 0.63 0.46 2.407   -0.81a 5.36b 1.943   -0.54abc -6.48c 4.6abc 12.02a 7.75ab -3.68bc 3.516   0.217 0.029 0.002 
Fuc -34.75 -46.97 -67.54 12.900   -45.26 -54.25 10.415   -37.61 -39.03 -59.13 -31.9 -54.9 -75.95 18.842   0.192 0.540 0.780 
Gal 14.52 9.71 3.95 4.235   9.89 8.89 3.419   10.75 7.49 11.43 18.28 11.94 -3.54 6.185   0.210 0.836 0.126 
GalA 34.38 32.42 28.23 2.820   30.21 33.15 2.277   33.59 27.94 29.09 35.17 36.9 27.38 4.119   0.285 0.361 0.375 
Glu 13.43ab 10.24b 13.93a 0.949   9.78a 15.28b 0.766   9.12b 2.22c 17.99a 17.74a 18.25a 9.86b 1.385   0.014 <.0001 <.0001 
Man 28.86a 17.03ab 5.43b 5.202   21.42 12.79 4.200   20.24a 16.24a 27.79a 37.47a 17.82a -16.94b 7.598   0.009 0.149 0 
Rha 24.42a 7.94b 12.98ab 3.570   20.77a 9.46b 2.882   28.34 17.03 16.94 20.51 -1.15 9.02 5.214   0.006 0.008 0.485 
Xyl 4.74 -0.58 6.19 2.378   -3.63a 10.54b 1.920   -3.18bc -15.65c 7.93ab 12.67a 14.50a 4.44ab 3.473   0.104 <.0001 <.0001 
Total NSP 10.56 5.85 6.82 1.997   4.60a 10.89b 1.612   5.00 abc -2.48c 11.26ab 16.12a 14.19a 2.37bc 2.917   0.217 0.008 <.0001 
a Data are means of 8 replicate samples per treatment. bCON; Control. cFOS; Fructo-oligosaccharides.d INU; Inulin. e XOS; Xylo-oligosaccharides, 0 = 
No XOS; 1= XOS. f AID; Apparent ileal digestibility. g NSP; Non-starch polysaccharides. h TiO2; Titanium dioxide. 
a-c Means within a row that do not 








Figure 5.1: (A) Apparent ileal digestibility (AID) of non-starch polysaccharide (NSP) constituent sugars and total NSP using cellulose or 
titanium dioxide (TiO2) as an inert marker. (B) AID of total NSP using cellulose or TiO2 as an inert marker. (C) Correlation between AID of 








5.4.3 ATTD of NSPs using TiO2 or cellulose as inert markers 
The average ATTD results obtained when using TiO2 and cellulose as inert markers were 
similar for NSP constituent sugars and total NSP (Figure 5.2a). However, the average 
total NSP values were lower when using cellulose (47.4 % ± 3.17) as a marker compared 
to TiO2 (62.5 % ± 5.20) (Figure 5.2b and Table 5.3). There was no correlation between 
the TiO2 and cellulose for ATTD of total NSP (Figure 5.2c; P > 0.05). Average ATTD 
of cellulose was 28.4 % (± 11.28 %; Table 5.3). There was a significant interaction of 
XOS and fructans on the ATTD of cellulose, whereby the CON group had lower 
digestibility compared to all other treatment groups (P < 0.038). Dietary treatment effects 














Figure 5.2: (A) Apparent total tract digestibility (ATTD) of non-starch polysaccharide (NSP) constituent sugars and total NSP using cellulose 
or titanium dioxide (TiO2) as an inert markers. (B) ATTD of total NSP between dietary treatments when using cellulose or TiO2 as inert 









Table 5.3: Effect of XOS and fructans (FOS and INU) on the ATTD of NSP constituent sugars and total NSP using TiO2 and cellulose as inert 
markers a 
  Fructan 
SEM 
  XOSe     CON FOS INU CON FOS INU 
SEM 
  P value 
  CONb FOSc INUd   0 1 SEM   0 0 0 1 1 1   Fructan XOS 
Fructan × 
XOS 
ATTDf of NSPg using TiO2h (%)                                 
Ara 55.47a 60.14b 59.14b 1.25   57.44 59.07 1.02   52.49 59.72 60.1 58.45 60.56 58.19 1.767   0.029 0.265 0.089 
Fuc 79.17 82.98 72.13 4.146   81.81 74.37 3.385   82.29 86.27 76.88 76.05 79.68 67.37 5.864   0.184 0.127 0.954 
Gal 82.81 83.93 82.71 1.127   83.25 83.04 0.92   82.51 83.58 83.67 83.1 84.28 81.76 1.594   0.699 0.872 0.653 
GalA 90.91 91.2 91.52 0.801   90.65 91.78 0.647   88.89 91.3 91.77 92.93 91.11 91.28 1.094   0.856 0.22 0.082 
Glu 45 48.44 50.09 1.816   46.4 49.28 1.482   40.35 47.17 51.68 49.65 49.7 48.5 2.568   0.143 0.176 0.063 
Man 90.4 87.62 88.21 2.098   89.69 87.8 1.713   90.75 87.63 90.68 90.05 87.62 85.74 2.967   0.619 0.441 0.670 
Rha 41.62 30.78 32.91 4.1   41.65a 28.56b 3.347   41.61 39.01 44.32 41.63 22.55 21.51 5.798   0.153 0.008 0.140 
Xyl 59.62 63.53 63.81 1.314   60.29a 64.36b 1.073   55.96 61.53 63.37 63.28 65.54 64.25 1.859   0.052 0.01 0.235 
Total NSP 60.14 63.28 63.11 1.214   61.26 63.09 0.991   57.07 62.55 64.15 63.21 64.01 62.06 1.717   0.134 0.198 0.067 
Cellulose 18.08 26.53 26.04 2.752   20.76 26.34 2.247   9.68a 28.68b 23.92b 26.48b 24.39b 28.16b 3.893   0.062 0.086 0.038 
ATTD of NSP using cellulose (%)                                 
Ara 41.86 43.09 40.57 0.76   41.12 42.56 0.621   42.16b 39.40b 41.80b 41.56b 46.79a 39.35b 1.075   0.076 0.107 <.0001 
Fuc 72.17 75.92 59.56 5.764   73.62 64.81 4.707   77.87 78.05 64.94 66.46 73.78 54.18 8.152   0.122 0.193 0.890 
Gal 77.21 76.99 74.74 1.635   76.75 75.87 1.335   78.41 75.36 76.48 76 78.61 73 2.313   0.504 0.644 0.305 
GalA 88.36 87.57 87.57 0.991   87.21 88.46 0.8   86.39 87.08 88.16 90.34 88.05 86.99 1.448   0.798 0.272 0.179 
Glu 28.46a 26.40b 27.86a 0.273   26.02a 29.12b 0.223   27.44c 20.55e 30.09b 29.48b 32.26a 25.63d 0.386   <.0001 <.0001 <.0001 
Man 87.78 82.22 83.42 2.794   85.13 83.82 2.281   88.68 81.08 85.62 86.88 83.36 81.21 3.951   0.343 0.687 0.697 
Rha 22.47a 1.28b 2.80b 5.673   17.56a 0.15b 4.632   27.55 7.47 17.65 17.39 -4.91 -12.04 8.023   0.019 0.011 0.419 
Xyl 47.5 47.8 47.6 0.593   45.19a 50.09b 0.485   46.50b 42.09c 46.97b 48.50b 53.52a 48.23b 0.839   0.934 <.0001 <.0001 
Total NSP 48.04 47.55 46.52 0.505   46.45a 48.29b 0.412   47.70bc 43.64d 47.99bc 48.38b 51.46a 45.04cd 0.714   0.105 0.003 <.0001 
a Data are means of 8 replicate samples per treatment. b CON; Control. c FOS; Fructo-oligosaccharides.d INU; Inulin. e XOS; Xylo-oligosaccharides, 0 = 
No XOS; 1= XOS. f ATTD; Apparent total tract digestibility. g NSP; Non-starch polysaccharides. h TiO2; Titanium dioxide. 
a-c Means within a row that 





5.5.1 Marker concentration in diet, ileal digesta and faeces 
Well-researched inert markers such as TiO2 and Cr2O3 are routinely used in digestibility 
studies for monogastric animals, with the majority of studies focusing on the digestibility 
of costly nutrients such as energy and amino acids (Kong and Adeola, 2014; Jagger et al., 
1992; Olukosi, O. et al., 2012). However, when using these markers for profiling NSP 
digestibility, previous studies have shown negative or unrealistically high coefficients 
(Bautil et al., 2019; de Vries, 2014). An ideal marker for digestibility studies has 
previously been described as being totally indigestible and unabsorbable, inactive within 
the GIT, to pass through the GIT at a uniform rate, be easily determined chemically and 
preferably be a substance that is intrinsically present in the feed (Jagger et al., 1992). The 
recovery of a marker in faecal matter relative to the proportion that is consumed indicates 
its efficacy in regard to its indigestible properties. However, this assessment requires a 
known quantity of feed to be ingested before total collection of excreta. This was not 
possible in the current study as the piglets were housed in groups of 5 and individual 
monitoring of feed intake and excreta collection was not possible. However, the efficacy 
of alternative markers can be estimated by comparing digestibility values against a marker 
with well-known recovery, such as TiO2 (Jagger et al., 1992).  
 
When comparing inert markers, calculating the ratio of one marker to another in the same 
GIT location indicates the relative differences in the transit time between markers. For 
example, if the ratio of TiO2 : cellulose remains constant throughout GIT sections then 
the transit time of markers would be assumed to be similar, but if they differ, the transit 
time likely differs between the markers. For example, de Vries (2014) found a low Cr2O3 




were detected in the caeca compared to co-EDTA which was detected abundantly, hence 
proving separation of the marker and digesta in the caecum. The same principal can be 
applied to the effect of diets, such that if the marker ratio differs between treatments, then 
it can be assumed that dietary treatment affects the transit time of the marker or digesta. 
For example, de Vries (2014) found that the Cr2O3 : co-EDTA ratios throughout the GIT 
were differently affected in birds fed a low-fibre diet compared to those fed a RSM diet, 
highlighting that dietary fibre content affected the flow and transit time of the marker or 
digesta. In the current study, the TiO2 : cellulose ratios in the ileum were not affected by 
dietary treatment, suggesting that the transit times of the marker or digesta were similar 
between treatments in the ileum. However, the concentration of TiO2 in the ileum tended 
to be affected by dietary treatment, whereby in the absence of XOS, addition of FOS and 
INU resulted in higher concentrations compared to the CON but were no different in the 
presence of XOS. As explained above, this trend cannot be explained by differences in 
the transit time of the marker given that the relative amounts of TiO2 to cellulose were 
not different between treatments. There was also no correlation between ileal DM and 
ileal TiO2 concentrations (data not shown). Hence, the reason for this trend is unknown 
but potentially could be due to separation and poor distribution of the marker in the ileal 
digesta samples meaning the analysed TiO2 concentrations were not homogenously 
representative or precise. To this point, the SEM relative to the means for ileal TiO2 
concentration differed by 33.7 % between diets, whereas cellulose concentration only 
differed by 17.5 % between treatments. Hence, variation between diets was almost twice 
as high for the ileal TiO2 concentrations compared to the cellulose concentrations, 
highlighting the trend for the treatment effect on the former could have been due to the 





At the faecal level, variation between diets was lower than in the ileum and there was 
similar variation between diets for TiO2 concentrations (13.2 %) and cellulose 
concentrations (11.4 %). The faeces are the final destination of any GIT matter, hence 
although separation in the ileum is likely, at the faecal level these issues would reach an 
equilibrium, such that the amount of undigested TiO2 relative to cellulose is a true ratio 
between the markers. There was an interaction between XOS and fructans on the TiO2 : 
cellulose ratio in the faeces, such that the CON diet had a lower ratio compared to all 
other treatments apart from FOS + XOS. This indicates that there was more TiO2 relative 
to cellulose with prebiotic addition, hence suggests an increased degradation of cellulose 
with prebiotics. To this point, although there was an insignificant dietary effect on 
individual faecal marker concentrations, the prebiotic treatments tended to have 
numerically lower faecal cellulose concentrations compared to the CON group. One 
likely explanation for this result is that the addition of prebiotics to the diet altered the 
bacterial community composition whereby cellulose-degrading bacteria were stimulated 
which consequently increased cellulose fermentation.  
 
5.5.2 AID and ATTD of NSPs using TiO2 and cellulose as inert markers 
Supporting hypothesis 1 and the literature, the results from this study showed highly 
negative AID of NSPs when using TiO2 as an inert marker, indicating proportionately 
higher NSP levels in the ileum to the feed compared to their TiO2 content. A negative 
correlation existed between TiO2 and cellulose for AID of total NSPs, whereby 
digestibility using TiO2 decreased as digestibility using cellulose increased. Indeed, 
negative digestibility figures for soluble NSP fractions are plausible as the breakdown of 
insoluble fractions results in the accumulation of soluble fractions (Bautil et al., 2019). 




GIT relative to the diet, thus produces negative digestibility coefficients (Bautil et al., 
2019). However, negative digestibility figures are implausible for total NSP as it 
encompasses both soluble and insoluble fractions which can only be hydrolysed through 
microbial fermentation and not formed like soluble fractions (Bautil et al., 2019). Hence, 
the negative NSP digestibility values observed in the current study can only be explained 
by fractionation of the TiO2 and digesta in the GIT or as an effect of differing transit rates.  
 
It has previously been noted that differences in transit times and the partitioning of 
nutrients into aqueous and solid phases in the digesta compared to the phase where the 
marker situates can complicate analysis of fibre digestibility (Choct et al., 1996; de Vries, 
2014). Negative digestibility results have been found when using TiO2 for total AX 
digestibility in broilers with the same conclusions drawn (Bautil et al., 2019). Calculating 
the AID of NSPs is naturally more complicated compared to other macronutrients as they 
are not simply digested by endogenous GIT processes and are therefore much more 
sensitive to marker transit issues. Taking starch as an example, if ileal starch recovery 
was 3 % and a marker transit issue caused a 50 % variation in recovery, then the SD 
would be 1.5 %, hence AID would be 97 % ± 1.5 %. However, ileal NSP recovery could 
be much higher at 90 %, meaning the same marker transit issue would cause 50 % 
variation in recovery such that AID would be 10 % ± 45 %, hence NSP digestibility would 
be much more affected by marker transit issues. Moreover, a sufficient adaptation feeding 
period is required before ileal digesta collection to ensure a constant marker concentration 
in the digesta - a period of 3 days has previously been suggested (Kim, B.G. et al., 2020). 
In the current study, the piglets received the TiO2 throughout the 28-day trial period hence 




constituent sugars and total NSPs when using TiO2 as a marker are not correct and that 
the separation of TiO2 from the NSP fraction confounded the digestibility results. 
 
There is a lack of information on cellulose as an intrinsic indigestible marker in swine, 
and to the author’s knowledge there is no literature available comparing markers 
specifically for NSP digestibility. Supporting hypothesis 1, when using cellulose as an 
inert marker in the current study, the AID values were mainly positive as expected and 
much less variable compared to when using TiO2. A positive AID of NSPs can be 
interpreted as a loss of NSP through fermentation or due to an impact on transit times of 
different NSP fractions. It is therefore important that markers of fermentation are 
measured alongside NSP digestibility data to aid explanations of the results. In the current 
study, fermentation markers correlated well with AID of NSPs (section 6.4.1) hence the 
positive AID results were explained by fermentation. Indeed, there was at least one 
treatment mean with negative AID for rha, ara, xyl and gal, suggesting there was still a 
degree of fractionation of cellulose and sugars in the ileum, but to a lesser extent than for 
TiO2.  
 
AID of fuc remained highly negative when both cellulose and TiO2 were used as markers. 
Mucin polysaccharides are rich in fuc and can be used as a marker of endogenous losses 
via mucus secretion, hence highly negative values suggest increased mucus secretion and 
endogenous losses (Cadogan and Choct, 2015). However, the AID of fuc was not affected 
by dietary treatment. The lack of dietary treatment effect on cellulose concentration and 
TiO2 : Cellulose ratio in the ileum indicates that the proportionate transit time of cellulose 
and TiO2 were similar in the ileum, and cellulose concentration remained unaffected by 




cellulose is a potentially more reliable inert marker for NSP digestibility analysis in the 
ileum compared to TiO2.  
 
At first view, the ATTD of NSPs were much closer when using TiO2 and cellulose as 
inert markers compared to the AID results. The pattern of digestibility of each NSP 
constituent sugar was also encouragingly similar across the markers. However, the 
average ATTD for total NSP was 15.1 % lower when using cellulose as a marker 
compared to TiO2, this was explained by the average ATTD of cellulose being 28.4 %. 
In a study using growing pigs (~29 kg ), the ATTD of cellulose has been reported to be 
~57 % which was higher than the current study at 28.4 %. However, this is not surprising 
as piglets in the current study were younger and would have had a relatively less 
developed microbiota to cope with cellulose degradation (Le Sciellour et al., 2018). If 
TiO2 and cellulose were working in tandem, a positive correlation with an R
2 of 1 would 
have been expected and observed, yet there was no correlation between the markers, 
rejecting hypothesis 2. Moreover, there was a significant effect of dietary treatment on 
the ATTD of cellulose, indicating prebiotic addition increased the fermentation of 
cellulose. Taken together, this therefore renders the use of cellulose as an inert marker for 
ATTD of NSPs implausible. In summary, fractionation of TiO2 and NSP occurred in the 
ileum, making cellulose a more promising inert marker for AID of fibre fractions. Whilst 
the fractionation and consequent mis-estimation of AID when using TiO2 was rectified at 
the faecal level, but post-ileal cellulose degradation rendered the use of cellulose as an 






5.5.3 Conclusion and future work 
This study, along with others (de Vries, 2014; Jamroz et al., 2002; Brenes et al., 2003; 
Bautil et al., 2019), has highlighted the care that needs to be taken when inert markers are 
used to estimate the digestibility of NSPs. Highly negative AID values for NSPs were 
found when using TiO2 as an inert marker, indicating separation of the marker and NSP 
fraction within the GIT. In contrast, using cellulose as an inert marker yielded more 
realistic, less negative and less variable AID of NSP. Moreover, there was a negative 
correlation between AID of total NSP when using TiO2 as a marker relative to cellulose. 
At the faecal level, positive and more similar ATTD of NSPs were observed between the 
markers but no positive correlation was seen. Post-ileal cellulose degradation caused the 
average ATTD for total NSPs to be 15.1 % lower compared to when using TiO2 as a 
marker, and cellulose fermentation was also affected by dietary treatment. Overall, this 
study has shown that TiO2 is an unsuitable inert marker for AID of NSPs, whilst cellulose 
showed more realistic initial results as an alternative marker, but further validation work 
is required. On the contrary, the fractionation and consequent mis-estimation of AID 
when using TiO2 was rectified at the faecal level, but post-ileal cellulose degradation 
rendered the use of cellulose as an inert marker for ATTD infeasible.  
 
Future work into inert markers like cellulose is timely as the safety of TiO2 has recently 
been questioned for its use as a food or feed additive due to concerns over its accumulation 
in the body and potential genotoxicity effect (EFSA, 2021). To the authors knowledge, 
there is no literature available on the use of intrinsic cellulose as markers for NSP 
digestibility studies, with the current study showing encouraging initial results at the ileal 
level. Albeit, further work is required to investigate the suitability, reliability and accuracy 




digestibility analyses. Key to this future work is the comparison and validation of well-
known markers like Cr2O3 and potential alternative intrinsic markers like AIA or lignin 
against the gold standard method of total collection for different fibre fractions. 
Comparative total collection and marker studies should ensure that digestibility is 
compared along all GIT sections and in combination with digesta flow rates due to their 





Chapter 6  
Investigating the effect of xylo-oligosaccharides with or without 
fructans on gut bacterial fermentation activity and non-starch 
polysaccharide digestibility in weaned piglets.  
6.1 Abstract  
Supplementation of prebiotics can positively influence the gut bacterial community 
composition, increase fermentative activity and fibre degradation, consequently 
improving the health of the host and nutritive value of feedstuffs. This study aimed to 
investigate the effect of XOS and fructans (FOS and INU) on piglet gut pH, lactate 
concentration and NSP digestibility. A total of 474 weaner piglets (7.88 ± 1.51 kg) were 
blocked into mixed sex pens of 4‒5 piglets and assigned to 1 of 6 dietary treatments in a 
2 × 3 factorial treatment design. Diets contained 2 levels of XOS (0 and 0.286 g/kg) and 
3 levels of fructans [(0 g/kg) and 6.50 g/kg of short-chain FOS and 4.08 g/kg of INU to 
supply 3.8 g/kg of pure fructans)]. At the end of the experiment, 48 piglets were 
euthanised for the collection of ileal and colonic digesta to analyse the pH and lactate 
concentration as indicators of fermentative activity. AID and ATTD of NSPs were also 
analysed. Compared to the CON group, XOS reduced ileal digesta pH and increased ileal 
lactate concentration (P < 0.001), indicating increased bacterial fermentative activity. The 
AID of NSP ara, glu, xyl and total NSP was higher for the CON and/or FOS groups with 
XOS compared to without, indicating XOS stimulated an increase in NSP constituent 
sugar digestibility in the ileum (P < 0.050). However, the effects of XOS on fermentative 
activity and AID of NSPs were lost when combined with INU, indicating incompatibility 
of the products. Compared to the CON, both XOS and INU increased the AID of 
stachyose (P < 0.047). All prebiotics and their combinations increased the ATTD of 
cellulose compared to the CON (P < 0.038), whilst similar interaction trends were seen 




also affected the selective fermentation of remaining cellulose and NSP fractions at the 
faecal level. In summary, XOS increased ileal fermentative activity and the AID of NSP 
fractions, suggesting XOS has a stimulatory effect on increasing the fibre-degrading 
capacity of the ileal bacteria. Both XOS and fructans when offered separately, as well as 
in combination, increased the ATTD of cellulose and NSP fractions, indicating beneficial 












Alongside increased pressure to reduce antimicrobial usage, the UK pig industry is facing 
an imminent ban on therapeutic levels of ZnO. As such, seeking suitable alternatives that 
promote health and prevent disease is of utmost importance for the industry. Prebiotics 
are defined as ‘non-digestible food ingredients that beneficially affect the host by 
selectively stimulating the growth and/or activity of one or a limited number of bacteria 
in the gut, thus improving host health’ (Gibson and Roberfroid, 1995). The majority of 
prebiotics are differing lengths of carbohydrate chains that are non-digestible by 
endogenous GIT enzymes, hence survive host digestion and are instead fermented by 
resident bacteria in the GIT (Cummings et al., 2001). The fermentability characteristics 
of different prebiotics depends on their monomeric unit composition, linkage type, DP 
and bacterial communities residing in the GIT (Sako et al., 1999). As previously discussed 
in section 4.2, substrates with a longer DP are generally fermented at a slower rate than 
those with shorter a DP due to the number of linkages that need to be broken. Yet 
differences still exist between prebiotics with a similar DP such that short-chain XOS is 
fermented at a slower rate than short-chain GOS (Smiricky-Tjardes et al., 2003a). Well-
researched prebiotics like fructans have received much attention in both human and 
animal nutrition, but new-generation prebiotics like XOS are of increasing interest. 
Fructan supplementation, in the form of FOS (Xu, C. et al., 2005; Xu, Z.R. et al., 2002) 
and INU (Grela et al., 2014; He et al., 2002) have been shown to improve pig performance 
and gut health parameters. Similarly, XOS has shown promising improvements in growth 
performance, gut structure, and gut bacterial community composition in broilers and 
weaner pigs (Liu, J. et al., 2018; Ribeiro et al., 2018). Both XOS and fructans have 
previously been shown to selectively increase the abundance of beneficial bacteria like 
Lactobacillus whilst decrease pathogenic bacteria like Escherichia coli, hence have a 




et al., 2002). The end-products of fermentation are SCFAs such as acetate, propionate, 
butyrate and lactate which act as an energy source for the host or cross-feeding substrate 
for other resident bacteria. The presence of SCFA in the GIT reduces the pH of the gut 
environment which prevents the growth of pH sensitive pathogenic bacteria. Hence, an 
increase in the concentration of SCFAs and a reduction in gut pH is an indicator of 
increased fermentative activity. 
 
Compared to other well-studied prebiotics like FOS and INU, relatively low levels of 
XOS (0.2 g/kg and 1.0 g/kg) or AXOS (2.5 g/kg) have been shown to stimulate the 
abundance of beneficial bacteria (Ribeiro et al., 2018; Liu, J. et al., 2018; Courtin et al., 
2008). Courtin et al. (2008) showed that FOS failed to increase caecal levels of 
Bifidobacterium in broilers at inclusion rates of 10 g/kg, yet AXOS did so at levels four 
times lower (2.5 g/kg), highlighting the higher prebiotic potential of AXOS despite its 
low inclusion rate. However, the fermentation of these substrates cannot solely explain 
the performance results observed. For example, supplementation of XOS at 0.10 g/kg has 
previously been shown to improve broiler growth performance by +320g from day 0-42. 
However, even if the substrate was converted to SCFAs with 100 % efficiency, it would 
only equate to < 0.3 Kcal/kg of energy provision which is not enough to explain the 
growth response reported. The classical definition of a prebiotic describing the 
quantitative fermentation of a substrate eliciting SCFAs as a sole mode of action is 
therefore questionable for XOS (Bedford, Michael R, 2018; Bautil et al., 2020).  
 
An alternative hypothesis for the mechanism of XOS has been proposed, whereby XOS 
acts as a signal to encourage fibre-degrading bacteria to increase in activity, ferment fibre 




of digestion and growth (Ribeiro et al., 2018). This mechanism has recently been 
investigated in broilers, whereby the supplementation of AXOS was shown to increase 
the ATTD of wheat AX in young birds (Bautil et al., 2020). The author concluded that 
there was a ‘kick-start’ effect of AXOS on the development of the fibre-degrading 
bacterial community and consequent increased AX digestibility. To this point, the term 
‘stimbiotic’ has recently been given to ‘non-digestible but fermentable additives that 
stimulate fibre fermentability but at a dose that is too low that the stimbiotic itself could 
contribute in a meaningful manner to SCFA production’ (González-Ortiz et al., 2019). 
Ultimately, this stimulatory effect could improve the nutritive value and energy utilisation 
of fibrous feed ingredients via their increased fermentation, which could potentially lead 
to increased growth performance and health benefits (Bautil et al., 2020; Morgan, N. et 
al., 2021).  
 
The majority of work on this new concept has been conducted in broilers, with little focus 
on pigs. However, one piglet study has shown that provision of a stimbiotic (XYL + XOS) 
altered the intestinal bacterial community composition to favour fibre fermentation which 
likely contributed to improved performance, particularly in poor sanitary conditions (Cho 
et al., 2020). However, to the author’s knowledge, there has been no investigation into 
the stimulatory effect of XOS specifically on fibre fraction digestibility in pigs. 
Furthermore, different prebiotics selectively stimulate different bacterial species, hence 
upregulate a diverse range of bacterial metabolic activities and functions within the GIT. 
It is unknown whether feeding a combination of substrates with differing DP and 
monomer composition would increase fermentative activity and NSP digestibility over 
and above feeding them alone. This study aimed to investigate the effect of XOS and 




6.2.1 Study aims  
There is a lack of information in the literature on the effect of feeding different prebiotics 
alone or in combination on gut bacterial fermentative activity and NSP digestibility. The 
aim of this study was to determine the effect of XOS with or without fructans (FOS and 
INU) on gut bacterial fermentation activity and NSP digestibility to decipher if they have 
a stimulatory effect as described in the literature for broilers. 
  
6.2.2 Hypotheses 
1. Due to differing DP, supplementation of FOS will have a greater fermentative 
activity (higher lactate concentration and lower pH) in the ileal digesta of piglets, 
whereas XOS and INU will have a greater fermentative activity in the colonic 
digesta.  
2. Combining FOS and XOS together will increase fermentative activity in the ileal 
and colonic digesta of piglets, whilst addition of XOS and INU together will 
increase fermentative activity in the colonic digesta. 
3. Despite its low inclusion, feeding XOS alone or in combination with FOS and 
INU will increase the digestibility of NSP fractions compared to treatments 
without XOS.  
 
6.3 Materials and methods 
Study protocols were approved by the University of Leeds Pig Research Centre and 
ethical approval was granted by the Animal Welfare and Ethical Review Body as 





6.3.1 Animals, housing, experimental design and dietary treatments 
The animals, housing, experimental design and dietary treatments used in this study were 
as described in section 4.3.1 and 4.3.2.  
 
6.3.2 Measurements and sampling 
6.3.2.1 Digesta pH and lactate  
At the end of the experiment, 48 piglets were euthanised for the collection of ileal and 
colonic digesta as described in section 4.3.3.2. Once collected, the pH was measured 
immediately using a handheld electrode (Extech SDL100), rinsed in distilled water and 
re-measured for duplicate readings. The electrode was calibrated using pH 4 buffer.  
 
From previous testing and review of the literature, it was identified that the lactate 
concentration of ileal digesta was higher than that for colonic digesta, hence ileal digesta 
was diluted to ensure the readings were within the measuring device range, whilst the 
colonic digesta remained undiluted.  
- Ileal digesta: 0.3 g of ileal digesta was weighed into a 2 ml Eppendorf and 1.2 ml 
of distilled water was added. The sample was homogenised by vortexing, 
followed by centrifugation at 14,000 × g for 2 minutes. The supernatant was 
collected in a 2 ml Eppendorf and the lactate concentration was measured in 
duplicate using a handheld lactate device (Lactate Scout, EKF Diagnostics, UK). 
As described and pictured in section 3.3.3.2, to take a reading, a sensor was 
inserted into the handheld device and then placed into the media. This was 





- Colonic digesta: 1 g of colonic digesta was weighed into a 2 ml Eppendorf. The 
sample was homogenised by vortexing, followed by centrifugation at 14,000 × g 
for 2 minutes. The supernatant was collected in a 2 ml Eppendorf and the lactate 
concentration was measured in duplicate using the same method as described for 
the ileal digesta. 
 
Lactate concentrations were corrected for any sample dilution, for the constant automatic 
haematocrit adjustment made by the handheld device (0.2 – as described in section 
3.3.3.2) and were back calculated to mM per g of digesta. Duplicate readings were 
averaged.  
 
6.3.2.2 DM determination   
Ileal digesta was collected as described in section 4.3.3.2, whilst a faecal sample was 
collected in a 30 ml universal container from each selected piglet in the holding pen before 
euthanasia and stored at -80 °C pending analysis. Ileal and faecal samples were weighed, 
freeze dried (as per section 4.3.3.2), and then re-weighed to determine DM. The samples 
were then ground and homogenised using a pestle and mortar.  
  
6.3.2.3 NSP content  
6.3.2.3.1 Total NSP, NSP constituent sugars and cellulose content 
Total NSP, NSP constituent sugars and cellulose content of the feed, ileal digesta and 






6.3.2.3.2 Other carbohydrates: fructan, starch and alpha-galactoside content  
Other carbohydrates present in the feed and ileal digesta were determined by a combined 
approach applying enzymatic hydrolysis and high pressure ion chromatography (HPIC). 
The initial step involved a heat dispersion of the sample in phosphate buffer pH 7.0 and 
an internal standard. An aliquot was taken for direct determination by HPIC of sugars 
(gal, glu, fructose and sucrose) and alpha-galactosides (raffinose and stachyose). A 
second aliquot was treated with fructanase and alpha-glucosidase for the hydrolysis of 
fructans and starch respectively, with the released fructose and glu quantified by HPIC. 
The following calculations (Equation 6.1 and Equation 6.2) were applied to correct for 
other sources of glu and fructose. The glu component of the fructans was not taken into 
consideration for this application where the emphasis was on changes observed in the 
ileal samples compared to the diets. 
 
𝐹𝑟𝑢𝑐𝑡𝑎𝑛𝑠 = 𝐹𝑟𝑢𝑐𝑡𝑜𝑠𝑒 (𝑒𝑛𝑧𝑦𝑚𝑒 𝑡𝑟𝑒𝑎𝑡𝑚𝑒𝑛𝑡) − (𝑠𝑢𝑔𝑎𝑟 𝑓𝑟𝑢𝑐𝑡𝑜𝑠𝑒)
− (0.525 × 𝑠𝑢𝑐𝑟𝑜𝑠𝑒) − (0.333 × 𝑟𝑎𝑓𝑓𝑖𝑛𝑜𝑠𝑒)




𝑆𝑡𝑎𝑟𝑐ℎ = 𝑔𝑙𝑢𝑐𝑜𝑠𝑒 (𝑒𝑛𝑧𝑦𝑚𝑒 𝑡𝑟𝑒𝑎𝑡𝑚𝑒𝑛𝑡) − (𝑠𝑢𝑔𝑎𝑟 𝑓𝑟𝑢𝑐𝑡𝑜𝑠𝑒)











6.3.2.4 AID and ATTD of DM and NSPs  
As explained in Chapter 5, the AID of DM and NSPs were calculated using cellulose as 
an inert marker, whilst the ATTD of DM and NSPs were calculated using TiO2 as an inert 
marker. AID and ATTD were calculated using Equation 5.3 and Equation 5.4 
respectively, as detailed in section 5.3.2.3.  
 
6.3.3 Statistical analysis 
The individual piglet served as the experimental unit for all data in this chapter. Lactate 
concentrations were calculated back to mM per g of digesta before analysis. Normality 
of data and homogeneity of variance were assessed as per section 2.3.5.1. The statistical 
package JMP® (Version 15.1. SAS Institute Inc., Cary, NC, 1989 - 2019) (SAS, 2020) 
was used to analyse the digesta pH, digesta lactate concentrations, AID and ATTD of DM 
and NSP data as a 2-way ANOVA. The statistical model included the fixed effects of 
XOS, fructans and their interaction. Significant differences were classed as P < 0.05 and 














6.4.1 Digesta pH and lactate concentration 
The effect of XOS and fructans on ileal and colonic digesta pH and lactate concentrations 
are shown in Table 6.1 and Figure 6.1. There was a significant interaction between XOS 
and fructans on ileal pH (P < 0.001) and lactate concentration (P < 0.001) whereby there 
was no difference in the FOS or INU group with or without XOS, but in the CON group 
pH was significantly higher and lactate was significantly lower without XOS than with 
XOS (Table 6.1 and Figure 6.1). The interaction pattern for pH and lactate concentration 
between treatments was the same but opposite, such that lactate concentration was highest 
when pH was lowest, and lactate concentration was lowest when pH was highest. There 









Table 6.1: Effect of XOS with or without short-chain (FOS) and long-chain (INU) fructans on ileal and colonic pH and lactate concentration. 
  Fructan 
SEM 
  XOS     CON FOS INU CON FOS INU 
 
SEM 
  P value  
  CON FOS INU   0 1 SEM   0 0 0 1 1 1    Fructan XOS Fructan × XOS 
pH                  
Ileum 6.94 6.93 6.95 0.050  7.00 6.88 0.040  7.12a 7.02ab 6.85ab 6.75b 6.84ab 7.06a  0.070  0.944 0.054 0.001 
Colon 5.77 5.70 5.65 0.059  5.67 5.74 0.048  5.71 5.68 5.61 5.83 5.71 5.68  0.083  0.350 0.275 0.848 
Lactate concentration (mM per g of digesta) 
 
                                 
Ileum  51.82 33.59 36.04 8.510  32.49 48.48 6.948  19.53b 22.93b 55.02ab 84.12a 44.26ab 17.05b  12.035  0.272 0.113 0.001 
Colon 0.75 0.85 0.84 0.048  0.85 0.78 0.039  0.77 0.94 0.83 0.73 0.76 0.85  0.068  0.281 0.243 0.325 
a CON; Control. b FOS; Fructo-oligosaccharides. c INU: Inulin. d XOS; Xylo-oligosaccharides.  
 
Figure 6.1: Effect of xylo-oligosaccharides (XOS) with or without short-chain (Fructo-oligosaccharides (FOS)) and long-chain (Inulin (INU)) 




6.4.2 Ileal and faecal NSP and other carbohydrate content   
The main NSP constituent sugars available for fermentation in the ileal digesta were ara, 
glu and xyl (Table 6.2); the same was true in the faeces (Table 6.3). Although the lowest 
NSP constituent sugar, ileal rha content were similar in the CON and FOS groups with 
and without XOS, values tended to be higher without XOS and lower with XOS in the 
INU group (P = 0.079; Table 6.2). The main other carbohydrate available for fermentation 
in the ileal digesta was starch (Table 6.2). There was a significant interaction between 
XOS and fructans on total alpha-galactoside (P < 0.028) and stachyose content (P  < 
0.022) in the ileal digesta, whereby there was no difference in the FOS and INU groups 
with or without XOS, but content was higher in the CON without XOS than with XOS 
(Table 6.2). There was a trend for the same interaction pattern for alpha-galactoside 
















Table 6.2: Effect of XOS and fructans (FOS and INU) on ileal NSP constituent sugars, total NSP and other carbohydrate content (g/100g 
DM)a.  
  Fructan 
SEM 
  XOSe     CON FOS INU CON FOS INU 
SEM 
  P value 
  CONb FOSc INUd   0 1 SEM   0 0 0 1 1 1   Fructan XOS Fructan × XOS 
Ileal content (g/100g DM)                                 
Ara 6.74 6.85 6.54 0.286   6.69 6.73 0.231   6.48 6.88 6.72 7.00 6.82 6.36 0.417   0.725 0.918 0.538 
Fuc 0.37 0.38 0.42 0.020   0.38 0.40 0.016   0.34 0.36 0.44 0.40 0.39 0.40 0.028   0.130 0.552 0.186 
Gal 4.07 4.18 4.10 0.175   4.04 4.19 0.141   3.81 4.14 4.18 4.33 4.23 4.01 0.255   0.889 0.460 0.366 
GalA 1.43 1.44 1.40 0.080   1.42 1.42 0.065   1.32 1.48 1.45 1.53 1.40 1.34 0.117   0.911 0.972 0.302 
Glu 9.16 9.07 8.43 0.492   8.90 8.86 0.398   8.78 9.26 8.67 9.53 8.88 8.18 0.719   0.506 0.944 0.610 
Man 0.88 0.89 0.90 0.032   0.89 0.89 0.026   0.87 0.89 0.91 0.88 0.89 0.88 0.047   0.901 0.937 0.900 
Rha 0.33 0.33 0.31 0.017   0.32 0.32 0.014   0.30 0.33 0.34 0.35 0.34 0.28 0.025   0.707 0.910 0.079 
Xyl 9.86 9.92 9.18 0.490   9.75 9.55 0.396   9.59 10.27 9.41 10.13 9.58 8.95 0.716   0.482 0.720 0.636 
Total NSPf 33.02 33.25 31.59 1.417   32.65 32.59 1.144   31.69 33.82 32.43 34.35 32.69 30.75 2.069   0.652 0.974 0.498 
Other carbohydrate content (g/100 DM)                                 
Alpha-galactosides – raffinose 0.37 0.31 0.29 0.104   0.40 0.25 0.085   0.64 0.31 0.25 0.10 0.32 0.33 0.147   0.844 0.219 0.084 
Alpha-galactosides – stachyose 1.18 0.69 0.62 0.321   1.09 0.57 0.262   2.18a 0.68ab 0.40ab 0.17b 0.69ab 0.84ab 0.454   0.417 0.166 0.022 
Alpha-galactosides - Total 1.55 1.00 0.91 0.418   1.49 0.82 0.341   2.82a 0.99ab 0.64ab 0.27b 1.01ab 1.17ab 0.591   0.509 0.171 0.028 
Total fructans  1.92 1.87 2.07 0.354   2.11 1.79 0.289   2.72 1.87 1.76 1.11 1.87 2.38 0.501   0.913 0.428 0.084 
Starch 4.30 5.15 4.06 0.600   4.55 4.46 0.490   3.93 5.65 4.07 4.67 4.66 4.04 0.848   0.405 0.898 0.599 
Total carbohydrates excl NSP 9.58 10.52 9.38 0.790   10.37 9.28 0.645   11.23 10.96 8.91 7.93 10.08 9.84 1.117   0.555 0.242 0.177 
a Data are means of 8 replicate samples per treatment. bCON; Control. cFOS; Fructo-oligosaccharides.d INU; Inulin. e XOS; Xylo-oligosaccharides, 0 = 








Table 6.3: Effect of XOS and fructans (FOS and INU) on faecal NSP constituent sugars and total NSP content (g/100g DM)a. 
  Fructan 
SEM 
  XOSe     CON FOS INU CON FOS INU 
SEM 
  P value 
  CONb FOSc INUd   0 1 SEM   0 0 0 1 1 1   Fructan XOS Fructan × XOS 
Faecal content (g/100g DM)                                 
Ara 5.49 5.09 5.31 0.141  5.32 5.27 0.115  5.56 5.01 5.38 5.43 5.16 5.23 0.200  0.135 0.792 0.699 
Fuc 0.10 0.08 0.13 0.019  0.09 0.12 0.016  0.09 0.07 0.12 0.12 0.09 0.14 0.027  0.206 0.288 0.946 
Gal 1.41 1.40 1.47 0.089  1.42 1.43 0.072  1.36 1.43 1.48 1.47 1.36 1.47 0.125  0.817 0.942 0.774 
GalA 0.34 0.35 0.33 0.030  0.36 0.32 0.024  0.41 0.34 0.33 0.27 0.35 0.33 0.044  0.916 0.210 0.145 
Glu 9.92 9.51 9.48 0.239  9.83 9.44 0.195  10.36 9.49 9.64 9.47 9.52 9.32 0.339  0.362 0.163 0.403 
Man 0.21 0.25 0.21 0.038  0.23 0.22 0.031  0.19 0.26 0.23 0.23 0.24 0.20 0.054  0.721 0.896 0.789 
Rha 0.43 0.46 0.45 0.020  0.45 0.45 0.016  0.44 0.46 0.44 0.43 0.46 0.46 0.028  0.673 0.986 0.842 
Xyl 7.18 6.67 6.94 0.206  7.02 6.84 0.168  7.43 6.52 7.11 6.94 6.82 6.78 0.292  0.224 0.466 0.373 
Total NSPf 25.31 24.00 24.57 0.580  24.91 24.34 0.474  26.03 23.77 24.94 24.59 24.24 24.20 0.821  0.289 0.396 0.505 
a Data are means of 8 replicate samples per treatment. bCON; Control. cFOS; Fructo-oligosaccharides.d INU; Inulin. e XOS; Xylo-oligosaccharides, 0 = 






6.4.3 AID and ATTD of DM 
There was a trend for an interaction between XOS and fructans on AID of DM; AID 
tended to be higher for the CON group with XOS compared to without, whereas for the 
INU group, AID tended to be higher without XOS compared to with XOS (Figure 6.2; P 
= 0.100). This similar interaction trend was seen for fermentative activity (pH and lactate 
concentration; Figure 6.1). There was no effect of treatment on ATTD of DM (P > 0.05).  
 
 
Figure 6.2 Effect of xylo-oligosaccharides (XOS) and fructans (Fructo-
oligosaccharides (FOS)) and (Inulin (INU)) on apparent ileal digestibility (AID) of 
dry matter (DM) (P = 0.100). 
 
6.4.4 AID of NSP 
There was a significant interaction between XOS and fructans on the AID of NSP ara (P 
< 0.002), glu (P < 0.001), xyl (P < 0.001) and total NSP (P < 0.001;Table 6.4). The 
interaction pattern was similar for the digestibility of the above-mentioned NSP 
constituent sugars and total NSP as seen in Figure 6.3 A-D. Taking all the interaction 
patterns together, AID tended to be higher for the CON and FOS groups with XOS 
compared to without, whereas for the INU group, AID tended to be higher without XOS 




the CON and INU groups with or without XOS, but AID was significantly higher in the 
FOS group with XOS compared to without XOS. Similarly, there was no difference in 
the AID of NSP xyl in the INU group with or without XOS, but AID was significantly 
higher in the CON and FOS group with XOS compared to without XOS. For NSP glu, 
AID in the CON and FOS groups was significantly higher with XOS compared to without 
XOS, whilst in the INU group, glu AID was significant lower with XOS compared to 
without XOS. There was a significant interaction between XOS and fructans on AID of 
NSP man; there was no difference in the CON and FOS group with or without XOS, 
whereas in the INU group AID was higher without XOS compared to with XOS (Table 
6.4E; P < 0.001).  
 
There was a significant interaction between XOS and fructans on AID of the alpha-
galactoside stachyose; XOS and INU independently increased the AID of stachyose 
compared to the CON, but reduced the AID when combined to levels not dissimilar from 
the CON (Table 6.4; Figure 6.3F; P < 0.047). Similar interaction trends were seen for the 
AID of alpha-galactoside raff (P = 0.079), total alpha galactosides (P = 0.052), fructans 










Table 6.4: Effect of XOS and fructans (FOS and INU) on AID of NSP constituent sugar, total NSP and other carbohydrates a. 
  Fructan 
SEM 
  XOSe     CON FOS INU CON FOS INU 
SEM 
  P value 
  CONb FOSc INUd   0 1 SEM   0 0 0 1 1 1   Fructan XOS Fructan × XOS 
AIDf of NSPg (%)                                 
Arabinose 5.74 0.63 0.46 2.407  -0.81a 5.36b 1.943  -0.54abc -6.48c 4.6abc 12.02a 7.75ab -3.68bc 3.516  0.217 0.029 0.002 
Fucose -34.75 -46.97 -67.54 12.900  -45.26 -54.25 10.415  -37.61 -39.03 -59.13 -31.90 -54.90 -75.95 18.842  0.192 0.540 0.780 
Galactose 14.52 9.71 3.95 4.235  9.89 8.89 3.419  10.75 7.49 11.43 18.28 11.94 -3.54 6.185  0.210 0.836 0.126 
Galacturonic acid 34.38 32.42 28.23 2.820  30.21 33.15 2.277  33.59 27.94 29.09 35.17 36.90 27.38 4.119  0.285 0.361 0.375 
Glucose 13.43ab 10.24b 13.93a 0.949  9.78a 15.28b 0.766  9.12b 2.22c 17.99a 17.74a 18.25a 9.86b 1.385  0.014 <.0001 <.0001 
Mannose 28.86a 17.03ab 5.43b 5.202  21.42 12.79 4.200  20.24a 16.24a 27.79a 37.47a 17.82a -16.94b 7.598  0.009 0.149 0.000 
Rhamnose 24.42a 7.94b 12.98ab 3.570  20.77a 9.46b 2.882  28.34 17.03 16.94 20.51 -1.15 9.02 5.214  0.006 0.008 0.485 
Xylose 4.74 -0.58 6.19 2.378  -3.63a 10.54b 1.920  -3.18bc -15.65c 7.93ab 12.67a 14.50a 4.44ab 3.473  0.104 <.0001 <.0001 
Total NSP 10.56 5.85 6.82 1.997  4.60a 10.89b 1.612  5.00 abc -2.48c 11.26ab 16.12a 14.19a 2.37bc 2.917  0.217 0.008 <.0001 
AID of other carbohydrates (%)                                 
Alpha-galactosides – raffinose 65.50 71.94 73.08 11.707   63.74 76.60 9.452   37.90 71.10 82.23 93.09 72.77 63.93 17.099   0.883 0.336 0.079 
Alpha-galactosides - stachyose 70.43 81.21 81.49 10.352   72.00 83.42 8.358   44.28b 80.24ab 91.49a 96.58a 82.18ab 71.49ab 15.120   0.687 0.334 0.047 
Alpha-galactosides - Total 69.30 79.05 79.56 10.594   70.11 81.83 8.553   42.84 78.12 89.37 95.77 79.97 69.75 15.473   0.739 0.333 0.052 
Total Fructans  36.86 40.87 46.24 13.652   35.15 47.49 11.023   4.68 40.03 60.75 69.04 41.71 31.73 19.940   0.884 0.428 0.055 
Starch 96.77 96.02 96.91 0.407   96.36 96.77 0.329   96.51 95.57 97.00 97.03 96.48 96.82 0.595   0.246 0.371 0.618 
Total carbohydrates excl NSP 93.49 92.32 93.38 0.821   92.54 93.59 0.663   91.57 91.85 94.19 95.40 92.80 92.58 1.199   0.527 0.261 0.070 
a Data are means of 8 replicate samples per treatment. bCON; Control. cFOS; Fructo-oligosaccharides.d INU; Inulin. e XOS; Xylo-oligosaccharides, 0 = 
No XOS; 1= XOS. f AID; Apparent ileal digestibility. g NSP; Non-starch polysaccharide. a-c Means within a row that do not share a common superscript 








 Figure 6.3: Effect of xylo-oligosaccharides (XOS) and fructans (Fructo-oligosaccharides (FOS)) and (Inulin (INU)) on apparent ileal 
digestibility (AID) of NSP arabinose (ara; A), glucose (glu; B), xylose (xyl; C), total non-starch polysaccharide (NSP) (D), mannose (man; E) 
and stachyose (stach; F) (P < 0.05).  
C B A 




6.4.5 ATTD of NSP 
As seen in Table 6.5 and Figure 6.4D, there was an interaction between XOS and fructans 
on ATTD of cellulose; the digestibility was lower in the CON group compared to all other 
dietary treatments (P < 0.038). There was a similar interaction trend for NSP ara (P = 
0.089; Figure 6.4A), glu (P = 0.063; Figure 6.4B) and total NSP (P = 0.067; Figure 6.4C), 
whereby ATTD tended to be higher for all prebiotic dietary treatments compared to the 
CON. There was a trend for an interaction between XOS and fructans on NSP Gal A, 
whereby there was no difference in the FOS and INU group with or without XOS, but 
ATTD was higher with XOS compared to without XOS in the CON group (Figure 6.4E; 
P = 0.082). There was a trend for a main effect of fructans (Figure 6.4F; P = 0.052) on 
NSP xyl whereby ATTD was higher with FOS and INU compared to the CON. There 
was a significant effect of XOS (Figure 6.4G; P < 0.010), whereby the ATTD of xyl was 
increased with XOS compared to without. The ATTD of NSP rha was lower with XOS 
compared to without (P < 0.008; Figure 6.4H). 
6.4.6 Faecal NSP constituent sugar ratios 
Faecal ara : cell ratio was higher in the INU group compared to the FOS group, but no 
different from the CON (P < 0.029), whilst the ratio was higher with XOS compared to 
without XOS (P < 0.032; Table 6.6). Faecal ara : glu ratio was higher in the CON and 
INU groups compared to the FOS group (P < 0.035; Table 6.6), whilst the ratio tended to 
be higher with XOS compared to without XOS (P = 0.055). Faecal xyl : cell ratio (P < 
0.017) and xyl : glu (P < 0.029) was higher in the INU group compared to the FOS group, 
but no different from the CON (Table 6.6). A positive correlation was found between 
ATTD of cellulose and ara : cell content (P < 0.001), ara : glu content (P < 0.003), glu : 
cell content (P < 0.003) and ara :  xyl content (P < 0.001; Figure 6.5 A-C & E), whilst 







Table 6.5: Effect of XOS and fructans (FOS and INU) on ATTD of NSP constituent sugars and total NSP a. 
  Fructan 
SEM 
  XOSe     CON FOS INU CON FOS INU 
SEM 
  P value 
  CONb FOSc INUd   0 1 SEM   0 0 0 1 1 1   Fructan XOS 
Fructan × 
XOS 
ATTDf of NSPg (%)                                 
Arabinose 55.47a 60.14b 59.14b 1.250   57.44 59.07 1.020   52.49 59.72 60.10 58.45 60.56 58.19 1.767   0.029 0.265 0.089 
Fucose 79.17 82.98 72.13 4.146   81.81 74.37 3.385   82.29 86.27 76.88 76.05 79.68 67.37 5.864   0.184 0.127 0.954 
Galactose 82.81 83.93 82.71 1.127   83.25 83.04 0.920   82.51 83.58 83.67 83.10 84.28 81.76 1.594   0.699 0.872 0.653 
Galacturonic 
acid 
90.91 91.20 91.52 0.801   90.65 91.78 0.647   88.89 91.30 91.77 92.93 91.11 91.28 1.094   0.856 0.220 0.082 
Glucose 45.00 48.44 50.09 1.816   46.40 49.28 1.482   40.35 47.17 51.68 49.65 49.70 48.50 2.568   0.143 0.176 0.063 
Mannose 90.40 87.62 88.21 2.098   89.69 87.80 1.713   90.75 87.63 90.68 90.05 87.62 85.74 2.967   0.619 0.441 0.670 
Rhamnose 41.62 30.78 32.91 4.100   41.65a 28.56b 3.347   41.61 39.01 44.32 41.63 22.55 21.51 5.798   0.153 0.008 0.140 
Xylose 59.62 63.53 63.81 1.314   60.29a 64.36b 1.073   55.96 61.53 63.37 63.28 65.54 64.25 1.859   0.052 0.010 0.235 
Total NSP 60.14 63.28 63.11 1.214   61.26 63.09 0.991   57.07 62.55 64.15 63.21 64.01 62.06 1.717   0.134 0.198 0.067 
Cellulose 18.08 26.53 26.04 2.752   20.76 26.34 2.247   9.68a 28.68b 23.92b 26.48b 24.39b 28.16b 3.893   0.062 0.086 0.038 
a Data are means of 8 replicate samples per treatment. bCON; Control. cFOS; Fructo-oligosaccharides.d INU; Inulin. e XOS; Xylo-oligosaccharides, 0 = 
No XOS; 1= XOS. f ATTD; Apparent total tract digestibility. g NSP; Non-starch polysaccharide. a-c Means within a row that do not share a common 











Figure 6.4: Effect of xylo-oligosaccharides (XOS) and fructans (Fructo-oligosaccharides (FOS)) and (Inulin (INU)) on apparent total tract 
digestibility (ATTD) of NSP arabinose (ara; A; P = 0.089), glucose (glu; B; P = 0.063), total NSP (C; P = 0.067), cellulose (D; P < 0.038), 
galacturonic acid A (gal A; E; P = 0.082). Main effect of fructans and XOS on ATTD of xylose (xyl; F; P = 0.052; G; P < 0.010) and main effect 
of XOS on ATTD of rhamnose (rha; H; P < 0.05). 
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Table 6.6: Effect of XOS and fructans (FOS and INU) on faecal NSP constituent sugar ratios.  
  Fructan 
SEM 
  XOSe     CON FOS INU CON FOS INU 
SEM 
  P value 
  CONb FOSc INUd   0 1 SEM   0 0 0 1 1 1   Fructan XOS 
Fructan × 
XOS 
Faecal NSPf fraction ratios                                 
Ara : cell 0.61ab 0.59b 0.62a 0.008   0.60a 0.62b 0.007   0.59 0.58 0.62 0.63 0.60 0.62 0.011   0.029 0.032 0.138 
Ara : glu 0.56a 0.53b 0.56a 0.007   0.54 0.56 0.006   0.54 0.53 0.56 0.57 0.54 0.56 0.010   0.035 0.055 0.247 
Ara : xyl 0.77 0.76 0.77 0.008   0.76 0.77 0.007   0.75 0.77 0.76 0.78 0.76 0.77 0.012   0.924 0.253 0.195 
Glu : cell 1.10 1.11 1.11 0.004   1.10 1.11 0.003   1.09 1.11 1.11 1.10 1.10 1.11 0.006   0.196 0.599 0.490 
Xyl : cell 0.79ab 0.76b 0.81a 0.009  0.79 0.80 0.007  0.78 0.76 0.82 0.81 0.79 0.81 0.012  0.017 0.186 0.204 
Xyl : glu 0.72ab 0.70b 0.73a 0.008   0.71 0.72 0.007   0.71 0.69 0.74 0.73 0.72 0.73 0.012   0.029 0.208 0.211 
a Data are means of 8 replicate samples per treatment. bCON; Control. cFOS; Fructo-oligosaccharides.d INU; Inulin. e XOS; Xylo-oligosaccharides, 0 = 
No XOS; 1= XOS. f NSP; Non-starch polysaccharide. a-c Means within a row that do not share a common superscript are significantly different. 
 
 
Figure 6.5: Correlation between ATTD of cellulose (%) and faecal NSP arabinose : cellulose content (ara: cell; A; P < 0.001), ara : glucose 
(glu; B; P < 0.003) content, glu :  cell content (C; P < 0.003), xylose : cell (xyl; D; P  < 0.060) content and ara : xyl content (E; P < 0.001).  
B C D E A 
R2 = 0.31 R2 = 0.18 
R2 = 0.075 
R2 = 0.22 





6.5.1 Digesta pH and lactate concentration 
SCFAs including acetate, propionate and butyrate, are the main metabolites produced by 
bacterial fermentation in the GIT. Lactate is an intermediate metabolite which is rapidly 
converted to acetate, propionate and butyrate by intestinal bacteria. An increase in the 
production of SCFAs and lactate lowers the GIT pH which often increases nutrient 
digestibility by stimulating intestinal peristalsis and enzyme activity. A more acidic 
environment also affects the gut bacterial composition by preventing the growth of pH 
sensitive pathogenic bacteria like Enterobacteriaceae and Clostridiaceae. 
 
In the current study, as expected, higher ileal lactate concentrations lowered gut pH, 
whilst lower lactate concentrations increased pH. Lactate was likely the dominate SCFA 
present in the ileum and thus had a major role in determining pH. Supplementation of 
XOS reduced ileal pH compared to the CON and INU + XOS groups, and increased 
lactate concentration compared to the CON, INU + XOS and FOS groups. Hence, these 
results indicate that XOS fed piglets had a higher level of ileal fermentative activity than 
the CON, INU + XOS and FOS groups. This can be explained by an increased abundance 
of OTUs associated with lactate producing g__Lactobacillus in the ileum of XOS fed 
piglets (section 4.4.2.1). This indicates that XOS is a good fermentative substrate for 
Lactobacillus species and general stimulator of fermentative activity. Supporting this, in 
vitro growth experiments have shown XOS to grow on Lactobacillus species and produce 
lactate (Moura, P. et al., 2008; De Figueiredo et al., 2020), whilst in vivo work has also 
shown that XOS increased the abundance of Lactobacillus in the ileum, colon (Chen, Y. 
et al., 2021) and faeces (Liu, J. et al., 2018; Zhang et al., 2002) of weaned piglets. 




promoting properties are deemed beneficial in improving the health of the host (Gibson 
and Roberfroid, 1995). Moreover, an important underlying cross-feeding network exists 
which often explains the butyrogenic effect of certain dietary substrates and the beneficial 
effects obtained from increased butyrate concentrations in the GIT. Bacteria capable of 
fermenting oligosaccharides are often lactate producers, whilst bacteria capable of 
utilising lactate are often butyrate producers, hence although not measured, a higher 
concentration of lactate could lead to a higher level of beneficial butyrate production 
(Duncan et al., 2004).  
 
The benefit of XOS described above was lost in the presence of INU such that ileal digesta 
lactate concentration was reduced and pH increased to levels not dissimilar from the 
CON. This indicates that the combination of INU and XOS together counteracted each 
other and reduced fermentative activity. The reason for this effect is unknown and the 
16S rRNA data does not provide any further clarity. However, one possible reason could 
be that the combination of INU and XOS increased the transit rate of the digesta, leading 
to less time for bacterial fermentation and measured activity. Alternatively, as explained 
in section 4.5.1, XOS and INU could stimulate lactate-producing bacteria which 
somehow compete with each other when combined. There was no effect of treatment on 
colonic pH or lactate concentration, indicating the majority of fermentative activity of the 
supplemented prebiotics took place in the ileum, hence rejecting hypothesises 1 and 2. 
 
6.5.2 Ileal and faecal NSP content 
NSPs are polysaccharides containing β-linkages and they vary in their constituent sugar 
composition (Englyst, K. et al., 2007). Large amounts of soluble and insoluble NSPs are 




diets used in the current study were wheat based, hence the main NSP constituents in the 
diet were ara, xyl and glu. As expected, the NSP constituent sugar profile available in the 
ileal digesta and faeces reflected that of the diet, such that ara, xyl and glu were the main 
NSP components measured. Other carbohydrates like starch and alpha-galactosides are 
well digested in the small intestine, hence were not analysed in the faeces. Starch is the 
main storage carbohydrate in wheat making up 60-75 % of the grain, hence the presence 
of some starch in the ileum is expected despite the fact it is highly digestible simply due 
to its preponderance in the diet (Shevkani et al., 2017). Alpha galactosides, such as 
stachyose and raffinose are low molecular weight sugars that are commonly found in 
seeds, roots and tubers of many legumes like soya (Martínez-Villaluenga et al., 2008). 
The content of stachyose and total alpha-galactosides were very similar between dietary 
treatments, yet despite this, the content in the ileum was affected by dietary treatment, 
indicating a digestibility effect which will be discussed below.  
 
6.5.3 AID and ATTD of DM 
A positive correlation between DM digestibility and passage rate of digesta has been 
shown to exist in pigs, whereby the higher the DM digestibility, the slower the rate of 
total passage (longer retention time) (Kim, B. et al., 2007). This relationship is explained 
by increased time available for enzymatic digestion, intestinal absorption and bacterial 
fermentation leading to higher DM digestibility. In the current study, AID of DM tended 
to be higher for the CON group with XOS compared to without, whereas for the INU 
group, AID tended to be higher without XOS compared to with XOS. Although transit 
time was not measured in this study, if the same concept was applied it would indicate 
that supplementation of XOS tended to slow the rate of passage and increase AID of DM 




viscosity by hydrolysing xylan into low molecular weight XOS. As such, direct inclusion 
of XOS is not capable of creating a viscous digesta and therefore would not explain the 
potential slower rate of passage. It is therefore proposed that the presence of XOS in the 
ileum greatly increased fermentative activity which is supported with the observed higher 
abundances of Lactobacillus, a lower pH and higher lactate concentration. In turn, this 
high fermentative activity increased the presence of microbial fermentation products 
which caused the release of hormone peptides from the gut to activate the ileal brake 
mechanism which slowed the rate of passage, reduced feed intake and increased AID of 
DM. This concept is supported by the ADFI data described in section 4.5.1, whereby the 
intake of piglets in the last two weeks (day 14-27) before sample collection showed a 
similar but opposite interaction trend to AID of DM and fermentative activity. Similar 
reductions in ADFI have been seen when feeding albus lupins that are high in 
oligosaccharide content to pigs (Dunshea, F. et al., 2001; Moore et al., 2021). In 
comparison, the lower fermentative activity observed in the CON and INU + XOS group 
likely had an insignificant effect on the ileal brake mechanism, hence passage rate would 
have been relatively quicker than the XOS group, thus explaining the reduced AID of DM 
and higher ADFI.   
 
6.5.4 AID of NSPs  
The predominant site of fermentation is in the large intestine of monogastrics, but it is 
now recognised that fermentation can also occur within the stomach and small intestine, 
particularly the terminal ileum (Williams et al., 2017). Quantitively, the digestibility of 
NSP fractions at the terminal ileum were relatively low as expected, with the maximum 
AID of total NSPs reaching 16 %. Others have shown results not too dissimilar from the 




Lindberg, 2004), or weaner pigs (~15 kg) between 28 and 32 % (Yin, Y.-L. et al., 2001) 
and 19.4 and 28 % (Yin, Y. et al., 2001). The AID of fuc remained highly negative which 
was discussed in section 5.5.2. 
 
Supplementation of AXOS in broilers has previously been shown to have a stimulating 
effect on the dietary degrading capacity of the hindgut microbiota (Bautil et al., 2020). It 
is suggested that providing a highly fermentable substrate which is similar to the main 
dietary fibre source can train the metabolic activity of resident GIT microbiota to ferment 
dietary fibre. Bedford, M. and Apajalahti (2018) showed that feeding XYL to chickens 
increased the ability of the caecal bacteria to ferment xyl, XOS, AXOS and wheat bran, 
further suggesting a degree of bacterial modulation towards a greater fibre degrading 
capacity that would otherwise not occur. Moreover, adding an extra source of dietary fibre 
like β-glucans has also been shown to alter the fermentation and digestibility of 
alternative dietary fibres other than the main source, hence has an effect on overall fibre 
digestibility (de Vries et al., 2016). The current study supports this concept and hypothesis 
3, as addition of XOS to the CON and FOS group increased the AID of NSP xyl from the 
main dietary fibre constituent xylan (compared to in the absence of XOS). Furthermore, 
the addition of XOS to the FOS group increased the AID of NSP ara and total NSP, whilst 
addition of XOS to both the CON and FOS group increased the AID of NSP glu. 
Moreover, XOS increased the AID of total fructans to a numerically greater extent than 
FOS. Hence, XOS not only increased the AID of substrates similar to the main dietary 
fibre source but also other dietary fibre fractions. The reason for this is not clear but likely 
due to a broader stimulation of fibre-degrading bacteria in the GIT via cross-feeding and 
consequent upregulation of their fibre-degrading activity such as enzymes or membrane 




shown that XOS affects carbohydrate metabolism, cell motility, cellular processes and 
signalling, lipid metabolism and metabolism of amino acids, hence likely has a broad 
mode of action (Yin, J. et al., 2019). Interestingly the inclusion rate of XOS (0.10 g/kg of 
pure XOS) was much lower than that of FOS and INU (3.82 g/kg of pure FOS or INU), 
yet XOS had the largest and most consistent effect on increasing NSP digestibility. This 
suggests that only small amounts of XOS are required to stimulate the GIT bacteria 
towards an increased fibre-degrading capacity.  
 
In a study using growing pigs, diets containing high levels of NSP have been shown to 
increase the AID of total sugars, ara, xyl, total NSPs and dietary fibre compared to CON 
rations (Hogberg and Lindberg, 2004). The increase in AID was suggested to be due to 
adaptation of the gut microflora to high fibre diets, such that they increased the microbial 
activity in the distal small intestine. To this point, the AID results of the current study 
support the data obtained for the ileal fermentative activity and AID of DM. An increase 
in the abundance of g_Lactobacillus and lactate concentration in the ileum along with a 
reduction in pH indicates increased fermentative activity, which helps explain the 
increased AID of DM and NSPs for piglets receiving XOS.  
 
Analysing the bacterial community composition helps provide explanations for 
digestibility results in terms of identifying which bacteria were upregulated or 
downregulated by XOS. For example, Cho et al. (2020) showed that supplementation of 
a stimbiotic increased the abundance of specific fibre-degrading bacteria. Indeed, an 
increase in the abundance of g_Lactobacillus was observed in the current study which 
agrees with others (Chen, Y. et al., 2021), but the specific species was unknown. Previous 




et al., 2002; Moura, Patrícia et al., 2007), whilst the majority of other Lactobacillus 
species showed no growth on XOS (Crittenden et al., 2002). Despite this utilisation of 
XOS, various Lactobacillus species have been shown not to utilise β-glucans, xylan or 
AX (Crittenden et al., 2002), hence the increase in the abundance of g_Lactobacillus in 
the current study is unlikely to be the direct or single reason for the increase in AID of 
NSPs with XOS. Other bacterial changes with the XOS group included a decrease in 
g__Actinobacillus and g__Terrisporobacter from the CON (section 4.4.2.1), neither of 
which explains the current results. Hence, it is instead proposed that XOS could have had 
minimal effect on measurable fibre-degrading bacterial abundance, but could have still 
increased bacterial metabolic activity, for example fibre-degrading enzyme production, 
which led to increased AID of NSPs. Alternatively, the increased production of metabolic 
end-products like lactate in the ileum of XOS fed piglets were likely utilised by other 
species as their preferred source of energy (Smith et al., 2019). Hence, this could have 
created a cross-feeding network which ultimately increased overall NSP digestibility 
without observing direct and specific bacterial abundance effects.  
 
Addition of INU increased the AID of NSP glu to the same extent as XOS and FOS + 
XOS, but the combination of INU + XOS was significantly lower, hence these results did 
not support hypothesis 3. Similar increases of AID with INU were seen for other fibre 
fractions, though they were not significantly different from the CON or INU + XOS 
group. This highlights that the positive effects of XOS on the AID of NSPs were 
numerically confounded when combined with INU, once again agreeing with the reduced 
fermentative activity data and lower AID of DM in the INU + XOS group. As previously 
explained, this could be due to an increased transit rate of the digesta consequently leading 




NSPs to the 16S rRNA bacterial community data, there was a trend for an interaction 
between XOS and fructans on the abundance of ileal g__Prevotella 7. The abundance 
was similar with or without XOS in the CON and FOS group, but abundance tended to 
be higher with XOS compared to without XOS in the INU group (P = 0.087; Table 4.4). 
Similar numerical increases in the INU + XOS vs INU group were seen for g__Prevotella 
2, g__Prevotella 9 and g__Prevotellaceae_NK3B31_group but these were not significant 
or identified as a trend. Prevotella species are known to possess genes for fibre hydrolysis 
(Ivarsson et al., 2014), hence an increase in the AID of NSPs would be expected with an 
increased abundance in the INU + XOS group. However, this was not the case, and 
reductions in fermentative activity, AID of DM and AID of NSPs were seen with these 
elevated abundances. Interestingly certain species of Prevotella have been shown to 
produce extracellular viscous material that appears as meshwork-like structures under a 
microscope (Yamanaka et al., 2006). The viscous material has been shown to contain 
neutral sugars, uronic acids and amino acids, but with 83 % being composed of man. To 
this point, the AID of man in the XOS + INU group was indeed negative and significantly 
lower compared to all other treatment groups, indicating man was higher in the ileum 
compared to the feed and therefore produced in the ileum. This could indicate that the 
higher abundance of Prevotella species may have increased the amount of extracellular 
matrix produced by the bacteria, which in turn limited the interaction between digestive 
enzymes and dietary substrates. This could have therefore reduced fermentative activity 
and as such explained the lower AID of DM and NSPs. The reason as to why this may 
have only occurred when XOS + INU were combined over fed alone is unknown, but 
perhaps likely due to increased competition or a degree of bacterial community imbalance 
with an overload of fermentative substrate which allowed Prevotella species to thrive. 
Regardless, the combination of INU + XOS proved negative for NSP digestibility at the 




The AID of ‘other carbohydrates’ in the current study were relatively high, for example 
the average AID of starch was 96.6 %. This agrees with other studies whereby the AID 
of starch has been shown to be almost complete at 99.4 % in growing pigs. 
Supplementation of all prebiotics numerically increased the AID of stachyose, but only 
XOS and INU independently increased the AID of stachyose compared to the CON, with 
their combination showing numerically lower AID. This suggests that independently 
XOS and INU promoted the fermentation of stachyose, but their combination tended to 
be less effective, agreeing with the results for the AID of NSPs. Similar trends were also 
seen for raffinose, total alpha-galatcosides, total fructans and total carbohydrates 
excluding NSP. Again, the AID data followed similar interaction trends to the AID of 
NSPs and ileal fermentative activity results, however there were differences. For 
example, there was a clear negative effect of feeding FOS alone on the AID of NSP ara, 
glu, xyl and total NSPs compared to when FOS + XOS were fed together, and in the case 
of glu, also compared to the CON diet. In comparison, FOS tended to numerically 
increase the AID of raffinose, stachyose, total alpha-galactosides and fructans compared 
to the CON. This therefore indicates that FOS demoted the fermentation of NSP fractions 
in the ileum whilst it promoted the fermentation of ‘other carbohydrates’. The abundance 
of pathogenic g__E . coli tended to be higher in the FOS group compared to the FOS + 
XOS group (section 4.4.2.1) coupled with a main fructan effect for lower bacterial 
diveristy (section 4.4.2.3), likely suggesting a degree of dysbiosis. To this point the NSP 
fibre-degrading capacity of the bacterial community could have been compromised, 
coupled with a relative preference for simpler sugar structures. Moreover, the 
independent addition of FOS and INU tended to increase the AID of total fructans as 
expected, yet the largest increase from the CON group was with XOS. The combination 




and XOS reduced AID of fructans by almost half again indicating a negative effect when 
fed in combination.  
 
6.5.5 ATTD of NSPs 
Quantitively, the ATTD of NSP fractions were relatively high as expected, with the 
average ATTD of total NSPs reaching 62.2 % across treatments. Similar digestibility 
coefficients have been seen in the literature whereby the average ATTD of total NSPs in 
growing pigs has been reported at 59 % (Hogberg and Lindberg, 2004). The AID of NSPs 
described above were from the terminal ileum, hence the ATTD results represents any 
fermentation throughout the caecum, large intestine and faeces. The negative effects of 
combining INU + XOS on fermentative activity and AID of NSPs were no longer present 
at the end of the GIT. Interestingly, the addition of all individual prebiotics and their 
combination increased the ATTD of cellulose compared to the CON. Similar trends were 
seen for other fibre fractions like NSP ara, glu, total NSP and main effects for xyl. This 
is likely due to a stimbiotic effect whereby the prebiotics stimulated fibre-degrading 
bacteria and their metabolic activities. The bacterial communities in the faeces were not 
analysed in this study, hence only colonic data could be inferred to these results, albeit 
there were no clear bacterial abundance effects to explain these results. Supporting this, 
there was also no effect of treatment on colonic pH, colonic lactate concentration or 
colonic microbial endo-XYL production (section 4.4.3). Hence, taken together this 
suggests the stimbiotic effect on GIT bacteria to cause the increase in ATTD of NSPs 
likely occurred in the ileum and caecum. To this point, future studies investigating the 
stimbiotic mode of action of XOS should analyse the bacterial community compositions 




cellulase, arabinofuranosidase, β-glucanases and feruloyl esterase should be analysed in 
each GIT section to aid explanations of NSP digestibility results.  
 
Supplementation of XOS tended to increase the ATTD of gal A compared to the CON 
group, whilst the ATTD of rha was lower with XOS compared to without. This indicates 
that XOS selectively stimulated the utilisation of gal A whilst it reduced the utilisation of 
rha. Moreover, as described above, in the ileum FOS tended to demote the fermentation 
of NSP fractions whilst it promoted the fermentation of ‘other carbohydrates’. However, 
at the end of the GIT, this demotion effect was no longer present, and FOS tended to 
increase the ATTD of NSP fractions similar to the other prebiotics. Hogberg and Lindberg 
(2004) reported similar concepts whereby the pattern of fibre fraction digestion was 
different at the ileum compared to total tract and did not follow the same pattern with 
dietary treatment. For example, the AID of ara, xyl, total NSP and dietary fibre increased 
with high fibre diets compared to the CON diet, whereas the ATTD showed more 
extensive digestion in diets of low fibre compared to the CON diets.   
 
Despite these overall improvements in the ATTD of cellulose and NSP fractions, no 
beneficial effect on piglet growth performance was observed. This effect was not 
expected as an increase in fibre digestibility means greater amounts of energy were 
derived from the diet. It would be expected that this increased energy derivation would 
be utilised for extra lean tissue growth and thus improve host growth, however this was 
not observed. One possible explanation for this result is the reduced ADFI seen across 
the trial period in prebiotic supplemented pigs compared to the CON, meaning relatively 
less digestible DM would have been consumed. This feed intake effect likely outweighed 




ADFI to a greater extent than it improved NSP digestibility, consequently resulting in 
poorer performance. Moreover, the bacterial modulation effect of XOS was positive and 
the reduction in ADG was lessened in the second half of the trial. This suggests a longer 
feeding period was required for the benefits in NSP digestibility to surpass the ileal brake 
mechanism on ADFI.   
 
As previously discussed, the ATTD of cellulose and other NSP fractions were increased 
for all dietary treatments compared to the CON group, this therefore meant that relatively 
less cellulose and NSP substrate was present in the faeces of the prebiotic groups. The 
faecal NSP constituent sugar ratios therefore indicate the relative selective fermentation 
of the remaining fibre fraction substrates. The faecal ara : cell ratio was higher in the INU 
group compared to the FOS group, and higher with XOS compared to without XOS, 
indicating that cellulose was more selectively fermented relative to NSP ara with INU or 
XOS supplementation. This therefore suggests that the faecal bacterial community with 
INU or XOS had a higher capability or preference to ferment cellulose over NSP ara. To 
the author’s knowledge this effect has not been shown before. Similarly, the faecal ara : 
glu ratio was lower with FOS compared to the CON and INU groups, suggesting that the 
faecal bacterial community with FOS had a lower capability or preference to ferment NSP 
glu over ara. Moreover, the ara : glu ratio tended to be increased with XOS compared to 
without XOS indicating NSP glu was more selectively fermented relative to NSP ara with 
XOS. Finally, the xyl : cell and xyl : glu ratio were higher in the INU group compared to 
the FOS group, indicating that NSP cell and glu were more selectively fermented relative 
to NSP xyl with INU supplementation. Again, this therefore suggests that the faecal 
bacterial community with INU had a higher capability or preference to ferment NSP cell 




and XOS suggest their prebiotic effects remain throughout the GIT and are not isolated 
to just the ileum, coupled with a low preference for NSP ara relative to other NSP 
fractions.  
 
Furthermore, there was a positive correlation between ATTD of cellulose and faecal NSP 
constituent sugar ratios (ara : cell, ara : glu, glu : cell, and ara : xyl), and a trend for xyl : 
cell. For example, as the ATTD of cellulose increased, the faecal ara : glu ratio increased, 
hence as less cellulose substrate was present, more NSP glu was fermented compared to 
ara. In summary, the ATTD of cellulose and consequent remaining substrates available 
for fermentation affected the selective fermentation of different fibre fractions.  
 
6.5.6 Conclusion 
XOS increased ileal fermentative activity, the AID of DM and AID of NSP fractions, 
suggesting it is a suitable fermentative substrate for the bacteria inhabiting the small 
intestine and had a stimulatory effect on increasing the bacteria’s’ fibre-degrading 
capacity. However, these effects of XOS were lost when combined with INU indicating 
incompatibility of the products. At the end of the GIT both XOS and fructans, along with 
their combination, increased the ATTD of cellulose and NSP fractions, indicating 
beneficial effects on fibre digestibility with oligomer supplementation. Despite this 
improvement, supplementation of XOS with or without fructans had no beneficial effect 
on piglet growth performance. This was likely explained by reduced feed intake 




Chapter 7  
General discussion 
The main socio-economic factors that drive increased demand for food production are 
population growth, increasing urbanisation and rising incomes, with uncertainty 
surrounding the magnitude, nature and regional patterns of the first two factors (FAO, 
2009). Based on the projected growth of these socio-economic factors, it has been 
predicted that future global food demand can be met if certain conditions are addressed 
such as strong global economic growth, expansion of food supplies, food production 
growth in developing countries, global trade aiding low income countries and higher 
animal productivity (FAO, 2009). The latter factor relates to greater priority being given 
to agricultural research and development in order to achieve the yield and productivity 
gains required to feed the world in 2050 (FAO, 2009). Hence, improving the efficiency 
of animal production is of utmost importance to meet global food security challenges, yet 
this is only possible in healthy animals that are free of disease and able to express their 
maximum genetic potential. Improving animal health is therefore fundamental for 
sustainable meat production.  
 
Modulation of the GIT bacterial community via use of prebiotics to selectively promote 
the growth and activity of beneficial bacteria and inhibit pathogenic bacteria is one 
feeding concept to improve the health and growth of animals. New-generation prebiotics 
like XOS are gaining attention for monogastric nutrition, but most of the research has 
been conducted in chickens with little focus on pigs. This research therefore set out to 
determine the effects of XOS alone or in combination with alternative additives on pig 




mechanisms of XOS within the pig GIT. The main objectives of this research were set 
out in section 1.4.4.  
 
7.1 Objective 1 
As described in Chapter 2, provision of AXOS and XOS can be direct via the addition of 
commercially produced oligomers or via the supplementation of XYL and production of 
AXOS and XOS in situ. In broilers, both XYL and AXOS improved feed utilisation in 
broilers suggesting that the AXOS released in situ by the action of XYL contributed to 
the beneficial effects of feed supplemented XYLs (Courtin et al., 2008). AXOS increased 
the abundance of caecal Bifidobacterium, an effect which was not seen with XYL 
addition. This indicated that the mode of action of XYL and AXOS were not identical 
and suggests the XYL did not release much AXOS with the direct provision having a 
larger microbiota-modulating effect. Hence, a dual combination of XYL and XOS may 
synergise by having a greater stimulatory effect on the GIT bacterial community whilst 
also eliciting the traditional mechanisms of XYL such as viscosity reduction and 
increased nutrient digestibility (González-Ortiz et al., 2019). Hence, the first objective of 
this research was to determine the effects of XYL and XOS on grower pig performance 
and faecal bacterial community composition. In Chapter 2, results showed that XYL had 
no effect on grower pig performance, nor was there an interaction between XYL and 
XOS. Pigs supplemented with XOS were less efficient in the first week of the trial, whilst 
ADG was improved in the second week; but there were no performance effects in the 
overall trial period. Given the scarcity of research of XOS in pigs these results can only 
be compared to current literature available. The data from the current thesis agreed with 
a weaner pig study that showed no effect of XOS (Yin, J. et al., 2019), but was contrary 




addition (Chen, Y. et al., 2021; Liu, J. et al., 2018). Hence, the effect of XOS on pig 
growth performance is inconsistent. As described in Chapter 2, results of this trial and 
comparison with the literature suggest a higher concentration of pure XOS (≥ 0.10 g/kg) 
in younger weaned pigs may be necessary to observe performance benefits. An initial 
study investigating a dose response effect of XOS in different aged pigs would have been 
beneficial and is an important learning of this thesis. Despite a lack of performance 
benefits, supplementation of XYL or XOS, individually or in combination, increased the 
abundance of OTUs belonging to the Muribaculaceae and Prevotellaceae families. These 
bacteria are associated with carbohydrate metabolism, hence are likely involved in the 
mechanistic pathways of XYL and XOS and suggest the start of a bacterial modulation 
effect of the supplemented products. Future work needs to focus on the bacterial 
modulation effect of XOS along the entire GIT and not just the faeces as this only 
provides a limited view of the mechanism of XOS. This is an important learning of this 
thesis as Chapter 6 revealed the main effect of XOS was at the ileal level. 
 
7.2 Objective 2 & 3 
In Chapter 2, the abundance of lactate-utilising bacteria from the Veillonellaceae family 
were shown to increase in pig faecal matter over time; although not measured, this was 
likely explained by an increased level of lactate within the GIT. As described in Chapter 
3, lactate is a metabolic intermediate that is quickly utilised by bacteria in the GIT, thus 
it is seldom detected in the faeces of healthy subjects or at low concentrations (< 3 mM) 
(Hove et al., 1994). However, accumulation of faecal lactate indicates the inability of the 
GIT bacterial community to clear hyper-lactate concentrations and could therefore act as 
an indicator of bacterial imbalance and gut health status, albeit this is a new research area 




whether L-lactate could be detected in piglet faeces over the stressful weaning period and 
whether concentrations changed with age as the bacterial community developed and 
became more established (Chapter 3). Results showed that L-lactate concentrations were 
low or below the minimum detectable range of the assay (< 0.02 mM) in piglet faeces, 
with only 20 % of samples having detectable concentrations, the majority of which were 
immediately post-weaning. The relative absence of L-lactate in the faeces may have been 
due to it being metabolised by faecal bacteria before analysis. Hence, the third objective 
of this research was to determine how quickly a known concentration of L-lactate would 
be metabolised by pig faecal bacteria, and whether this differed between sample 
collection solutions, sample fractions (whole or supernatant) or analytical methods 
(Chapter 3). A large learning from this experiment was that the assay incorrectly 
measured lower baseline measurements of the spiked L-lactate concentration (~ 5 mM at 
0 min), indicating the specific assay used in this study was not a suitable method of L-
lactate analysis in pig faeces. The reason for this is unknown, but it is proposed that 
elements within the faecal matrix may have interfered with the assay since a blank spiked 
sample without faecal matter correctly measured the spiked concentration. Hence, the 
failure of the assay to correctly measure the spiked L-lactate concentration casts doubt 
over the results reported for the secondary objective; it is therefore suggested that the 
secondary objective is repeated in more depth with future work. The suitability of a real-
time L-lactate detection method was investigated with a handheld SCT device which is 
commonly used by human athletes to measure blood L-lactate (Goodwin et al., 2007). To 
the authors knowledge, the SCT device has not previously been tested on faecal matter. 
If successful, this novel approach would allow for on-site real-time detection of L-lactate 
in biological samples. Results showed that the handheld L-lactate SCT device correctly 
measured the spiked L-lactate concentration at baseline measurements, proving the 




samples decreased to ~0.60 mM after 360 min when measured by the SCT device, 
indicating rapid L-lactate metabolisation by pig faecal bacteria as expected. Similar 
results have been seen in the literature whereby 20 mM of lactate was fully metabolised 
within 6 hours by pig caecal bacteria (Ushida and Hoshi, 2002). However, when bacteria 
were separated via centrifugation prior to L-lactate addition, the concentration remained 
stable over time proving that L-lactate was not metabolised which was likely due to 
separation of lactate-utilising bacteria. Chapter 3 concluded that the SCT device was a 
suitable real-time method for measuring L-lactate concentrations. L-lactate metabolism 
was rapid and therefore faecal collection and processing must be rapid. This data has not 
been shown in the literature before and is a novel method of on-farm L-lactate analysis, 
but as described in section 3.5.1, further research and validation are required to identify 
the potential of faecal L-lactate concentration as a non-invasive marker of gut health. In 
particular, the normal range of L-lactate concentration in pig faecal matter at different 
ages, in healthy and diseased individuals is important. Furthermore, there is also great 
potential for the handheld SCT device to provide further insight into the fermentative 
activity of bacteria from different GIT sections and provides a useful real-time method 
for L-lactate analysis during dissections. Hence, this is a new, insightful and rapid tool to 
use in future animal studies.   
 
7.3 Objective 4 
Digestibility studies are an important method of evaluating the nutritive value of feed 
materials or additives in monogastric nutrition. As described in section 5.2, the gold 
standard traditional total collection method is time consuming and laborious compared to 
the commonly used inert marker method. However, the accuracy of the marker technique 




nutrients to facilitate calculation of accurate and precise digestibility values. Numerous 
studies have shown negative or unexpectedly high digestibility values for fibre fractions 
using Cr2O3 (Jamroz et al., 2002; Brenes et al., 2003) or TiO2 (Bautil et al., 2019) with 
the overall concluding reason being due to separation of the indigestible marker and 
digesta. This highlights that the marker method can yield erroneous results, especially in 
high fibre diets, ultimately leading to mis-estimation and confounded digestibility results. 
Therefore, the fourth objective of this research was to evaluate TiO2 and intrinsic 
cellulose as inert markers for AID and ATTD of NSPs in piglets. Results of Chapter 5, 
indeed supported the literature in that highly negative AID of NSPs were found when 
using TiO2 as an inert marker, indicating separation of the marker and NSP fraction. In 
contrast, using cellulose as an inert marker yielded more realistic, less negative and less 
variable AID of NSP. At the faecal level, positive and more similar ATTD of NSPs were 
observed between the markers compared to AID, yet no positive correlation was seen 
between the ATTD of the NSP fractions determined using the different markers. The lack 
of a positive correlation between the markers proves that the TiO2 and cellulose were not 
working in tandem. The lack of a positive correlation can be explained by post-ileal 
cellulose degradation causing the average ATTD for total NSPs, obtained using cellulose 
as a marker, to be 15.1 % lower compared to when using TiO2 as a marker. Hence, Chapter 
5 concluded that TiO2 is an unsuitable inert marker for AID of NSPs, with cellulose 
yielding more realistic initial results. Whilst, TiO2 should be used for ATTD of NSPs, as 
post-ileal cellulose degradation rendered the use of cellulose as an inert marker infeasible. 
These learnings were applied in Chapter 6. Homogenous distribution and transit rates of 
inert markers within GIT digesta are fundamental for accurate and correct digestibility 
estimates, but this data proves that this criterion cannot be met when analysing fibre 
fractions. This work therefore demonstrates the need for a re-evaluation of current and 




chapter provides the baseline knowledge in this complex area; however, a more in-depth 
series of studies are required to address this knowledge gap. Key to this future work is 
the comparison and validation of well-known markers like Cr2O3 and potential alternative 
intrinsic markers like AIA or lignin against the gold standard method of total collection 
for different fibre fractions along the entire GIT. Nutritive fibre is a vast topic area and 
advancing the methodologies to accurately measure its degradation within monogastric 
animals will advance this field greatly and ensure mis-estimation does not occur in future 
work. 
 
7.4 Objective 5 
Chapter 2 concluded that 0.07 g/kg of pure XOS may not have been enough to elicit 
performance benefits in 7-week old pigs, and that younger piglets may have responded 
better to XOS supplementation. Hence, a higher inclusion of pure XOS (0.10 g/kg) and 
younger piglets (4-weeks of age) were used in Chapter 4 and Chapter 6. 
 
The mechanism of XOS in the GIT is multi-factorial and is not yet completely understood. 
As described in Chapter 6, the amount of XOS required to elicit measurable bacterial 
modulation effects and performance improvements is relatively low compared to 
conventional prebiotics like FOS and INU. An alternative hypothesis for the mechanism 
of XOS has therefore been proposed, whereby XOS acts as a signal to encourage fibre-
degrading bacteria to increase in activity, ferment fibre more efficiently and interact with 
the GIT in such a way that improves overall efficiency of digestion and growth. 
Moreover, the combination of different prebiotic substrates should theoretically broaden 
the number of different GIT bacteria that are stimulated, leading to a wider range of 




prebiotics work in synergy. Hence, the fifth objective of this research was to determine 
the effect of XOS with or without fructans on piglet performance and various GIT 
functions, including bacterial community composition, microbial endo-XYL activity, 
fermentation activity and NSP digestibility (Chapter 4 and Chapter 6). The fermentative 
activity was assessed by measuring digesta pH and L-lactate concentration using the SCT 
device from Chapter 3. 
 
Overall, supplementation of XOS with or without short and long-chain fructans had no 
beneficial effect on piglet growth performance, likely because of the large reduction in 
ADFI. The ADG of XOS fed piglets was reduced in the first 2 weeks of the trial compared 
to the CON, but to a much lesser extent in the last 2 weeks of the trial, suggesting piglets 
adjusted to XOS with age and a longer feeding period may have been required to observe 
performance benefits. Regarding piglet ADFI, an interaction between XOS and fructans 
existed, whereby XOS, FOS and INU reduced ADFI compared to the CON, whilst XOS 
+ FOS and XOS + INU had intermediate ADFI levels. This feed intake effect was 
proposed to be due to the ileal brake mechanism. As described in Chapter 4, this concept 
is based upon partially digested nutrients and their microbial fermentation products 
stimulating the release of hormone peptides from the GIT epithelium. This effect slows 
gastric emptying, gastric acid production and the intensity of peristaltic contractions, all 
of which reduce feed intake (Dunshea, F.R. et al., 2018). Supporting this theory, as 
reported in Chapter 6, the fermentative activity in the ileal digesta of XOS fed piglets was 
indeed increased (lower pH and higher lactate concentration) which would explain the 
commencement of the ileal brake mechanism and reduction in ADFI. Moreover, Chapter 
4 showed that bacterial community structure differed with prebiotic supplementation in 




bacteria inhabiting the distal small intestine compared to the large intestine. This was an 
unexpected finding as initially it was hypothesised that XOS and long-chain INU would 
mainly be fermented in the large intestine given the slower rate of fermentation 
(Smiricky-Tjardes et al., 2003a) or longer chain length (Paßlack et al., 2012). Moreover, 
addition of XOS to diets stimulated beneficial Lactobacillus in the ileum, hence despite 
the lack of performance benefits observed, the bacterial modulation effect of XOS was 
positive and a longer feeding period was likely required for these bacterial benefits to 
reflect in increased growth performance.  
 
Regarding NSP digestibility, the learnings from Chapter 5 were applied, whereby 
cellulose was used as an inert marker for AID of NSPs, whilst TiO2 was used as an inert 
marker for ATTD of NSPs. XOS and XOS + FOS increased the AID of DM and NSP 
fractions suggesting that XOS had a stimulatory effect on increasing the bacteria’s’ fibre-
degrading capacity. Moreover, the independent addition of FOS and INU tended to 
increase the AID of total fructans as expected, but the largest increase from the CON 
group was with XOS. This highlights that XOS is capable of improving the AID of fibre 
fractions different from its own structure and composition above and beyond that of 
substrates with similar structure. To the authors knowledge, this effect has not been shown 
in the literature before. There was no clear effect on bacterial community composition to 
explain these results at the ileal level. It was therefore proposed that XOS likely had 
minimal effect on measurable fibre-degrading bacterial abundance, but could have still 
increased bacterial metabolic activity, for example fibre-degrading enzyme production, 
which led to increased AID of NSPs. Moreover, an interesting but unexpected observation 
across the performance, fermentative activity and AID data was that the effect of XOS 




To the authors knowledge, this effect has not been shown in the literature before and the 
reason for this interaction is unclear. However, possible explanations could include an 
increased transit rate when the products were combined leading to less time for bacterial 
fermentation of NSP fractions or it could be associated with an increase in Prevotella 
species as described in section 6.5.4. The fact that INU increased the AID of NSPs to 
similar levels as XOS also suggests the substrates stimulated certain ileal bacteria when 
fed alone, which somehow negatively competed when combined.  
 
At the faecal level, the negative effects of combining INU + XOS on fermentative activity 
and AID of NSPs were no longer present at the end of the GIT, suggesting this negative 
competition and effect on NSP digestibility was mainly driven at the ileal level. Both 
XOS and fructans, as well as their combination, increased the ATTD of cellulose and 
NSP fractions compared to the CON. Albeit, there was no benefit of combining the 
prebiotics together over and above feeding them independently, leading to the conclusion 
that feeding multiple prebiotics is not required. The increase in fibre digestibility suggests 
a greater energy provision from the dietary fibre fractions ingested that the host would 
not have received without oligomer supplementation. Despite this improvement in 
digestibility, no beneficial effect on piglet growth performance was observed. The 
individual ADFI of dissected piglets was not measured as the piglets were housed in 
groups of 5. However, the reduced ADFI seen across the trial period would have meant 
relatively less digestible DM was consumed. This intake effect likely outweighed the 
benefits seen in NSP digestibility. Hence, the ileal brake mechanism reduced ADFI to a 
greater extent than it improved NSP digestibility, consequently resulting in poorer 
performance. Given that the bacterial modulation effect of XOS was positive and the 




period was required for the benefits in NSP digestibility to surpass the ileal brake 
mechanism on ADFI. Moreover, with the negative performance effect lessened in the 
second half of the trial coupled with the positive effects of XOS on NSP digestibility at 
the end of the trial suggests there may be an optimal time to introduce XOS post-weaning. 
New to the literature, the effect of XOS in this study was mainly observed at the ileal 
level at the end of trial. Perhaps feeding XOS immediately after weaning overloaded the 
ileal bacteria with fermentable substrate that could not be utilised at that point in time and 
instead primed the caecal and colonic bacteria. Then, as the pig aged, the ileal bacterial 
community developed and were able to utilise XOS more efficiently, hence essentially 
starved the caecal and colonic bacteria from XOS. It could therefore be a combination of 
overloading the ileum with fermentable substrate immediately after weaning with a 
subsequent starving effect on the caecal and colonic bacteria as the pig aged that caused 
this performance drop in the first 2 weeks. Hence, further work on the optimal timing of 
XOS introduction is required. 
 
Chapter 6 provided insights into the mechanism of XOS within the GIT of piglets, 
however further work is required to expand on this knowledge. Firstly, the complex 
interaction between fermentation and transit time upon addition of prebiotic substrates 
warrants further research. Combined with this, the effect of XOS on bacterial 
fermentative activity and consequent regulation of appetite via GIT hormone mechanisms 
is important. Likewise, identifying the main bacteria responsible for increased 
fermentation of specific substrates is key in furthering knowledge on targeted bacterial 
modulation effects. As described in Chapter 6, one important learning from this thesis 
was that bacterial abundance changes may not show significant changes but 




bacterial activity as well as abundance. All of these factors are closely intertwined, hence 
focusing on one individual aspect can lead to extrapolation and mis-interpretation of 
results. It is therefore recommended that in future similar studies a minimum of bacterial 
abundance and activity along the GIT, fermentative activity and GIT hormone 
concentrations are measured to provide sufficient information to help explain results. 
 
7.5 Conclusions 
This research set out to determine the effects of XOS alone or in combination with 
alternative additives on pig performance, and with a view of providing more clarification 
on the underlying mechanisms of XOS within the pig GIT. From this work it can be 
concluded that XOS has an inconsistent effect on pig growth performance and there was 
no benefit of combining different prebiotic substrates. Compared to the literature, the lack 
of performance benefits seen in this thesis stem from not enough XOS inclusion, age of 
pig and duration of the feeding period. It is clear from the literature and this thesis that a 
minimum inclusion of pure XOS for piglets should be 0.10 g/kg and supplementation 
from a young age after weaning increases the likelihood of observing performance effects. 
It is suggested that introduction of prebiotic substrates like XOS from a young age is 
required to prime the GIT bacterial community and the feeding period needs to be longer 
than 4 weeks to provide sufficient time for performance benefits to be observed. 
Furthermore, this work has shown a clear effect of XOS and other prebiotic substrates on 
ADFI, likely due to the ileal brake mechanism. Coupled with this, XOS increased ileal 
fermentative activity, positively altered the ileal bacterial community and increased the 
AID of DM and NSPs, indicating XOS increased the fibre degrading capacity of the ileal 
bacteria despite its low inclusion rate. Whilst at the faecal level, all prebiotic substrates 




effect of XOS observed in the ileum was met by other prebiotic substrates at the faecal 
level. Despite these beneficial effects on fibre digestibility and energy provision, they did 
not translate into growth performance benefits. This was likely due to a complex 
relationship between the ileal brake effect outweighing the positive effect of NSP 
digestibility, with a longer feeding period required. In summary, based on the findings of 
the current work and those of others, it is clear that there are considerable opportunities 
to improve the health and performance of pigs through prebiotic supplementation. 
However, the optimal inclusion rate, age of introduction and feeding period in piglets 
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A.1 General ethics statement  
The University of Leeds Animal Welfare and Ethical Review Body approved all 
experimental protocols prior to their commencement. As set out in the Directive 
2010/63/EU, the principles of the ‘3Rs’of replacement, reduction and refinement were 
applied throughout all experimental designs. Pig husbandry practices and housing were 
compliant with the Council Directive 2008/120/EC standards and the Welfare of Farmed 
Animals (England) Regulations 2007. Moreover, all scientific procedures carried out 
during the experiments were compliant with the Animals (Scientific Procedures) Act 
1986, as revised by the Directive 2010/63/EU. 
 
A.2 Standard Spen farm practice 
All animal experiments were conducted on the indoor pig production system at the 
University of Leeds farm, Spen Farm, Leeds, UK. All experiments used crossbred pigs 
that were sourced directly from Spen Farm’s breeding herd. All pigs used throughout this 
research were treated according to standard Spen Farm practice before and after the 
experiments. Spen Farm is a 200-sow herd that operates on an indoor 3-week batch 
farrowing system. Progeny pigs were reared on site from birth to slaughter. After 
farrowing, sows remained in their farrowing crates with their litter for approximately 4 
weeks. During this time, piglets suckled on the sow but also had access to a standard 
commercial creep feed and water. Within the first 24 hours of birth, all piglets had their 
teeth clipped, tails docked, and ears tagged. Piglets were weaned from their mother at 
approximately 4 weeks of age and sows were returned to the main herd before being 




Circo + MH RTU for the prevention of Porcine Circovirus and the bacteria Mycoplasma 
hyopneumoniae which causes enzootic pneumonia. After vaccination, piglets from 
different litters were mixed according to size into pens (155 × 129 cm) in a conventional 
fully slatted weaner-grower facility. Each pen had 2 nipple drinkers and 1 multi-space 
feeding trough for the first 3 weeks (from 4–7 weeks of age) where a standard commercial 
piglet diet was fed. Following this, a standard grower diet was fed in a single-spaced 
feeding trough for the remaining 5 weeks (from 7–12 weeks of age) until exit from the 
building. After 8 weeks in the weaner-grower facility, pigs were moved into finisher 
accommodation where they remained until they were sent to the abattoir for slaughter at 
~110 kg. Individual pig weights were recorded weekly to determine average pig 
performance. Dependant on BW, pigs were either lifted and placed into a weighing cage 
on a stationery trolley or walked out of their pen into a corridor floor weigher.  
 
Throughout the experiments, all pigs had ad libitum access to feed and water. Feed 
troughs were topped up with a known quantity of feed when required and all feed data 
was recorded. Diets were formulated with the assistance of Associated British Nutrition 
(ABN, Peterborough, UK), a leading British pig feed manufacturer in the UK and industry 
sponsor of this research. Details of dietary specifications are provided in the relevant 
chapters. All feed additives were incorporated into the pelleted diets at the time of feed 
manufacture. Representative samples of all experimental diets were collected weekly 
from a mixture of feed bags on farm and stored at –20ºC prior to analyses.  
 
 
 
